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9General Introduction and outline
Introduction
Stroke (or cerebrovascular accident) is a leading cause of death and an important 
cause of persistent disability around the world.1 In the Netherlands, stroke affects 
around 46.000 persons each year.2 Survivors are either diagnosed with ischemic 
stroke (due to lack of blood flow) or haemorrhagic stroke (due to bleeding). 
As the global population older than 65 years of age continues to increase by 
approximately nine million people per year3 and stroke incidence is associated 
with ageing, its prevalence is expected to increase significantly around the 
world. Next to that, the percentage of stroke survivors will most likely increase 
due to improved healthcare facilities for patients in the acute phase of stroke. 
Therefore, in the future, stroke survivors may form an increasing demand on 
rehabilitation services. Generally, stroke puts a high burden on both patients and 
their caregivers as well as a considerable financial burden on society. Currently, 
approximately 3–4 % of total healthcare expenditures in Western countries are 
spent on stroke.4 Even greater healthcare expenditures are likely in the near future 
with the expected growth of the elderly population and the availability of new 
and better treatments for stroke patients. As healthcare resources are limited, 
interest in the economic aspects of stroke and stroke-specific interventions has 
increased in the past few years.
Functional consequences of stroke
Stroke may be accompanied by functional consequences in many different 
domains. One year after stroke, 35% of stroke survivors are still functionally 
dependent5 and around 70% of them experience considerable long-term 
sensorimotor, cognitive and/or behavioural impairments and emotional 
consequences. Sensorimotor impairments entail deficits such as paresis (muscle 
weakness), spasticity (increased muscle tone), loss of sensibility, pain and visual 
field deficits. Important cognitive impairments are slow information processing, 
attention deficits, memory loss, visuospatial deficits, language impairments, 
and executive problems impairing planning, learning and decision making. 
Behavioural impairments after stroke can be present, such as, for instance, 
irritability, lack of impulse control, and apathy. The aforementioned impairments 
often limit pre-stroke daily routines and activities and may restrict social 
participation and quality of life.5–8 Stroke often causes a high burden of disease 
not only on patients, but also on partners and family members. Partners of stroke 
survivors are often forced to adopt a caregiver role, which changes the pre-
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stroke relationship dramatically.9 Cognitive , behavioral and emotional sequelae 
of stroke negatively influence caregivers’ well-being.10,11 In addition, providing 
care at home for the stroke patient requires substantial effort,12 which brings 
about considerable change to the caregiver’s life and own health condition. 
Emotional problems after stroke
In addition to the sensorimotor, cognitive and behavioural impairments, stroke 
may lead to significant emotional problems such as depressed mood and anxiety. 
At least one third of all stroke survivors deal with such emotional complaints 
during the first year after stroke.13 Indeed, in the chronic phase, usually defined as 
> 6 months, post stroke, the most frequent emotional symptoms are depressive 
symptoms (23-25%) and anxiety (19-23%).13–16 Both have a negative influence on 
quality of life.17,18 The definition of ‘post-stroke depression’ has been subject of 
considerable debate. Also, it seems that there is no consensus in the literature 
on how to measure ‘depressed mood’, ‘depression’, depressive symptoms’ or 
‘emotional complaints’ after stroke. Clinically, post-stroke depression is usually 
diagnosed by a psychologist or psychiatrist using the DSM-V.19 However, in 
research, post-stroke depression is rarely assessed by a psychologist or psychiatrist 
based on DSM-V criteria.20–22 Instead, in scientific studies, depressive symptoms 
are customarily assessed by means of questionnaires such as the Beck Depression 
Inventory (BDI) or Hospital Anxiety and Depression Scale (HADS). These 
questionnaires offer no strict diagnosis of ‘depression’ post-stroke.23 Therefore, 
some researchers have proposed that ‘post-stroke depression’ assessed with BDI 
or HADS should be referred to as ‘mood disorder as a specific complication 
of stroke’,24 ‘post-stroke mood disorder’,25 or ‘post-stroke depressive complaints’ 
or ‘depressive symptoms’.26 Others have even argued that depressed mood 
after stroke is mainly a matter of ‘psychological distress’.27 The vast amount of 
research on this topic, however, implies that many stroke patients do experience 
measureable mood problems that require clinical attention and treatment. In this 
thesis, we will adopt this latter position and use the term ‘post-stroke depressive 
symptoms’ for patients with a score of >7 on the HADS-depression subscale. 
Likewise, ‘post-stroke symptoms of anxiety’ will be used for patients with a score 
>7 on the HADS-anxiety subscale. 
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Pathophysiology of post-stroke depressive symptoms
A possible ‘endogenous’ cause of post-stroke depressive symptoms has received 
much attention in the scientific literature, but so far there is no consensus on 
what neuroanatomical, neurophysiological or neurochemical brain substrates 
mood disorders post stroke are attributable to.28–30 In contrast, many researchers 
have argued that the relationship between stroke and post-stroke mood disorders 
is mediated by the significance that individual patients attribute to the causes 
and functional consequences of stroke, irrespective of the type, extent, and 
location of the stroke.31–34 From a psychological perspective, it is not surprising 
that emotional problems such as depressed mood and anxiety are common 
after stroke. Stroke generally occurs without any warning and patients and their 
families are unprepared in facing a new situation that drastically changes their 
independence, life circumstances, hopes, and plans for the future. Nevertheless, 
in the subacute phase (i.e., the first 6 months post stroke), rehabilitation of 
sensorimotor and cognitive impairments requires much effort and reactive 
depressive symptoms or complaints may remain unnoticed. Once this phase is 
over and patients have returned home, the intensity of rehabilitation decreases 
and patients and their families need to pick up their lives again. In this phase, 
social participation may still be severely restricted due to physical and cognitive 
impairments, chronic fatigue, and other health issues (e.g. pain, disturbed sleep) 
that are often invisible to and poorly understood by the outside world. As a 
consequence, patients may become discouraged, which further restricts their 
participation and initiative20 and eventually leads to a vicious circle. Indeed, due 
to functional limitations, stroke survivors experience reduced independence and 
are less able to participate in activities that used to be pleasurable or meaningful 
(e.g., gardening, assisting in preparing a meal; reading; babysitting (grand) 
children).8,35 Particularly in this phase, latent mood problems may be unmasked. 
Moreover, with increasing age and associated health problems, stroke survivors 
are more likely to encounter stressful life events such as increased fall risk (due 
to poor balance, limb paresis, spasticity or visual deficits), bereavement (due to 
death or disease of close relatives) and social disruption (e.g. change of housing).35 
Both participation restrictions and stressful life events are risk factors for mood 
problems after stroke. Inadequate adjustment to these changes may easily lead 
to depressive symptoms as well as symptoms of anxiety. This notion is in line 
with behavioural theories that suggest that depressed mood is caused by lack 
of positive reinforcement when individuals are no longer able to participate in 
activities that were once meaningful or pleasurable.36 From this psychological 
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perspective, mood problems after stroke are ‘reactive’ in nature, as they result 
from inadequate adjustment to the (functional) consequences of stroke. 
Psychological treatment of post-stroke depressive symptoms
Besides having a major impact on the quality of life,16 post-stroke depressive 
symptoms impede functional recovery and rehabilitation due to feelings 
of hopelessness and apathy,37 which leads to increased hospitalization and 
healthcare costs.38 Therefore, is important to recognize and treat mood problems 
as early as possible after stroke. Unfortunately, both during primary rehabilitation 
and thereafter, symptoms of depression and anxiety are easily missed due to a 
focus on physical and cognitive impairments. If patients do get treatment for 
post stroke mood disorders, they are commonly treated with pharmacological 
agents. However, the benefits of pharmacotherapy are debatable,39 which is 
not surprising given the often ‘reactive’ nature of both depressive symptoms 
and anxiety. Considering that these emotional symptoms (e.g., depressive and 
anxiety symptoms) are the result of an inadequate adjustment to the (functional) 
consequences of stroke, one would assume that psychological interventions 
are a better approach to treatment. Yet, psychological interventions are used 
less frequently, mainly because their effects remain unclear.40–42 Nevertheless, 
psychological interventions seem promising in terms of (cost-)effectiveness, 
because they result in fewer side effects than psychotropic medication and have 
a stronger effect on preventing relapse of symptoms than pharmacotherapy.43–45 
Within the broad field of psychotherapy, cognitive behavioural therapy (CBT) 
seems one of the most promising methods to address symptoms of depression 
and anxiety post stroke. The core assumption in CBT is that thoughts – rather 
than external factors such as people, situations, or events – drive feelings and 
behaviours. If one can change the way one thinks, this can improve one’s 
feelings and actions, even if the situation itself remains unchanged. An important 
advantage of CBT over pharmacotherapy is that it is potentially more effective at 
preventing the relapse of emotional symptoms, as it aims to structurally change 
irrational cognitions and negative thoughts.33  
Thus far, only one study investigated the effectiveness of CBT for ‘post-stroke 
depression’. Lincoln and colleagues applied a treatment protocol in which 
elements of CBT, such as identifying and challenging negative thoughts as well as 
planning of joyful activities, were discussed with patients. However, they found 
inconclusive results with respect to the effectiveness of their intervention.46 CBT 
requires effort during treatment sessions and comes with a substantial amount 
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of homework. Yet, stroke survivors often suffer from impaired cognition, which 
Lincoln and colleagues (2003) did not take into account in their treatment protocol. 
In addition, as mentioned earlier, social participation and undertaking meaningful 
and pleasurable activities play an important role in well-being.36 However, next 
to discussing ‘activation’ with their patients, no further steps (such as stimulating 
an active life style or giving practical suggestions and encouragements directed 
at joyful activities) were taken by Lincoln and colleagues.46 In this perspective, 
the ambiguous results found by Lincoln and colleagues are not surprising. 
Augmented cognitive behavioural therapy for depressive symptoms post stroke
The scientific literature shows inconsistent results with regard to the effectiveness 
of psychological treatment programs for post-stroke depressive symptoms, but 
there is a strong feeling that implementation of CBT should take into account 
cognitive impairments (e.g. attention and memory deficits) as well as emotional 
barriers (e.g. lack of motivation, grief, anxiety) and self-awareness.47 To stimulate 
the generalization of treatment results, the use of behavioural exercises that 
have to be performed in daily life situations is recommended.33 Despite a lack 
of evidence, there is sufficient reason to believe that CBT offered by a trained 
psychologist can be effective when adapted and tailored to the specific needs of 
stroke survivors, as discussed above.33 Indeed, in a review by Broomfield,33 it was 
suggested that CBT protocols for depressive symptoms in patients post stroke 
need ‘augmentation’ and an ‘individualized approach’. Moreover treatment 
protocols should encompass motivational interviewing and grief resolution, be 
directed at meaningful goals, and integrate executive skills training.33 
At the start of the present research project a CBT protocol for post-stroke 
depressive symptoms had been evaluated in a pilot study with promising effects 
on patients’ mood.48 This preliminary treatment protocol was evaluated and 
adjusted where necessary and formed the basis for a new (‘augmented’) CBT 
protocol. The essence of the applied ‘augmentation’ is that the CBT is built around 
attainable functional goals, while goal attainment is supported by occupational or 
movement therapy. Hence, an occupational or movement therapist complements 
the psychologist and assists the patient in setting and achieving his/her individual 
goals. In addition, attention is given to concomitant symptoms of anxiety by 
implementing the training of specific relaxation techniques. 
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Aim of this thesis
This thesis aims to describe and evaluate a new, augmented CBT protocol for 
the treatment of post-stroke depressive symptoms, with or without symptoms 
of anxiety, in comparison to a (presumably ineffective) control treatment (i.e., 
computerized cognitive training). To determine differences in treatment effect, 
the effects on both patients and their caregivers will be evaluated. In addition, 
the effects will be evaluated from an economical perspective. In the present 
thesis, the following research questions will be addressed:
 
1. Are psychological determinants important risk factors for post-stroke 
depressive symptoms? 
2. What components should be part of an augmented CBT protocol for 
depressive symptoms, taking into account the physical, cognitive and 
emotional sequelae of stroke? 
3. Is such an augmented CBT effective in reducing depressive symptoms and 
improve social participation and quality of life of patients in the chronic 
phase after stroke? 
4. Is such an augmented CBT also beneficial with respect to the perceived 
burden by caregivers? 
5. Is such an augmented CBT for patients with depressive symptoms post 
stroke effective from an economical perspective? 
Thesis outline
In chapter two, the first research question is addressed. A longitudinal cohort 
study (based on The Restore4Stroke cohort study, see further) provides data to 
determine the importance of psychological risk factors for developing depressive 
symptoms and symptoms of anxiety one year after stroke. We hypothesized that 
psychological factors may be important in addition to previously established 
socio-demographic, premorbid, and stroke-related risk factors. If an important 
role for psychological factors can be demonstrated, this would support the role 
of psychological treatment in preventing and treating post-stroke symptoms of 
depression and anxiety.
Chapter three addresses the second research question and presents a new, 
augmented CBT protocol for post-stroke depressive symptoms. In this chapter, 
we describe the theoretical background of the treatment protocol, followed by 
the content of the intervention, and a comprehensive discussion. 
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Chapters four, five, six and seven address the third, fourth and fifth research 
questions. They present the methods and results of the RCT in which the augmented 
CBT protocol is compared to computerized cognitive training. Chapter four 
describes the research protocol in detail. It was hypothesized that patients treated 
with augmented CBT, tailored to their individual needs, would show a larger 
decrease in depressive symptoms than those receiving computerized cognitive 
training. Furthermore, it was hypothesized that the augmented CBT would be 
more beneficial with respect to alleviating the perceived burden (emotional as 
well as practical) of caregivers. Subsequently, chapter five presents the results 
of these interventions on patients and chapter six the possible influence of these 
results on caregivers. The economic evaluation in chapter seven describes the 
cost-effectiveness and cost-utility of the RCT from a societal perspective.
Restore4Stroke Research program
The present study is part of a comprehensive rehabilitation research program, 
Restore4Stroke, in the Netherlands (www.restore4stroke.nl) comprising four 
interrelated studies. Restore4stroke is funded by the VSBfonds, and coordinated 
by ZonMw (Dutch Organisation for Health Research and Development). The 
general aims of Restore4Stroke are to enhance successful social reintegration 
and to improve quality of life of stroke survivors and their caregivers. Besides 
the present RCT, three other studies are conducted: a longitudinal cohort 
study (Restore4Stroke Cohort study),49,50 an RCT aimed at evaluating the effects 
of a self-management group therapy,51 and an economical evaluation study 
(€-Restore4Stroke study).52,53  
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Chapter 2
Risk factors for symptoms of depression 
and anxiety one year post stroke:
A longitudinal study
Kootker JA, van Mierlo ML, Hendriks JC, Sparidans J, Rasquin 
SM, de Kort PL, et al. Risk factors for symptoms of depression 
and anxiety one year post stroke: a longitudinal study. Arch 
Phys Med Rehabil. 2016; 97(6):919-28
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Abstract
Objective: To estimate the relative contribution of psychological factors next to 
socio-demographic and premorbid/stroke-related factors to the risk of developing 
symptoms of depression and anxiety after stroke. 
Design: Multicenter longitudinal cohort study.  
Setting: Patients after stroke from 6 general hospitals. 
Participants: 331 patients were included at stroke onset and followed-up two and 
twelve months after stroke.  
Main outcome measures: Socio-demographic and premorbid/stroke-related 
information was recorded during hospital admission, whereas psychological 
characteristics were determined with postal questionnaires two months post 
stroke. Symptoms of depression and anxiety were assessed with the Hospital 
Anxiety and Depression Scale (HADS) two and twelve months post stroke. 
Multivariable logistic analysis was performed to analyze the influence of socio-
demographic, premorbid/stroke-related and psychological characteristics on 
depressive symptoms (HADS-D > 7) and symptoms of anxiety (HADS-A > 7) 
one year after stroke. 
Results: Early depression, stroke severity, posterior cerebral artery stroke, and 
neuroticism independently explained the variance of depressive symptoms one 
year post stroke (discriminative power 83%, adjusted R2-value 36%). Neuroticism 
and early anxiety independently explained the variance of symptoms of anxiety 
one year post stroke (discriminative power 88%, adjusted R2-value 44%). Based 
on these predictive models, nomograms were constructed to visually reflect the 
individual contribution of each risk factor to the development of long-term mood 
disorders after stroke. 
Conclusion: Psychological characteristics are important risk factors for post-
stroke symptoms of depression and anxiety.  
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Introduction
Mood disorders are very common after stroke with prevalence estimates varying 
from 31-38% for both depressive symptoms and symptoms of anxiety.1, 2 Moreover, 
post-stroke depression and anxiety often co-occur.2-6 Recent studies indicate that 
post-stroke depression is associated with reduced therapy compliance, poorer 
functional outcome, higher medical costs, reduced social participation, and 
increased mortality,7-10 while post-stroke anxiety and depression have both been 
associated with lower quality of life.2,7 In this perspective, knowledge about risk 
factors is essential for long-term prevention and treatment of mood disorders 
post stroke. 
The risk factors for mood disorders after stroke that have been reported in the 
literature are mainly ‘socio-demographic’, ‘premorbid’ and ‘stroke-related.’ The 
most frequently reported risk factors for depressed mood are female gender, 
stroke severity (in terms of functional consequences), lack of social support and 
history of depression.11,12 Although less frequently investigated, the reported risk 
factors for post-stroke anxiety are female gender, age under 65 years, stroke 
severity, inability to work, pre-stroke treatment for depression, and smoking.2 
Unfortunately, due to the methodology used in these studies, little is known about 
the strength of prediction of post-stroke mood disorders based on the above-
mentioned socio-demographic, premorbid and stroke-related characteristics.2,12 
Moreover, the aforementioned risk factors are mostly not amendable. 
There are indications that mood disorders after stroke are greatly determined by an 
individual’s ineffective cognitive and emotional adjustment to the consequences 
of stroke13,14 and, thus, may have an important psychological origin. The Common 
Sense Model of Levental,15 suggests that patients create mental representations 
of their illness when faced with a chronic disease. The ineffective cognitive 
and emotional adjustments to the consequences of stroke are expressed in: 
‘illness cognitions’, the way patients perceive their illness and its (uncontrollable) 
consequences; the worries and fears that come along with this adjustment to a 
new situation; and the concurrent behaviour or coping strategies patients attend 
to. In addition, a person’s stable characteristics, such as personality traits, are 
assumed to influence this adjustment process. Previous studies showed that 
neuroticism was indeed associated with post-stroke depression.16-19 In another 
study avoidance coping was associated with the severity of depressive symptoms 
after stroke.20 Unfortunately, these psychologically oriented studies were either 
small sized (n ≤ 61),16,17,20 used a cross-sectional design,16-18,21 or regarded a limited 
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set of psychological characteristics only.16,17,19
Hence, we conducted a longitudinal cohort study to explore possible risk 
factors for developing depressive symptoms and symptoms of anxiety one year 
after stroke, as part of the Restore4Stroke cohort study in the Netherlands.22 
We hypothesized that psychological factors would be important in addition 
to previously established socio-demographic, premorbid and stroke-related 
characteristics. Moreover, we aimed to determine the predictive strength of 
each of these characteristics with regard to symptoms of depression and anxiety 
one year post stroke. If an important role for psychological factors can be 
demonstrated, this would support the application of psychological treatment to 
prevent or treat post-stroke mood disturbances.
Methods
Subjects
Patients were recruited at stroke units of six participating general hospitals in 
the Netherlands from March 2011 until March 2013.22 Patients were eligible 
if: (1) they signed informed consent within the first week post stroke; (2) the 
diagnosis of cerebral stroke (ischemic or haemorrhagic) was clinically confirmed; 
(3) age was 18 years or older; and (4) they had sufficient knowledge of the Dutch 
language to complete the planned assessments. Exclusion criteria were: (1) any 
serious co-morbid condition that might influence study outcomes; (2) pre-stroke 
dependency in activities of daily living as defined by a Barthel Index of 17 or 
lower;22,23 and (3) pre-stroke cognitive impairments as defined by a score of 1 or 
higher on the Heteroanamnesis List Cognition.24 The study was approved by the 
medical-ethical committee of the St Antonius Hospital in Nieuwegein as well as 
by the medical-ethics board of each of the other participating hospitals.
Design and procedure
Patients were assessed within one week post stroke (‘stroke onset’) as well as 
two and twelve months later. Socio-demographic information was provided by 
patients or patients’ family members at inclusion during the first days of hospital 
admission. Most premorbid and stroke-related information was obtained from 
the medical files at inclusion by a specialized stroke nurse. The National Institutes 
of Health Stroke Scale (NIHSS) and the Barthel Index (BI) were recorded on day 
4 after stroke. Collection of information about use of anti-depressants and co-
morbidity was performed by a trained research assistant two months post stroke, 
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as was the assessment of cognitive functioning. All potential psychological 
risk factors, including symptoms of depression and anxiety, were obtained by 
means of postal questionnaires two months post stroke. In addition, depressive 
symptoms and symptoms of anxiety were re-assessed as outcomes one year post 
stroke by means of postal questionnaires.  
Outcomes 
Symptoms of depression and anxiety were assessed with the Hospital Anxiety 
and Depression Scale (HADS).25-27 The HADS consists of 14 items and is divided 
in two subscales directed at either depressive symptoms (HADS-D) or symptoms 
of anxiety (HADS-A) (7 items per subscale, range 0-21 on each subscale). 
According to the literature, both depression and anxiety may be defined by 
a HADS-subscale score >7,27 yet we will refer to depressive symptoms and 
symptoms of anxiety throughout this text. The HADS has demonstrated good 
psychometric properties, including good internal consistency, in patients with 
stroke.28 
Potential risk factors 
Socio-demographic: Information about sex (male/female), living together (yes/
no), age (years), and level of education was obtained. The Dutch classification 
system of Verhage served as an indicator of the level of education (low range of 
1-5, "elementary and secondary school"; high range of 6-7, "higher academic and 
vocational education").29,30 
Premorbid and stroke-related: The following stroke characteristics were recorded: 
type of stroke (ischemic/haemorrhagic), stroke location (left hemisphere, right 
hemisphere, brainstem, cerebellum), stroke circulation area (anterior (ACA) 
/ middle (MCA) / posterior (PCA), vertebral – basilar artery (VBA)), and stroke 
recurrence (yes/no). Stroke severity was assessed with the NIHSS (range 0-42)31 
and level of dependency in activities of daily living (ADL) with the BI (range 
0-20; levels: high≤17, low>17).23 Cognitive functioning was assessed with the 
Montreal Cognitive Assessment (MoCA) (range 0-30)32 and co-morbidity with the 
Cumulative Illness Rating Scale (CIRS) (range 0-52).33 Furthermore, information 
about duration of hospital stay (days), location of residence at two months 
post stroke (home/institution), history of depression (yes/no), and current use of 
antidepressants (yes/no) was recorded. 
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Psychological: Besides symptoms of depression and anxiety using the HADS, the 
following personality characteristics were assessed: self-efficacy with the General 
Self-Efficacy Scale (GSES) (range 10-40);34 neuroticism and extraversion with the 
Eysenck Personality Questionnaire – Revised Short Scale (EPQ-RSS-N;EPQ-
RSS-E) (range 0-12, both subscales);35 and pessimism and optimism with the Life 
Orientation Test-Revised (LOT-R) (range 0-12, both subscales).36 Furthermore, 
proactive coping was assessed with the Utrecht Proactive Coping Competence 
list (UPCC) (range 1-4)37 and passive coping with the passive coping scale of the 
Utrecht Coping List (UCL-P) (range 7-28).38 Both the UPCC and the UCL-P are 
originally Dutch assessment scales. The UPCC items are scored on a 4 point 
scale. The UPCC has shown good psychometric properties in stroke patients 
(e.g., reliability and validity).39 The UCL-P has shown good internal consistency 
and high test-retest reliability.21,40 Finally, illness cognitions were assessed 
with the Illness Cognition Questionnaire, measuring feelings of helplessness, 
acceptance and perceived benefits (ICQ) (range 6-24 for each subscale).41,42 For 
all psychological factors, higher scores reflect higher levels of the psychological 
characteristic assessed.
Statistical analysis
First, univariable logistic regression was performed to test the associations of 
each of the socio-demographic, pre-morbid/stroke-related, and psychological 
factors with ‘depressive symptoms’ (as defined by HADS-D > 7) and ‘symptoms 
of anxiety’ (as defined by HADS-A > 7) one year post stroke, separately. 
Next, multivariable logistic regression with selection procedures was performed 
to identify those factors that independently contributed to the occurrence of 
‘depressive symptoms’ and ‘symptoms of anxiety’ one year post stroke. All 
factors with p < 0.10 in the univariable model were valid for selection. The three 
categories of potential risk factors were introduced in the following order: 1) 
socio-demographic; 2) premorbid and stroke-related; 3) psychological. With each 
step a forward selection procedure was used. We also performed a backward 
selection procedure, which resulted in the same final model. Therefore, only the 
final model of the forward selection procedure is presented. 
Factors selected in previous steps were valid for selection in the following step. 
The adjusted ORs with 95%CIs of all factors that were maintained in the final 
model for ‘depressive symptoms’ and for ‘symptoms of anxiety’ separately are 
presented. Because the final model after the forward selection procedure does 
not include the variables that are highly correlated to the variables already 
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selected, the p-values for entry into the model were considered in order to find 
close alternatives to the final model presented (i.e., the variables selected).43 
The pseudo-R2 (Nagelkerke) of the final model was calculated to indicate the 
variance explained. The area under the receiver operating curve (AUC) was used 
as a measure of predictive discrimination. To evaluate reliability of the created 
prediction model, an internal validation was performed using 80 bootstrap 
samples. The cross-validated pseudo-R2 is presented as a measure of calibrated 
goodness of fit.44
Finally, because the (adjusted) ORs cannot easily be compared between different 
risk factors, a nomogram was constructed based on the multivariable model to 
visually reflect the individual contribution of each risk factor to the development 
of long-term mood disorders after stroke. A nomogram can be used by filling in 
the scores of an individual on each of the independent risk factors. The total score 
can be translated into a probability value for developing ‘depressive symptoms’ 
or ‘symptoms of anxiety’ one year post stroke. Each nomogram is presented with 
sensitivity, specificity, and positive predictive value at optimal cut-off point under 
the condition of equal costs of misclassification. 
All statistical analyses were performed with SPSS 20 and SAS 9.0 for Windows. 
The nomogram and the bootstrap analysis were performed using standard 
procedures in R version 2.6.1.
Results
Patient characteristics and follow-up
A total of 395 patients were enrolled in the Restore4Stroke Cohort study. At one 
year post stroke, 7 patients (1.7 %) had died, 32 patients (8.1%) refused to participate 
and 25 patients (6,3%) were lost to follow-up. Thus, 331 patients were included 
in this study. The characteristics of this study sample (socio-demographic, pre-
morbid/stroke-related, and psychological) are presented in Table 1. The majority 
of the patients (92.7%) had sustained an ischemic stroke in the territory of the 
Anterior Circulation Area or Middle Circulation Area (71.5%). Mild stroke (NIHSS 
median 2.0) was most common, but the range of stroke severity was large (NIHSS 
range 0-22). Two months after stroke the prevalence of depressive symptoms, 
and symptoms of anxiety was 22.1% and 20.1%, respectively. One year post 
stroke these percentages were 27.0% and 21.1%, respectively. The percentages 
of patients with both depressive symptoms and symptoms of anxiety were 11.7% 
and 13.0% at two months and one year after stroke, respectively. 
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Table 1. Patient characteristics 
Sociodemographic N† n (%) median (range)
Sex (male) 331 214 (64.6)
Age (years) 331 66.7 (24.5 - 93.5)
Living together 331 233 (70.4)
Level of education (high)* 330 86 (26.1)
Premorbid and stroke-related
Type of stroke (ischemic) 331 307 (92.7)
Stroke location 327
Left hemisphere 131 (40.1)
Right hemisphere 141 (43.1)
Brainstem 24 (7.3)
Cerebellum 31 (9.5)
Stroke circulation area 295
ACA / MCA 211 (71.5)
PCA 28 (9.5)
VBA 56 (19.0)
Recurrent stroke 331 1.0 (1;4)
No 288 (87.0)
yes 44 (12.8)
NIHSS 331 2 (0 - 22)
BI 331 19 (0 – 20)
MoCA 310 24 (9 -30)
CIRS 316 6 (0 - 17)
Duration of hospital stay (days) 331 5.7 (1 - 50)
Location of residence after 2mths (home) 331 275 (83.1)
Pre-morbid depression 331 17 (5.1)
Use of antidepressants 300 19 (6.3)
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Table 1. Patient characteristics (continued)
Psychological 
Depression (HADS-D) 308 4 (0 - 18)
Anxiety (HADS-A) 308 4 (0 - 19)
UPCC 311 3.1 (1.5 - 4.0)
UCL-P 312 10 (7 - 23)
GSES 311 32 (10 - 40)
EPQ-RSS-E 312 7 (0 - 12)
EPQ-RSS-N 312 3 (0 - 12)
LOT-R optimism 312 8 (2 - 12)
LOT-R pessimism 311 4 (0 - 12)
ICQ Helplessness 312 11 (6 - 24)
ICQ Acceptance 312 17 (6 - 24)
ICQ Perceiving benefits 312 15.0 (6.0; 24.0)
* Level of education (range low:1-5; high:6-7).
† N: The subgroup of patients for which this characteristic was available; n: subgroup indicated by 
category. 
Abbreviations: ACA/MCA, Anterior/Middle Cerebral Artery; PCA, Posterior Cerebral Artery; VBA, 
Vertebral Basilar Artery; NIHSS, National Institutes of Health Stroke Scale (assessed at day 4; range 
0-42); BI, Barthel Index (assessed at day 4; range 0-20); MoCA, Montreal Cognitive Assessment (range 
0-30); CIRS, Cumulative Illness Rating Scale (range 0-52); HADS-D, Depression subscale of the Hospital 
Anxiety and Depression Scale (range 0-21); HADS-A, Anxiety subscale of the Hospital Anxiety and 
Depression Scale (range 0-21); UPCC, Utrecht Proactive Coping Competence list (range 1-4) ; UCL-P: 
Passive coping subscale Utrecht Coping List (range 7-28); GSES, General Self-Efficacy Scale (range 10-
40); EPQ-RSS-E, Eysenck Personality Scale- Revised Short Scale-Extraversion (range 0-12); EPQ-RSS-N, 
Eysenck Personality Scale- Revised Short Scale-Neuroticism (range 0-12); LOT-R, Life Orientation Test-
Revised (range 0-12); ICQ, Illness Cognition Questionnaire (range 6-24). Note: MOCA, CIRS and all 
psychological characteristics were recorded at two months post stroke.
Depressive symptoms
The ORs (with 95%CIs) of the demographic, premorbid/stroke-related, and 
psychological factors based on univariable logistic regression are presented in 
tables 2, 3 and 4, respectively. In total, 18 variables were valid for selection. 
In table 5 the adjusted ORs (with 95%CIs) for the risk factors in the final 
model are presented. Depressive symptoms at two months post stroke, level 
of dependency, stroke in the territory of the Posterior Circulation Area, and 
neuroticism independently contributed to explaining depressive symptoms 
(HADS-D>7) one year post stroke. The discriminatory power of this model was 
good (AUC 83% (95%CI:78%-89%)) and the percentage explained variance was 
acceptable (Nagelkerke R2 38%). After adjustment for internal validation these 
values were 82% and 36%, respectively. Figure 1 depicts the nomogram for the 
final model for depressive symptoms (HADS-D>7) at one year post stroke. For 
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this nomogram, sensitivity was 77%, specificity was 76%, and positive predictive 
value was 54%.
Table 2. The odds ratios (OR) with 95% confidence intervals (95%CI) for the socio-
demographic characteristics with regard to ‘depression’ (HADS-D >7) and ‘anxiety’ 
(HADS-A >7) using univariable logistic regression analyses.
Depression Anxiety
n OR ( 95%CI) p n OR (95%CI) p
Sex
Female 213 1.10 (0.67 - 1.83) 0.71 214 1.88 (1.10 - 3.21) 0.02
Male 117 1.00 (reference) 117 1.00 (reference)
Age (years) 330 1.01 (0.99 - 1.03) 0.30 331 0.98 (0.96 - 0.98) 0.03
Living together
Yes 233 1.09 (0.64 - 1.87) 0.75 233 1.28 (0.70 - 2.32) 0.42
No 97 1.00 (reference) 98 1.00 (reference)
Level of education* 
Low 243 1.31 (0.74 - 2.32) 0.36 244 1.21 (0.65 - 2.26) 0.54
High 86 1.00 (reference) 86 1.00 (reference)
Living together: married or otherwise.
* Level of education (low:1-5; high:6-7).
Symptoms of anxiety 
The ORs (with 95%CIs) from the univariable analyses are presented in tables 2, 
3 and 4 for the socio-demographic, premorbid/stroke-related, and psychological 
patient characteristics, respectively. In total, 16 variables were valid for selection. 
In Table 5 the adjusted ORs (with 95%CIs) for the risk factors in the final model 
are presented. Early symptoms of anxiety, assessed at two months post stroke 
and neuroticism independently contributed to explaining symptoms of anxiety 
(HADS-A>7) one year post stroke. The predictive discrimination of this model 
was good (AUC 88% (95%CI: 83% - 92%)) and the percentage explained 
variance was acceptable (Nagelkerke R2 46%). After adjustment for internal 
validation these values were 87% and 44%, respectively. Figure 2 depicts the 
nomogram for the final model for symptoms of anxiety (HADS-A>7) at one year 
post stroke. For this nomogram, sensitivity was 77%, specificity was 84%, and 
positive predictive value was 57%.
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Table 3. The odds ratios (OR) with 95% confidence intervals (95%CI) for the premorbid and 
stroke-related characteristics with regard to ‘depression’ (HADS-D >7) and ‘anxiety’ (HADS-A 
>7) using univariable logistic regression analyses. 
Depression Anxiety
n OR (95%CI) p n OR (95%CI) p
Stroke type
Ischemic 306 1.92 (0.64 - 5.79) 0.25 307 0.79 (0.30 - 2.07) 0.63
Hemorrhagic 24 1.00 (reference) 24 1.00 (reference)
Stroke location
Left hemisphere 131 0.68 (0.29 - 1.95) 0.37 131 0.45 (0.19 - 1.08) 0.07
Right hemisphere 141 0.83 (0.36 - 1.92) 0.67 141 0.54 (0.23 - 1.28) 0.16
Brainstem 23 0.74 (0.22 - 2.45) 0.62 24 0.87 (0.27 -2.75) 0.81
Cerebellum 31 1.00 (reference) 31 1.00 (reference)
Affected circulation area
ACA / MCA 211 0.93 (0.47 - 1.85) 0.84 211 0.59 (0.30 - 1.15) 0.12
PCA 28 2.54 (0.97 - 6.62) 0.06 28 0.54 (0.18 - 1.68) 0.29
VBA 55 1.00 (reference) 56 1.00 (reference)
Recurrent stroke
Yes 43 1.54 (0.78 -3.05) 0.21 43 1.15 (0.54 - 2.47) 0.72
No 287 1.00 (reference) 288 1.00 (reference)
NIHSS 330 1.05 (0.98 - 1.13) 0.14 331 0.98 (0.90 - 1.07) 0.65
BI 330 0.91 (0.87 – 0.95 <0.01 331 0.98 (0.93 – 1.03) 0.44
MoCA 309 0.96 (0.90 – 1.02) 0.20 310 1.01 (0.94 - 1.08) 0.85
CIRS 315 1.12 (1.02 – 1.22) 0.01 316 1.13 (1.03 - 1.25) 0.01
Duration of hospital 
stay (days)
330 1.07 (1.03 - 1.12) <0.01 331 1.03 (0.99 - 1.07) 0.20
Stay at two months
Institution 56 2.65 (1.46 - 4.81) <0.01 56 1.16 (0.58 - 2.30) 0.68
Home 274 1.00 (reference) 275 1.00 (reference)
Pre-morbid depression
Yes 17 2.55 (0.96 - 6.82) 0.06 17 3.61 (1.34 - 9.74) 0.01
No 313 1.00 (reference) 314 1.00 (reference)
Use of antidepressants  
Yes 19 2.10 (0.81 - 5.43) 0.13 19 3.78 (1.47 - 9.77) 0.01
No 280 1.00 (reference) 281 1.00 (reference)
Abbreviations: ACA/MCA, Anterior/Middle Cerebral Artery; PCA, Posterior Cerebral Artery; VBA, 
Vertebral Basilar Artery; NIHSS, National Institutes of Health Stroke Scale (range 0-42); BI, Barthel 
Index (range 0-20); MoCA, Montreal Cognitive Assessment (range 0-30); CIRS, Cumulative Illness 
Rating Scale (range 0-52).
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Table 4. The odds ratios (OR) with 95% confidence intervals (95%CI) for the psychological 
characteristics with regard to ‘depression’ (HADS-D >7) and ‘anxiety’ (HADS-A >7) using 
univariable logistic regression analyses.
Depression Anxiety
n OR (CI 95%) p n OR (CI 95%) p
HADS-D 307 1.32 (1.22 – 1.42) <0.01 308 1.25 (1.16 – 1.35) <0.01
HADS-A 307 1.19 (1.11 – 1.28) <0.01 308 1.54 (1.38 – 1.72) <0.01
UPCC 310 0.39 (0.24 - 0.62) <0.01 311 0.35 (0.21 - 0.58) <0.01
UCL-P 311 1.29 (1.17 - 1.42) <0.01 312 1.35 (1.21 - 1.49) <0.01
GSES 310 0.95 (0.92 - 0.99) 0.01 311 0.93 (0.89 - 0.97) <0.01
EPQ-RSS-E 311 0.93 (0.86 - 1.01) 0.07 312 0.99 (0.91 - 1.08) 0.89
EPQ-RSS-N 311 1.23 (1.13 - 1.33) <0.01 312 1.41 (1.28 - 1.55) <0.01
LOT-R optimism 311 0.80 (0.70 - 0.90) <0.00 312 0.77 (0.68 - 0.88) <0.01
LOT-R pessimism 310 1.18 (1.07 - 1.29) <0.01 311 1.16 (1.05 - 1.28) <0.01
ICQ helplessness 311 1.20 (1.13 - 1.27) <0.01 312 1.12 (1.08 - 1.21) <0.01
ICQ acceptance 315 0.83 (0.80 - 0.89) <0.01 312 0.88 (0.83 - 0.93) <0.01
ICQ perceived benefits 311 0.95 (0.90 - 1.00) 0.04 312 0.96 (0.91 - 10.2) 0.18
Abbreviations: HADS-D, Depression subscale Hospital Anxiety and Depression Scale (range 0-21); 
HADS-A, Anxiety subscale Hospital Anxiety and Depression Scale (range 0-21); UPCC, Utrecht 
Proactive Coping Competence list (range 1-4) ; UCL-P: Passive coping subscale Utrecht Coping 
List (range 7-28); GSES, General Self-Efficacy Scale (range 10-40); EPQ-RSS-E, Eysenck Personality 
Scale-Revised Short Scale-Extraversion (range 0-12); EPQ-RSS-N, Eysenck Personality Scale-Revised 
Short Scale-Neuroticism (range 0-12); LOT-R, Life Orientation Test-Revised (range 0-12); ICQ, Illness 
Cognition Questionnaire (range 6-24). 
Discussion
The aim of our study was to explore possible risk factors for developing depressive 
symptoms and symptoms of anxiety one year after stroke. The identified 
prevalence of 27.0% for depressive symptoms one year post stroke in the present 
study was in line with the prevalence reported in a recent meta-analysis (33%, 
95%CI:23-43),2 while for symptoms of anxiety one year post stroke the observed 
prevalence in this study (21.1%) corresponded with the prevalence reported 
in a recent review (24%, 95%CI:19-29).6 Our hypothesis that psychological 
characteristics would be important in addition to the socio-demographic, pre-
morbid and stroke-related characteristics previously associated with post-stroke 
depressive symptoms and symptoms of anxiety was supported by the results from 
the multivariable logistic regression analyses. For depressive symptoms, early 
signs of depression, level of dependency, stroke in the territory of the Posterior 
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Circulation Area and neuroticism were identified as the most important risk 
factors, whereas for symptoms of anxiety, early signs of anxiety and neuroticism 
were found to be the most important risk factors. The constructed nomograms 
based on the final models visually reflect the predictive strength of each of the 
risk factors. Generally, the overall percentage of explained variance was fair for 
both the risk factor model for depressive symptoms (36%) and the model for 
symptoms of anxiety (44%), while the predictive discrimination of both models 
was good (83-88%).
Table 5. Adjusted odds ratios (OR) with 95% confidence intervals (CI) of the 
independent risk factors for ‘depression’ (HADS-D >7) and ‘anxiety’ (HADS-A >7), 
using multivariable logistic regression analyses
Depression Anxiety
n OR (95%CI) n OR (95%CI)
277 307
Premorbid and stroke-related factors
Affected circulation area
ACA / MCA 0.72 (0.30 – 1.69)
PCA 4.24 (1.31 - 13.76)
VBA 1.00 (reference)
Psychological factors
HADS-D 1.15 (1.08 – 1.23)
HADS-A 1.41 (1.24 – 1.59)
BI 1.92 (1.07 – 1.33)
EPQ-RSS-N 1.12 (1.01 – 1.26) 1.21 (1.06 - 1.37)
Nagelkerke R2 value was 38% for ‘depression’ and 46% for ‘anxiety’, respectively. 
Abbreviations: : ACA/MCA, Anterior/Middle Cerebral Artery; PCA, Posterior Cerebral Artery; 
VBA, Vertebral Basilar Artery; HADS-A/D, Anxiety subscale Hospital Anxiety and Depression 
Scale (early signs) (range 0-21); BI, Barthel Index (range 0-20);EPQ-RSS-N, Eysenck Personality 
Scale- Revised Short Scale-Neuroticism (range 0-12).
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Figure 1. The nomogram to calculate the individual probability of HADS-D >7 at one year post stroke 
based on the identified risk factors. A vertical line can be drawn from the score of each risk factor to 
the ‘points’ axis on top of the figure. The points for each risk factor can be summed and the sum score 
can be located on the ‘Total Points’ axis. Then, a vertical line can be drawn from the total points axis 
point down to the ‘Probability of HADS-D’ axis, which depicts the individual probability of developing 
depressive symptoms one year post stroke. Abbreviations: BI, Barthel Index; SCA: Stroke Circulation 
Artery; A/M, Anterior/Middle Cerebral Artery; Post, Posterior Cerebral Artery; Vert, Vertebral Basilar 
Artery; HADS-D, Hospital Anxiety Depression Scale – depression subscale (early signs); EPQ-RSS-N, 
Eysenck Personality Scale- Revised Short Scale-Neuroticism.
From a clinical perspective, our results indicate that the long term risk of 
symptoms of depression and anxiety post stroke can be estimated based on a 
relatively compact set of diagnostic information available at two months post 
stroke. Psychological characteristics, i.e. early mood problems and neuroticism, 
constitute the core of these diagnostic sets. As can be read from both nomograms 
(Figures 1 and 2), the early HADS-D and -A scores make the largest contribution 
to determining the probability of developing depressive symptoms and symptoms 
of anxiety one year post stroke, respectively. Other identified risk factors for 
depressive symptoms post stroke support previous studies11,12 that found that 
stroke severity, in terms of functional dependency, makes a unique contribution 
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to the risk of developing post-stroke depressive symptoms. Remarkably, stroke 
circulation area was identified as an independent risk factor for post-stroke 
depressive symptoms, although its predictive strength was relatively small (see 
Figure 1). A possible explanation for this finding may be that brain lesions in 
the Posterior Circulation Area often coincide with visuospatial deficits such as 
hemianopia that, on the one hand, may have a huge impact on daily functioning 
but, on the other hand, remain relatively ‘invisible’ for the social environment.45 
This discrepancy may put a disproportionate emotional burden on stroke patients 
with brain lesions in the Posterior Circulation Area.
Figure 2. The nomogram to calculate the individual probability of HADS-A >7 at one year post stroke 
based on the identified risk factors. A vertical line can be drawn from the score of each risk factor 
to the ‘points’ axis on top of the figure. The points for each risk factor can be summed and the sum 
score can be located on the ‘Total Points’ axis. Then, a vertical line can be drawn from the total points 
axis point down to the ‘Probability of HADS-A’ axis, which depicts the individual probability of 
developing anxiety one year post stroke. Abbreviations: HADS-A, Anxiety subscale Hospital Anxiety 
and Depression Scale – anxiety subscale (early signs); EPQ-RSS-N, Eysenck Personality Scale- Revised 
Short Scale-Neuroticism.
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In this study we aimed to identify the most concise predictive models for 
symptoms of depression and anxiety one year post stroke. As a consequence, 
regardless of the many factors that were valid for selection, only a limited set 
of variables remained in the final models. In both models, of all psychological 
risk factors, merely neuroticism made a unique contribution in addition to 
early symptoms of depression and anxiety. This does not imply that other 
psychological risk factors that were identified in the univariable analyses (Table 
4) would not be clinically predictive of depressive symptoms or symptoms of 
anxiety one year post stroke. Indeed, early signs of anxiety, passive coping and 
low levels of proactive coping, lack of optimism, and lack of acceptance can 
still be considered as relevant risk factors for depressive symptoms one year post 
stroke. Nevertheless, these psychological risk factors no longer showed added 
predictive value after including ‘early depressive symptoms’ in the multivariable 
model. This result implies that early signs of depression are highly correlated 
with these psychological characteristics, which was already found in a cross-
sectional analysis of the present cohort two months after stroke.21 The same 
line of reasoning applies to the final model for anxiety symptoms, as early signs 
of depression, passive coping, lack of optimism, pessimism, helplessness and 
lack of disease acceptance all highly correlated with early signs of anxiety. A 
high correlation of HADS scores with poor coping and acceptance supports 
the notion that depressive and anxiety symptoms post stroke often result from 
ineffective cognitive and emotional adjustment to the consequences of stroke,13 
although a reverse relationship (mood disorders leading to inadequate coping 
and emotional adjustment) cannot be ruled out. These are important clinical 
considerations as poor coping and acceptance (as well as psychological strain) 
may be amendable to psychological intervention early post stroke, for instance by 
means of cognitive behavior therapy. Indeed, a recent review has demonstrated 
promising effects of psychological interventions for depression after stroke and 
opted for finding more evidence for the efficacy of psychological treatment 
approaches to ameliorate mood problems after stroke.46 
A major strength of this study is the combination of a large sample size and a 
longitudinal multi-center study design with hospital-based patient recruitment 
during the first week post stroke. We also accounted for the hospital effect 
in our analysis, resulting in hospital-specific risk models. As we found almost 
identical results (as there are OR, AUC and CI-s), we preferred to present the 
individually based risk models. In addition, an innovative aspect of our study is 
that we presented nomograms that visually reflect the individual contribution 
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of each risk factor. As this study has an exploratory nature, these nomograms 
merely serve to assist in interpreting the explained variance of the odds ratios. 
Our results should be further validated in a prospective study, preferably using 
also other accepted tools to assess symptoms of depression and anxiety, with the 
ultimate goal to develop nomograms that can be used clinically to individually 
estimate the probability of developing long term symptoms of depression and 
anxiety post stroke. 
Study Limitations
The present study has several limitations. First, our results cannot be generalized 
to the entire stroke population. As we included a relatively mildly affected patient 
sample based on median NIHSS and BI scores, our results may not hold for more 
severely disabled stroke patients typically admitted to rehabilitation centers or 
nursing homes. Future studies should, therefore, focus on whether psychological 
risk factors are dominant for developing mood disorders in more severely 
disabled stroke survivors as well. Second, although we considered a broad 
variety of potential socio-demographic, pre-morbid and stroke-related factors, 
we did not assess the influence of smoking, employment status, social support 
or ethnicity as was the case in some previous studies.2,7,49 In addition, we did not 
include certain psychological characteristics that might form an additional risk 
of developing post-stroke mood disorders, such as lack of openness and self-
esteem.19,35,50,51 Future research should, thus, take these potential risk factors into 
account. A third limitation may be that we collected the HADS scores by postal 
mail, which may have influenced the accuracy of the measurements. 
Conclusion
Psychological characteristics are important risk factors for developing symptoms 
of depression and anxiety one year after stroke. As some of these psychological 
risk factors may be amendable to treatment, early recognition is important to 
prevent long-term mood disturbances after stroke.   
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Abstract
Background: Post-Stroke Depression with or without Anxiety (PSDA) is a 
common disorder in the chronic phase of stroke. Neuropsychiatric problems, 
such as PSDA, have a negative impact on social reintegration and quality of 
life. Currently, there is no evidence-based treatment available for reducing PSDA 
symptoms. In the recent literature on depression in the general population it has 
been shown that depression complaints can diminish by cognitive behavioural 
therapy (CBT). In the current study, the effectiveness of augmented, activation-
based and individually tailored CBT on the reduction of depression and anxiety 
will be investigated in patients with PSDA. Additionally, the effects on various 
secondary outcome measures, such as quality of life, goal attainment and societal 
participation will be evaluated. This study is embedded in a consortium of 4 
interrelated studies on quality of life after stroke (Restore4Stroke).
Methods/design: A multi-centre, assessor-blind, randomized controlled trial 
is conducted. A sample of 106 PSDA patients, as assessed with the Hospital 
Anxiety and Depression Scale (HADS depression subscale >7), will be recruited 
and randomly allocated to either an experimental or a control group. The 
experimental intervention consists of an augmented CBT intervention. The 
intervention is based on CBT principles of recognizing, registering, and altering 
negative thoughts and cognitions so that mood, and emotional symptoms 
are improved. CBT is augmented with direct in-vivo activation offered by 
occupational or movement therapists. Patients in the control group will receive 
a computerized cognitive training intervention. Outcomes will be assessed at 
baseline, immediately post intervention, and at 6 and 12 months follow up.
Discussion: This study is the first randomized clinical trial that evaluates the 
(maintenance of) effects of augmented CBT on post-stroke depression with or 
without anxiety symptoms. Together with three other projects, the Restore4Stroke 
PSDA trial will provide novel information about the (treatment of) emotional 
problems and quality of life after stroke.
Trial registration: Trial registration number: Dutch Trial Register NTR2999 
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Introduction
Background
Stroke causes a high burden of disease to patients as well as to their caregivers. 
One year after a stroke, 35% of the patients are functionally dependent, indicating 
that stroke is a leading cause of disability.1 Half of all patients has problems in 
returning to their pre-stroke daily routines.2 Particularly the ensuing psychosocial 
problems of stroke survivors have a negative impact on their quality of life.3 
Emotional adjustments are associated with changes in coping strategies which 
are related to quality of life.4,5 Additionally, it has been shown that caregivers 
experience substantial burden from their partners’ emotional problems as well.6 
Cognitive and emotional complaints are found in many patients in the chronic 
phase after stroke.7 Within the first three months, post-stroke depressive symptoms 
can spontaneously resolve. If this does not occur, these symptoms can take a 
chronic course.8 In the chronic phase (usually defined as > 6 months post stroke), 
the most frequent emotional symptoms are depression (23-25%) and anxiety (19-
23%).9-12 Post-stroke depression and anxiety often co-occur and interact, but may 
also be present in isolation. Apparently the post-stroke prevalence of anxiety 
is almost as high as it is for depression; hence, it is surprising that the literature 
largely focuses on post-stroke depression (PSD).9-12 Stressing the impact and co-
occurrence of anxiety on patients with stroke, in the present study, we introduce 
the new concept of ‘Post-Stroke Depression with or without Anxiety’ (PSDA).
Currently, we are not aware of any treatment studies on post stroke anxiety. 
Studies on the treatment of PSD have generally focused on pharmacological 
interventions,13,14 whereas psychological interventions for PSD have hardly 
been investigated.15 Several researchers have investigated the possibility of 
preventing depression after stroke.16-19 Different interventions were evaluated, 
such as meditation, breathing exercises and visualisation (i.e., encouraging a 
new way of thinking about disability)16 and visits by specialist outreach nurses 
providing information, advice and support.17 In the intervention studies, a small 
but statistically significant reduction in psychological distress was reported on 
a variety of health-related questionnaires. All intervention studies were based 
on contact with multiple disciplines providing information and support, yet no 
specific psychological therapies were administered.
Nevertheless, there are indications that the treatment of depressive symptoms 
using cognitive behavioural therapy (CBT) is effective in other chronic illnesses 
such as cancer and diabetes.20,21 Hence, psychological interventions seem 
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promising in terms of effectiveness, while they have fewer side effects than 
medication. Moreover, as CBT is aimed at changing irrational cognitions and 
negative thoughts, it is considered to have a stronger effect on preventing relapse 
of symptoms than pharmacotherapy.5,16,20,22,23 In one of the studies that dealt 
with treatment of PSD, Lincoln and colleagues, applied a treatment protocol 
in which identifying and challenging negative thoughts as well as planning of 
joyful activities was discussed with the patients. The authors found, however, 
inconclusive results with respect to the effectiveness of such a psychological 
intervention.24,25 CBT requires effort during treatment sessions and often comes 
with a substantial amount of homework. The inconclusive results could be due to 
the inclusion criteria that did not take into account cognitive deficits and impaired 
awareness after stroke. These factors are associated with poorer rehabilitation 
outcomes26 and are, therefore, deemed essential when applying CBT. Next to 
discussing activation with the patients, no further steps, such as stimulating an 
active life style or giving practical suggestions and encouragements directed at 
joyful activities, were taken by Lincoln and colleagues.25 Including such an extra 
step in an intervention could possibly catalyse generalisation of the content of 
the therapy to daily-life functioning.15 Furthermore, in a study with brain-injured 
patients, a combination of CBT and individual cognitive remediation seemed to 
diminish psychological distress (e.g., depression, anxiety, coping) and improve 
attention and cognitive functions. Nevertheless, which of the two therapy 
ingredients was (most) effective could not be determined.27 Implementation of 
CBT should take into account cognitive impairments as well as emotional barriers 
and awareness. To stimulate treatment generalisation, the use of behavioural 
exercises that have to be executed in daily life situations is recommended.15
Taken together, the scientific literature shows inconsistent results on the 
effectiveness of treatment programs for PSD. Despite a lack of clear evidence, 
there is sufficient reason to believe that CBT offered by a trained psychologist 
can be effective in PSDA when adapted and tailored to the specific needs 
of patients with stroke, as discussed above.15 Combining the results of earlier 
research on treatment and prevention of post-stroke depression and according to 
the recommendations expressed in these studies,7 an augmented psychological 
approach to CBT will be tested in the present study using a Randomised 
Controlled Trial (RCT) design. An equally intensive control intervention (i.e., 
computerized cognitive training) was selected with the prospect of improving 
intervention-related goals (e.g., attention, memory, executive functioning) and 
attaining previously reported high patient satisfaction.28
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The present study is a multi-centre randomized controlled trial (RCT). The 
primary objective is to evaluate the direct and long-term intervention effects on 
PSDA symptoms as assessed with the Hospital Anxiety and Depression Scale 
(HADS). It is hypothesised that patients treated with augmented CBT, tailored 
to their needs, will show a larger decrease in HADS scores than those receiving 
computerized cognitive training. The secondary objectives are:
 - to evaluate the effects on societal participation, quality of life, goal 
attainment and coping strategies. It is hypothesised that the augmented 
CBT will lead to better outcomes in all these domains.
 - to assess the level of burden of the patients’ caregivers. It is expected that 
the augmented CBT will be more beneficial with respect to alleviating the 
perceived burden (emotional as well as practical) of caregivers.
 - to evaluate the relationship between treatment participation of the patients 
in CBT on the one hand and treatment outcomes on the other hand.
The present study is part of a comprehensive rehabilitation research program, 
Restore4Stroke, in the Netherlands (www.restore4stroke.nl) comprising four 
interrelated studies. Restore4stroke aims to monitor, predict and improve the 
quality of life of patients and their caregivers. Besides the present RCT, three 
other studies are conducted: a longitudinal cohort study,29 an RCT aimed at 
evaluating the effect of a self-management group therapy, and an economical 
evaluation study.30 The design of the other studies will be published separately.
Methods
Study population
We intend to include 106 participants who experience depressed mood with 
or without symptoms of anxiety after stroke. When physicians, therapists or 
psychologists in the Netherlands notice such complaints during the rehabilitation 
process or thereafter, patients can be referred to various rehabilitation centres 
offering the experimental and control interventions distributed throughout the 
country. Participants may also be referred by other healthcare professionals or 
come on their own initiative based on ‘hear say’. They will be eligible if they 
have sustained any type of stroke in the past, if complaints developed after the 
stroke and if their depression sub-score on the Hospital Anxiety and Depression 
Scale (HADS) is above seven. Other inclusion criteria are: (1) being more than 
three months post stroke; (2) being 18 years or older; (3) having sufficient 
communication skills (MMSE > 27, communication-related NIHSS items); and (4) 
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mastering the Dutch language. Exclusion criteria are: (1) pre-morbid disability as 
assessed with the Barthel Index (score < 19/20); (2) stay in an inpatient setting; 
(3) co-morbidity that might affect outcome (e.g., cancer or major psychiatric 
illnesses for which psychological treatment is given at the moment of inclusion); 
(4) a major depression diagnosis requiring medication; and (5) a pre-morbid 
major depression diagnosis, or having received psychiatric care for depression.
Procedure
Participants will be screened, enrolled and subsequently treated in several 
rehabilitation centres or rehabilitation departments of hospitals in the Netherlands. 
They will be recruited over a period of one year. Each centre is expected to enrol 
at least 10 patients. The physicians of the affiliated centres are provided with 
information about the inclusion and exclusion criteria to perform a first test of 
eligibility (HADS assessment). When individuals are considered to be candidates 
for the study, they will be informed about the Restore4Stroke PSDA trial by 
written correspondence and will be asked for permission to be contacted by the 
primary investigator (JK). In the case of a positive reply, the primary investigator 
will make an individual appointment to confirm the inclusion and exclusion 
criteria, to obtain oral and written informed consent, and to perform the baseline 
assessment (T0).
Participants will be randomly allocated to an experimental group receiving 
augmented CBT or to a control group receiving computerized cognitive training. 
All outcome measures will be collected at baseline (T0), after 4 months (post 
treatment) (T1), and at 6 (T3) and 12 months (T4) follow up (see Figure 1). All 
assessments will take place in the (patients’ nearest) participating centres. From 
T1 assessments will be performed by research assistants who are not involved in 
the delivery of the interventions and who will be blind to the type of intervention 
in individual participants. Prior to each assessment, the assessor will explicitly 
ask the participant not to reveal or discuss the content of his/her intervention. 
Successfulness of assessor blinding will be tested by the primary investigator 
at the end of each individual intervention period using a short self-constructed 
questionnaire. During the intervention it is required that any antidepressant 
medication intake remains stable. Yet, when changes in medication occur 
these will be registered. This procedure was approved by the Committee on 
research involving Human Subjects, Nijmegen, The Netherlands, and all local 
participating centres.
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Pre selection of subjects in
rehabilitation centres or rehabilitation
 departments of hospitals
Check for inclusion
Baseline measurement (T0)
Randomisation
Exclusion of subjects
Post treatment measurement (T1)
(4 months after T0)
Augmented CBT intervention 
(13-16 sessions, 4 months)
Control intervention  
(13-16 sessions, 4 months)
Follow up measurement 1 (T2)
(10 months after T0)
Follow up measurement 1 (T3)
(16 months after T0)
Figure 1. Flow chart of trial design
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Randomization
Stratified block randomization (block size n = 4) will take place by a computer in 
each participating rehabilitation centre separately. Participants will be stratified 
according to their anxiety level (cut-off: HADS subscale anxiety score ≤7 vs. > 7). 
In this way, all blocks will assumedly consist of an equal number of participants 
with and without anxiety complaints and each participating centre will provide 
both interventions in approximately an equal number of participants.
Interventions
Augmented cognitive behavioural therapy
Subjects in the experimental group will be treated with an augmented CBT 
protocol using ‘CRASS’ communication techniques.31 The ‘CRASS’ techniques 
entail Concrete, Repetitive, Accessible, Structured and Specific communicative 
principles. Therapists will use motivational interviewing and interpersonal 
therapy techniques. Patients will be taught to recognize, register, and alter 
negative thoughts, cognitions and concurrent feelings. To encourage daily life 
integration of the CBT, content sheets will be provided and related homework will 
be given each session (i.e., one or two assignments per session). The intervention 
is individually administered and tailored according to specific subjects-own 
activity-related goals. The treatment program consists of 10–12 sessions with 
an experienced health-care psychologist and is augmented with three (or four; 
depending on HADS anxiety scores) sessions of occupational therapy (OT) or 
movement therapy (MT). These latter sessions will be provided concurrently 
with the psychological sessions and serve as a facilitator for reaching the pre-set 
goals in daily life. Therapy goals will be set in terms of increased participation 
in meaningful or joyful activities using Activity Card Sorting (ACS).32 This tool 
is incorporated to overcome problems with goal-setting because of the passive 
state PSDA patients can be in. With the ACS, patients can objectify their goals 
with the help of pictures/photos that represent elderly participating in various 
activities. In this way, patients are given concrete and accessible incentives to 
define their own personal goals more easily. The OT/MT will help to initiate 
and guide patients to execute goal-related activities. If patients’ HADS anxiety 
sub-score is >7, the protocol will be expanded with an additional (fourth) OT/
MT session. Therapists will be informed about the HADS anxiety sub-scores of 
the patient. The additional session entails relaxation techniques as provided by 
the Dutch Heart Foundation. The OT/MT can refer to the relaxation techniques 
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if patients report experienced anxiety during execution of their activities.33 Next 
to that, psychologists will address anxiety-related thoughts, cognitions and 
concurrent feelings when executing CBT.
The protocol framework is set out in five successive phases (see Table 1). The 
therapist will start with building rapport creating a safe atmosphere. Psycho-
education about current mood states will guide and prepare patients for the 
next phase: Goal setting. Subsequently, CBT will be executed using explanatory 
schemes about negative and positive cognitions.34 Themes of the CBT range 
within patients-own goals and concurrent mood states. From this stage the 
OT/MT will actively work with patients on their treatment goals as well. CBT 
succeeds with continuation of learned techniques and concludes with building a 
relapse plan for future challenging situations.
Table 1. Content of successive phases of the augmented Cognitive Behavioural Therapy
Phase Content
1. Introduction Building rapport; discussing grief; psycho-education about the 
relationship between mood and behaviour.
2. Goal setting Active goal setting with OT/MT.
3. CBT principles Recognising and registration of ‘hidden cognitions’.
4. CBT Challenging and altering ‘negative cognitions’.
5. Relapse prevention Building a relapse-prevention plan with taught techniques.
All treatment sessions are supervised by certified health-care psychologists who 
have sufficient experience with treatment of depression as well as with stroke 
rehabilitation. The psychologist will supervise the OT/MT and will determine 
the sequence of the treatment sessions according to the individual needs and 
capacities of the subjects. The program is executed within a four-month time 
span, with a minimum of 13 and a maximum of 16 sessions. Each session will 
take two 20–25 minute-blocks divided by a 10–15 minute break. Treatment will 
be given at the most nearby participating centre.
CogniPlus; computerized cognitive training
Subjects in the control group will be given a computerized cognitive training 
program (CogniPlus). The amount of training sessions will be equal to that of the 
experimental group (i.e., 13–16 sessions). The control intervention is individual and 
patient-tailored as well. Participating centres will be provided with software and 
a dongle with sufficient training hours. With headphones and coloured patches 
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attached to two keys on the keyboard, a desktop can be set up for CogniPlus 
execution. Patients register on the system and for each session, content and results 
of the training will be saved. The program is an impairment-oriented intervention 
which suits the stroke population. In specific self-determined cognitive domains 
(i.e., attention, memory, executive functioning, and visual attention) patients will 
be executing computer tasks on performance-own related levels. A research or 
psychological assistant will be present during the training sessions for support or 
to answer any questions about the intervention. This person will, however, not 
engage in conversations with the patients about topics other than the cognitive 
training. To assess deterioration of mood, Visual Analogue Scales (VAS) will be 
filled out by the participant after each session. The assistant will monitor VAS 
scores and, when substantial deterioration occurs, will notify the researcher and 
the psychologist of the department.
Outcome assessment
Patients
Primary and secondary outcome measures are listed in Table 2. The HADS is a 
depression and anxiety questionnaire developed for use in patients with somatic 
co-morbidity such as stroke. We will assess domain-specific as well as health-
related quality of life. The primary outcome measure is the depression subscale of 
the HADS.35,36 Health-related quality of life will be assessed in general (EQ6D),37 
and stroke specific (SSQoL).38 Domain-specific quality of life is represented 
by participation assessment (USER-P),39 Emotional functioning (HADS), and 
subjective well-being (life satisfaction questionnaires).
Next to these quality of life related assessments, a semi-structured questionnaire 
specifically regarding post-stroke depression will be used. The Post Stroke 
Depression Rating Scale (PSDRS) will accompany HADS results emphasizing 
the phenomenological aspects of post-stroke depression.40 This scale comprises 
a characterization of all depressive post stroke symptoms (e.g., psychological, 
physical and vegetative aspects). CBT is aimed at different aspects of coping 
such as regulating emotional reactions and reassuring thoughts (emotion-focused 
coping), changing stressful situation and learning new skills (problem-focused 
coping).41 Consequently, we will assess coping using the Utrecht Proactive Coping 
Competence scale (UPCC).42 Goal setting will be performed with the therapist, 
and Goal Attainment Scaling (GAS) will be carried out by the primary investigator 
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(JK).43 Treatment participation will be scored by the therapist per session. The 
Pittsburgh Rehabilitation Participation Scale (PRPS) is a short quantitative 
measure that is easy to administer.26 The PRPS will be completed in each session 
and can provide: 1) direct feedback on individual treatment participation for the 
therapist, 2) direct feedback on treatment participation per session in general. If 
we come across trends in reported participation, the protocol could be adjusted.
Table 2. Outcome measures
Primary outcome measure Tests
Depression and Anxiety Hospital Anxiety and Depression Scale (HADS)
Secondary outcome measures Tests
Quality of Life
General Stroke Specific quality of Life (SSQoL-12)
EuroQuality of Life (EQ6D)
Domain specific User-P
Life Satisfaction questions
Post-stroke depression Post Stroke Depression Rating Scale (PSDRS)
Goal attainment Goal Attainment Scale (GAS)
Participation in therapy Pittsburgh Rehabilitation Participation Scale (PRPS)
Coping strategy Utrecht Proactive Coping Competence scale (UPCC)
Caregiver outcome measures
Domain specific quality of life Hospital Anxiety and Depression Scale (HADS)
Subjective strain Caregiver Strain Index (CSI)
Emotional burden Involvement Evaluation Questionnaire (IEQ)
Caregivers
In addition to patient-related outcomes we will also assess caregivers’ emotional 
and practical burden with the HADS, the Involvement Evaluation Questionnaire 
(IEQ)44 and the Caregiver Strain Index (CSI).6,45,46
Statistical analysis
Statistical analysis will be performed using PASW 18. Baseline characteristics will 
be presented using descriptive statistics. Differences between groups at baseline 
will be tested using chi-square and t-tests, depending on the type of variable. 
General linear model (GLM) analysis will be used to investigate the main effects 
of Time and Group (experimental vs. control) and the Time x Group interaction. 
Because it is hypothesized that augmented CBT causes a greater effect on the 
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HADS than cognitive training and that this effect will last at least 6 months after 
cessation of the therapy, the primary endpoint will be at 6 months post treatment 
(T2). Data analysis will be performed by an independent statistician who will be 
blinded for group intervention. Data will be analysed according the intention-to-
treat principle. Alpha will be set at 0.05.
Power
With a minimally detectable effect size of 0.6 SD on the HADS, α= .05 and 
β = .80, minimally 45 participants in each group are required. With an expected 
drop-out rate of 15%, 106 participants will need to be recruited.
Discussion
Currently, no multi-centre RCT has been conducted that has evaluated the 
effectiveness of an (augmented) CBT intervention on post-stroke depression with 
or without anxiety.47 Reduction of PSDA could positively influence psychosocial 
functioning, rehabilitation outcome and concurrently improve different domains 
of quality of life. An innovative aspect of the current study is that the CBT 
intervention takes into account recommendations by Broomfield and colleagues 
for the design of a post-stroke CBT intervention.15 Specifically, the proposed 
CBT is augmented with occupational therapy or movement therapy to facilitate 
change of behaviour in real life by promoting and encouraging meaningful or 
pleasurable activities. This augmentation may, however, be a challenging factor 
in some individuals with lack of initiative. These individuals may find it difficult 
to cope with the amount of homework. Striving to overcome this problem, only 
therapists with sufficient experience with the stroke population will deliver the 
intervention, and treatment participation will be monitored. Next to that, the 
protocol continually emphasizes CRASS communication principles, and the 
ACS is offered as a tool to provide input for conversation about joyful activities. 
Another innovation in the present study is that depressive symptoms are used for 
inclusion of subjects, but that symptoms of anxiety are not considered a reason 
for exclusion. In contrast, anxiety complaints will be incorporated as a target for 
the proposed cognitive behavioural therapy.
An important methodological aspect of the present study is that subjects from 
different parts of the Netherlands are included, which will enable us to control 
for possible cultural differences between subgroups. Another methodological 
strength is that the augmented CBT is compared to an ‘active’ intervention (and 
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not to ‘usual care’) to control for Hawthorne effects. Lastly, a parallel economic 
evaluation study within the Restore4Stroke program will shed light on the cost-
effectiveness of the proposed intervention.30
Taken together, the Restore4Stroke PSDA trial is an essential part of the 
Restore4Stroke program that focuses on the effectiveness of an augmented 
and individually tailored CBT protocol for treating post-stroke depression with 
or without anxiety. The Restore4Stroke program will: provide longitudinal 
information about the course of quality of life of patients and caregivers and 
the influence of personal factors on quality of life, evaluate two interventions 
designed for stroke patients, and last but not least will evaluate the economical 
effectiveness of both trials.
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Abstract
Aim: Currently, no evidence-based treatment is available for mood problems 
after stroke. We present a new psychological intervention designed to reduce 
depressive complaints after stroke.
Method of protocol development: This intervention was based on cognitive 
behavioural-therapy principles and was shown feasible in a pilot study In order 
to meet the specific needs of stroke patients (concerning both sensori-motor, 
cognitive and behavioural problems), we incorporated motivational interviewing, 
grief resolution, and psycho-education. We emphasised for each session to take 
into account the cognitive deficits of the patients (i.e. be concrete, accessible, 
structured, specific and repeat information). Moreover, we augmented the 
psychologist-administered therapy with the contribution of an occupational or 
movement therapist aimed at facilitating patients’ goal setting and attainment. The 
intervention consisted of twelve 1-hour sessions with a psychologist and three 
or four 1-hour sessions with an occupational or movement therapist. Currently, 
the effectiveness of the intervention is evaluated in a randomised controlled trial. 
Discussion: The proposed psychological treatment protocol is innovative, as it 
applies cognitive behavioural therapy in a stroke-specific manner; moreover, it 
supports goal attainment by incorporating occupational or movement therapy 
sessions.
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Introduction
Following a stroke, approximately 70% of survivors experience considerable 
long-term sensorimotor, cognitive, and/or behavioural impairments. These 
impairments often limit normal daily life activities and may restrict social 
participation,1-3 which may lead to feelings of depression. Although the reported 
prevalence of mood complaints varies, approximately more than 30% of all stroke 
survivors experience severe emotional complaints4-6 that negatively impact their 
quality of life.7,8 
Developing treatment programmes for depressive symptoms in patients after 
stroke requires a basic understanding of the underlying aetiology. This aetiology 
has been the subject of considerable debate. Researchers that investigated 
neuroanatomical and neurochemical substrates of post-stroke depression have not 
been able to establish that post stroke depression can be attributed to a particular 
type of stroke or level of stroke severity.9-11 Moreover, it has been suggested that 
the relationship between functional impairments and post-stroke depression is 
mediated by the significance that the patient attributes to his/her impairments.12,13 
From this perspective, post-stroke depression may be viewed as the result of an 
inadequate adjustment to the consequences of stroke. Therefore, it is important 
to address the reactive aspects of post-stroke depression when developing a 
psychological intervention for depressive complaints after stroke. Additionally, 
since post-stroke depression often coincides with increased anxiety,4,14,15 feelings 
of anxiety should also be taken into account in such an intervention. 
Mood disturbances after stroke are commonly treated with pharmacological 
agents. However, the benefits of pharmacotherapy in the treatment of post-stroke 
depression are debatable.16 Psychological interventions are used less frequently, 
possibly because their effects are also unclear.17-19 Yet, such interventions 
have yielded beneficial effects on mood disturbances in patients with other 
chronic disorders such as cancer and diabetes.20,21 Within the broad field of 
psychotherapy, cognitive behavioural therapy seems one of the most promising 
methods to address post-stroke depression. In this respect, it is important to note 
that cognitive behavioural therapy was recently found to be beneficial for treating 
post-stroke fatigue.22 The core assumption in cognitive behavioural therapy is 
that thoughts - rather than external factors such as people, situations, or events 
- drive feelings and behaviours. If one can change the way patients think, this 
can improve their feelings and actions, even if the situation does not change. A 
key advantage of cognitive behavioural therapy over pharmacotherapy is that it 
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is more effective at preventing the relapse of emotional symptoms, as it causes 
structural changes in irrational cognitions and negative thoughts.23 Another 
advantage is that cognitive behavioural therapy has a more favourable side-effect 
profile than pharmacotherapy.16
The goal of the current paper is to present a new psychological treatment protocol 
for post-stroke depression based on cognitive behavioural therapy, which is 
currently evaluated in a multicentre randomised controlled trial as part of the 
Restore4Stroke study in the Netherlands (Dutch Trial Register NTR2999).24 We 
will first describe the theoretical background of the treatment protocol, followed 
by the content of the intervention and a comprehensive discussion. Two case 
descriptions are presented in boxes to illustrate how the protocol can be applied 
in clinical practice. 
Theoretical background
The psychological treatment of post-stroke depression is still in its infancy. 
The application of conventional cognitive behavioural therapy for post-
stroke depression has not yielded unambiguous results yet. To date, only one 
randomised controlled trial examined the effect of cognitive behavioural therapy 
on post-stroke depression. In this trial, Lincoln and Flannaghan25 found no 
group differences of cognitive behaviour therapy versus interviews. The authors 
acknowledged that their study had several methodological shortcomings, such 
as early inclusion after stroke (< 1 month), low therapy intensity, and the use of 
relatively inexperienced therapist who participated in both interventions, thereby 
running the risk of ‘contamination’.25 Most importantly, the cognitive behavioural 
therapy did not take into account individual cognitive and/or sensorimotor 
deficits, nor were the participants provided with practical advice about how to 
achieve behavioural change.
Many stroke patients have sensory, motor, and/or cognitive impairments that 
limit their behavioural potential. Therefore, challenging and modifying irrational 
and negative thoughts using traditional cognitive behavioural therapy does not 
necessarily lead to effective behavioural changes. Cognitive impairments may 
lead to problems with information processing and, for instance, the correct 
understanding of the content of interventions. Stroke patients also may lack 
processing speed and can experience memory problems, which complicates 
the course of therapy. In addition, after having experienced a traumatic event 
(i.e., stroke), patients regularly misinterpret their bodily sensations, inducing fear 
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and anxiety, which may hamper the process of behaviour change. Also, grief 
that accompanies a traumatic event makes the patient less receptive to cognitive 
behavioural therapy. 
In an attempt to take into account these impairments, and to enhance the 
applicability of cognitive behavioural therapy in the treatment of post-stroke 
depression, Broomfield et al. (2010) recommended the integration of the following 
five psychological approaches that will be illustrated in the procedure section:
 - Motivational interviewing26,27
 - Grief resolution28
 - Cognitive deficits adaptation29
 - Selective optimisation with compensation23,30,31
 - Executive skills training23
Box 1. Motivational interviewing and grief resolution
Patient MC used to be a consultant in organisation management. After his stroke, 
he experienced considerable difficulty resuming his professional work, causing 
loss of self-esteem and sense of identity. When discussing therapy goals, at first, 
MC aimed to regain his old job. By posing an open-ended question about the 
way he thought he would attain this goal, MC gradually realised that regaining his 
former job was out of reach. Moreover, by making a pro-con list, he realised that 
sticking to the current situation would cost too much energy and lead to many 
mistakes. Before encouraging him to think about other types of occupation, the 
psychologist stimulated MC to reflect on and discuss the grief and emotional 
impact of his vocational loss.
Method of protocol development
We previously conducted a pilot study to assess the feasibility of cognitive 
behavioural therapy in five patients. An existing cognitive behavioural therapy 
intervention developed for patients with chronic disease32 was modified to fit 
the cognitive impairments of stroke patients.33 We reduced the amount of 
information and repeated information several times throughout the intervention. 
The intervention reduced mood complaints in three out of five patients. Next to 
that, we showed that the intervention was feasible. After evaluation of this pilot 
study, we further developed the protocol by incorporating the recent suggestions 
of Broomfield and colleagues as follows:23
1. Throughout the treatment, the psychologist used motivational interviewing 
to enhance the patient’s motivation for behavioural change.26,27 By asking 
open-ended questions, discussing pros and cons of behaviour change, and 
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by addressing goal planning to bring about behavioural change, the patient 
was encouraged to be creative and think autonomously for setting therapy 
goals and find ways to improve his/her self-efficacy (see box I).
2. Early in the treatment protocol, the psychologist promoted grief resolution 
by explaining the phases of bereavement and by discussing the effects 
of reduced physical independence, mobility, cognitive capacity, and 
emotional control on self-esteem and future perspective (see box I ).  
3.  Throughout the treatment, cognitive impairments were taken into account 
when explaining and implementing the principles of cognitive behavioural 
therapy.34 In line with “cognitive deficits adaptation”, the psychologist used 
cognition schemes to explain the relationship between thoughts, feelings, 
and actions in a step-by-step fashion (see Figure 1). In addition, the intensity 
of therapy sessions was adjusted to the patient’s cognitive capacities while 
psychologists were instructed to adjust their communication style to the 
patient’s functional level through the consistent use concrete, repetitive, 
accessible, structured, and specific (CRASS) communication principles.35 
For example, therapists communicated the essentials of therapy by talking 
slowly, illustrating them with tangible examples while avoiding professional 
jargon. During each session, the psychologist repeatedly mentioned 
the most important components, thereby ensuring that the patient fully 
understood all key elements. ‘Take home’ information sheets also described 
the most important therapy components.
4. The most crucial adjustment of our treatment protocol was based on 
“selective optimisation with compensation”. Based on this approach, the 
psychologist-administered cognitive behavioural therapy was augmented 
with three sessions of occupational or movement therapy to facilitate goal 
setting and attainment. An occupational or movement therapist supported 
patients with functional limitations (or doubts about their capacities) by first 
identifying meaningful personal goals and then helping them to achieve 
these goals. 
5. When a patient reported feelings of anxiety in addition to depressive 
complaints, cognitive behavioural therapy also addressed anxiety-related 
thoughts and problems. Moreover, a fourth occupational or movement 
therapy session was planned to teach the patient relaxation techniques 
(e.g., breathing exercises), as advised by the Dutch Heart Foundation.36 The 
aim of this extra session was to alleviate anxiety-driven bodily tension that 
might impede the patient’s ability to reach his/her activity-related goals. 
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Event
Other take over 
things I used to do 
Feeling
Miserable, sad
Behaviour
Lack of initiative, 
passiveness
Thought
They think I am 
useless
Event
Other take over 
things I used to do 
Feeling
Miserable, sad
Behaviour
Lack of initiative, 
passiveness
Figure 1. Hidden cognition scheme as it is introduced in the expanded 4-step scheme (bottom 
row). The top row shows the simplified 3-step scheme.
Procedure
Table 1 gives an overview of the content of the treatment protocol.
Target group 
This treatment protocol was designed for the Restore4Stroke randomised 
controlled trial aimed at patients with chronic mood complaints after stroke; 
until now, the protocol has been applied in this trial only.24 Stroke patients with 
a pre-treatment score of >7 on the depression subscale of the Hospital Anxiety 
and Depression Scale were eligible for participation (see Table 1). Although the 
Hospital Anxiety and Depression Scale anxiety sub-score was not regarded for 
inclusion, it was used to individualise the treatment, for instance to indicate the 
need of additional relaxation exercises. The following exclusion criteria were 
applied: insufficient communication skills, a diagnosis of a ‘major depression’ 
that required pharmacotherapy (based on the medical file), and a history of pre-
stroke mood disorder or any co -morbidity that could affect mood.12
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Table 1. Characteristics of the protocol: Augmented Cognitive Behavioural Therapy
Inclusion criteria  - Patients with post-stroke depression with or without anxiety as 
defined by a depression sub-score on the HADS >7. 
 - Any type of stroke in the past. 
 - Depressed mood occurring >6 months post stroke. 
 - Sufficient communication skills.
Exclusion criteria  - Patients with pre-stroke physical disability (Barthel Index: <19/20). 
 - Inpatients.
 - Co-morbidity that could affect mood. 
 - Diagnosis of ‘major depression’ requiring medication.
 - Diagnosis of pre-stroke depression or previous psychiatric care for 
depression. 
Therapists’ competence Psychologist: healthcare psychologist with CBT experience and 
familiarity with stroke rehabilitation. 
Occupational or movement therapist: familiarity with stroke 
rehabilitation. 
Both therapists: received training by developer of protocol for correct 
application.  
Location Psychologist sessions: in the psychologist’s office.
Occupational or movement therapist sessions: in the rehabilitation 
facility, at various locations within the community, or at the patient’s 
home.
Number of sessions 15-16 individual sessions over a period of 4 months; 
11 sessions with the psychologist and one session with both the 
psychologist and the occupational or movement therapist;  
3-4 additional sessions with the occupational or movement therapist 
alone.
Duration of session One hour per week, with each session comprised of two blocks of 
20-25 minutes separated by a 10-15 minute break.
Materials Protocol booklet for therapist; ACS cards for photo interview; 
homework assignment booklet for patient.
Tailoring The psychologist has certain degrees of freedom concerning content 
of the final sessions, either attention to problems with acquired skills 
or evaluation of the intervention, depending on the patient’s progress.
Role of therapists
The treatment protocol was administered by a certified, experienced healthcare 
psychologist who was familiar with treating depression and providing rehabilitation 
to patients with stroke. Prior to working with the protocol, each psychologist 
received two hours of training by an expert psychologist with ample experience 
in cognitive behavioural therapy. If needed, the expert psychologist was available 
for assistance throughout the intervention. To prepare the goal-setting stage, the 
psychologist selected either an occupational or movement therapist, depending 
on the patient’s tentative goals; an occupational therapist was preferred when the 
goals included optimising activities in the domains of self-care, leisure, household, 
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and/or work; a movement therapist was chosen when the goals included 
improving mobility-related activities such as sports and walking. Because of their 
education and experience, occupational and movement therapists are optimally 
equipped to assess patients’ individual functional limitations and identify 
potential compensatory strategies. They worked in parallel with the psychologist 
to successfully translate the patients’ goals into daily life and help them achieve 
behavioural change. By maintaining close contact with the individual patient 
and the treating psychologist, it was ensured that all parties adhered to the same 
treatment principles, while the psychologist kept the lead in the intervention. 
In the case of increased anxiety (i.e., Hospital Anxiety and Depression Scale 
anxiety sub-score >7), the patient received a fourth session with the therapist that 
was entirely devoted to teaching relaxation techniques. 
Treatment stages 
The treatment protocol consisted of 15-16 individual treatment sessions. Twelve 
sessions were administered by the psychologist, and three (or four) additional 
sessions by the occupational or movement therapist. The treatment protocol 
consisted of five successive stages (see Table 2). 
1. In stage 1 (three sessions), the psychologist began building rapport with the 
patient and creating a safe atmosphere by striving to experience the world 
from the patient’s perspective without judgement or criticism. This was 
followed by grief resolution, which entailed reassurance of the patient with 
regard to emotional reactions to the consequences of his/her stroke by 
explaining that such reactions are normal after a painful and threatening 
life event (see box I). After that, psycho-education encompassed the 
provision of information about the consequences of stroke and useful 
compensatory strategies. In addition, the psychologist emphasised the 
relationship between becoming more active in daily life and the positive 
impact on emotions and behaviour.
2. Stage 2 (two sessions) was the goal-setting stage. The first of the two sessions 
was administered by the psychologist; the second was multidisciplinary 
and delivered together with the occupational or movement therapist. In 
line with CRASS principles, the protocol was made ‘accessible’ to the 
patient using the Activity Card Sorting. This tool facilitated the discussion 
about the patient’s personal activities and attainable goals.37 The Activity 
Card Sorting consists of 78 pictures representing people engaged in a wide 
array of activities, including leisure, sports, and daily life activities. 
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Thus, the stroke patient was given concrete examples to help him/her 
select personal goals. In preparation for the goal-setting sessions, patients 
listed the Activity Card Sorting cards most relevant to them as homework 
assignment to become familiar with the themes of the cards. 
 - In the first goal-setting session pre-stroke activity levels were discussed, 
using the Activity Card Sorting cards that the patient had selected. The 
psychologist and patient then discussed the patient’s current activity 
levels. Finally, activities that could help achieve the patient’s desired 
future situation were addressed, resulting in five tentative therapy 
goals. The content of these goals determined whether the psychologist 
contacted either the occupational or movement therapist. The 
psychologist introduced the patient to the therapist and together they 
prepared the multidisciplinary session. 
 - During the second session, each goal was discussed with respect to 
its feasibility. The psychologist and therapist together with the patient 
designed a concrete and realistic plan. This plan encompassed three 
specific agreed-upon therapy goals, taking into account the patient’s 
cognitive and physical limitations. This plan detailed the contents and 
timing of the three additional sessions in the following two stages with 
the occupational or movement therapist. 
3. In stage 3 (two sessions), the psychologist used cognitive behavioural 
therapy to help the patient recognise the thoughts that triggered negative 
mood and behaviour (see box II). In these sessions, the psychologist used 
schemes to explain negative and positive cognitions and to prepare the 
homework assignments (see Figure 1):
 - First, the psychologist explained a ‘3-step sequence’ of occurrences: 
events leading to feelings leading to behaviour (event -> feeling -> 
behaviour). The patient was taught that events engender feelings, 
which in turn influence behaviour. The patient was then encouraged to 
think of specific events in his/her daily life that led to negative feelings 
and subsequent behaviour. When he/she understood this sequence 
of occurrences, a fourth step (‘hidden cognition’) was added to the 
explanatory scheme (event -> thought -> feeling -> behaviour).34 
 - Hidden cognitions are thoughts that are not directly accessible, but 
can be made explicit by paying specific attention to the sequence 
of occurrences. During the homework assignments, the patient was 
advised to to fill in the new ‘4-step sequence’: event -> thought -> 
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feeling -> behaviour (Figure 1). Once the patient was familiar with 
this technique, the psychologist explained that hidden cognitions may 
either have a negative or a positive influence on feelings and behaviour 
(see box II).34
Box II. Recognising and adjusting irrational thoughts 
Patient RS suffered from a stroke 1 year earlier. He avoided visiting his football 
club since he had been involved in an ‘embarrassing situation’ in which he had 
called a friend by the wrong name. As the psychologist discussed this situation 
(wrong name for a friend) – his accompanying feelings (shame) – and ensuing 
behaviour (avoid going to social events), ‘hidden thoughts’ were explored by 
posing questions such as: ‘what did you think at this particular moment; do 
people generally get labelled after misnaming a person’. The patient described 
a hidden thought as ‘off course the other person thinks I am an idiot’. Then, the 
irrational aspects of this particular thought were further explored by questions 
such as: ‘Does this thought actually reflect reality?; can you imagine a more 
realistic thought to deal with this situation?’. Accordingly, RS asked his friend 
what he thought of him. These experience made him believe that people did 
not actually consider him stupid. Moreover, RS now explains people in advance 
that he sometimes tends to forget names or relevant information. Next to that, he 
often points out that it would be of help when people would signal his mistakes. 
4. In stage 4 (three sessions), the patient was taught to challenge specific 
irrational, negative thoughts and to change these thoughts into rational 
‘helping’ thoughts. The patient and psychologist together analysed concrete 
examples of 4-step sequences, thereby teaching the patient to use these 
examples in homework assignments. Primarily, the patient’s three therapy 
goals were used as a basis to apply the 4-step sequences. During the 
homework assignments, the patient practised reappraising events based 
on helping and rational thoughts (see Box II). In this stage, the psychologist 
repeatedly tested whether the patient fully understood the 4-step 
sequences and was constantly in close contact with the occupational or 
movement therapist to follow-up on goal attainment in terms of achieving 
actual behavioural change.
5. In stage 5 (two sessions), the treatment protocol was devoted to identifying 
relapse symptoms and evaluation. During the penultimate session, the 
psychologist discussed a possible future relapse of ‘old’ feelings and 
behaviours, which entailed listing the feelings that were once problematic. 
Subsequently, the patient was encouraged to manage recurrences of these 
feelings by applying the same cognitive behavioural techniques that were 
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previously taught. Accordingly, he/she prepared a 4-step scheme that could 
be used in future situations. The patient was stimulated to continue using a 
homework booklet after the therapy had ended. The last session was used 
for evaluation by asking the patient’s opinion about the treatment process. 
Discussion
Given the urgent need for an effective therapy,23,33 we developed an augmented 
cognitive behavioural therapy protocol for treating depressive symptoms after 
stroke. Because depression in the chronic post-stroke phase is assumed to be 
mainly reactive in nature, cognitive behavioural therapy may be the most promising 
treatment. The augmentation - which was a multidisciplinary approach using 
co-therapy by both a psychologist and an occupational or movement therapist - 
was expected to facilitate realistic goal setting and effective goal attainment by 
taking into account the individual patient’s preferences as well as his/her physical 
and cognitive capacities. The aim of the intervention was to give patients with 
depressive symptoms (and possible concurrent feelings of anxiety) the cognitive 
tools to realise behavioural change, thereby improve their self-efficacy. At the 
same time, patients were taught to manage the functional consequences of their 
stroke more effectively. To reach this goal, we incorporated several suggestions 
from previous studies,23,24,33 and we adapted the cognitive behavioural therapy 
protocol by incorporating motivational interviewing,26,27 adding sessions devoted 
to grief resolution,28 and addressing cognitive impairments using psycho-
education29 and CRASS communication principles.35 Wherever possible, the 
functional consequences of stroke were optimised or compensated.23,30,31 
The treatment protocol presented here has several strengths and limitations. 
The major strength is that the proposed intervention is innovative, as it applies 
cognitive behavioural therapy in a stroke-adjusted manner, a feature not found in 
former applications of cognitive behavioural therapy for post-stroke depression. 
The intervention is also innovative because it supports goal attainment by 
incorporating occupational or movement therapy sessions. Another strength is 
that we included the treatment of concurrent anxiety complaints. Anxiety and 
depressive symptoms often co-occur following stroke. Moreover, feelings of 
anxiety can hinder the patients’ actual performance of activities. Therefore, we 
addressed feelings of anxiety in our treatment protocol when applicable. Although 
we incorporated only a brief intervention for anxiety, we recognise that our 
treatment protocol may not be suitable for patients with severe anxiety disorders 
75An augmented CBT for treating post-stroke depression: Treatment protocol
that require other therapeutic approaches such as systematic desensitisation and 
graded exposure.34  
As for limitations, we acknowledge that a multifaceted treatment protocol is hard 
to test for its specific efficacy, because the various elements incorporated may 
differently contribute to mood improvement in different individuals. Indeed, 
research in the field of psychological interventions for post-stroke depression 
is in a ’proof-of-principle’ stage, in which effective treatments or combinations 
of treatments are still sought-after. More fine-grained analyses of effective or 
ineffective treatment elements should therefore be subject of future studies. 
Although we incorporated nearly all of the suggestions made by Broomfield et 
al.23 we opted not to include executive skills training in our treatment protocol. 
Broomfield and colleagues reported that patients with severe executive problems 
are usually excluded from intervention trials for post-stroke depression, and 
argued that combining executive skills training with cognitive behavioural 
therapy may help such patients to better engage in therapy.23  Although we agree 
that such a combined treatment approach might be of value for some patients, 
we did not incorporate distinct executive skills training as a standard component 
because such a treatment is relatively long and complex, which would unduly 
prolong the treatment in many patients without executive problems.   
Clinical message
 - Psychological interventions for post-stroke depression should be adjusted 
to the sensori-motor, cognitive and behavioural impairments observed in 
many stroke survivors.
 - Cognitive behavioural therapy is a promising method for treating post-
stroke depressive symptoms and can take into account concurrent feelings 
of anxiety.
 - Cognitive behavioural therapy for post-stroke depression can effectively be 
augmented with occupational or movement therapy to support individual 
patients in goal setting and goal attainment, taking into account their 
physical and cognitive abilities.  
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Abstract
Objective: To evaluate the effectiveness of individually tailored cognitive 
behavioral therapy (CBT) for reducing depressive symptoms with or without 
anxiety post stroke. 
Design: Multi-center, assessor-blinded, randomized controlled trial. 
Setting: Six ambulatory rehabilitation settings in The Netherlands. 
Participants: Patients who had a Hospital Anxiety and Depression Scale – 
subscale Depression (HADS-D) score > 7 at least three months post stroke.
Interventions: Sixty-one participants were randomly allocated to either 
augmented CBT or computerized cognitive training (CCT). The CBT intervention 
was based on the principles of recognizing, registering, and altering negative 
thoughts and cognitions. CBT was augmented with goal-directed real-life activity 
training given by an occupational or movement therapist.
Main outcome measures: HADS–D was the primary outcome and measures 
of participation and quality of life were secondary outcomes. Outcome 
measurements were performed at baseline, directly post treatment, and at four 
and eight months follow-up. Analysis was performed with linear mixed models 
using group (CBT vs CCT) as between-subjects factor and time (4 assessments) as 
within-subjects factor. Results: Mixed model analyses showed a significant and 
persistent time effect for HADS–D (MD:-4.6, 95%CI=-5.7;-3.75, p<0.00) as well 
as for participation and quality of life in both groups. There was no significant 
group x time effect for any of the outcome measures.
Conclusions: Our augmented CBT intervention was not superior to computerized 
cognitive training for the treatment of mood disorders after stroke. Future studies 
should determine whether both interventions are better compared to natural 
history.
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Introduction 
Approximately one third of all stroke survivors experience depressive symptoms at 
some point in time,1 with a negative impact on the outcome of rehabilitation and 
quality of life.2 Hence, adequate treatment of post stroke depressive symptoms is 
of utmost importance. Typically, studies on the treatment of depressive symptoms 
after stroke have focused on pharmacological interventions. However, drug 
treatment only produces small improvements in mood, while it is associated with 
a frequent occurrence of side effects,3,4 restricting routine prescription. Since post 
stroke depressive symptoms are strongly associated with individuals’ perception 
of, and coping with the consequences of stroke,5 a psychological treatment 
approach seems warranted. As CBT is aimed at changing irrational cognitions 
and negative thoughts, its effects may endure after treatment and chances of 
relapse of symptoms may be smaller compared to pharmacotherapy.6-8 In 
addition, the side-effect profile of psychological treatment is favorable compared 
to medication.6 However, psychological treatments of post stroke mood disorders 
have not yet yielded convincing results.9,10
To our knowledge only one randomized controlled trial (RCT) has been reported 
investigating a psychological treatment of post stroke depressive symptoms,10 
This study yielded inconclusive results with regard to the effectiveness of CBT. 
As the authors acknowledged, this work was a pioneering study with several 
methodological weaknesses that compromised its quality. For instance, cognitive 
impairments were not considered in the inclusion criteria and therapy content 
was insufficiently adjusted to the cognitive consequences of stroke. In addition, 
the training of therapists was limited. Other researchers argued that, in order to 
optimize the effectiveness of CBT in patients with stroke, cognitive and emotional 
impairments and limited awareness of deficits should be taken into account.8 It 
was also recommended that CBT should be augmented with real-life activity 
training to help patients and their caregivers set and attain realistic goals aimed at 
social participation, taking into account their motor and cognitive impairments.8 
In addition, anxiety symptoms should be recognized and addressed in the CBT 
treatment as these are often associated with depressive symptoms after stroke.11,12
In a pilot study, we already assessed the feasibility of a CBT intervention aimed at 
reducing depressive symptoms in stroke survivors.13 Three out of five participants 
showed positive results on mood and quality of life directly after treatment and 
these positive results were retained at three months follow-up. These findings 
justified the conduct of a multi-center RCT as part of the Restore4Stroke study 
82 Chapter 5
in the Netherlands.14,15 In the present study we hypothesized that patients treated 
with individually tailored augmented CBT would show a larger decrease in 
depressive symptoms and more improvement in social participation and quality 
of life than those receiving a computerized cognitive training (CCT). CCT was 
selected as the comparator intervention to control for Hawthorne effects, in the 
expectation that CCT might improve cognition but not mood.     
Methods 
Subjects
Participants were recruited over a period of 18 months. They were screened 
for eligibility by their treating physicians and psychologists during regular 
outpatient visits in the following six participating rehabilitation centers or hospital 
rehabilitation departments in the Netherlands: Groot Klimmendaal, Arnhem; 
St Maartenskliniek, Nijmegen; Adelante, Hoensbroek; Roessingh, Enschede; 
VieCuri, Venlo; Tolbrug; ‘s Hertogenbosch; ViaReva, Apeldoorn. Participants 
were eligible when they met the following inclusion criteria. They should (1) have 
sustained any type of clinically confirmed stroke at least three months earlier; (2) 
score > 7 on the Hospital Anxiety and Depression Scale–subscale Depression 
(HADS-D);16,17 (3) be 18 years or older; (4) have only mild cognitive impairments 
(Mini Mental State Examination score (MMSE)18 > 27/30 and score positively on 
the communication-related items of the National Institute of Health Stroke Scale 
(NIHSS);19 and (5) master the Dutch language. Exclusion criteria were (1) pre-
stroke major depression requiring psychiatric care; (2) pre-morbid disability as 
reflected in a Barthel Index score < 19/20;20 (3) stay in an inpatient setting; (4) 
severe co-morbidity that might affect mood (e.g., cancer); and (5) post stroke 
major depression requiring a start with medication. 
The study design and methods were previously published16 and approved by the 
medical ethical committee of Nijmegen (The Netherlands) and by the executive 
boards of all participating rehabilitation institutes. The adjusted time points of 
assessment were approved post hoc by the same medical ethical committee.
Procedure
After referral to the primary investigator (JK), participants were enrolled based 
on the inclusion and exclusion criteria. Oral and written informed consent was 
obtained by JK. Subsequently, patients were randomized to either 4 months of 
augmented CBT or an equal period of CCT. Interventions were given in the same 
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six rehabilitation institutions as where patients were treated. 
All outcome measures were collected at four time points. Initially we intended to 
measure at baseline, directly post treatment, and 6 and 12 months post treatment.15 
Due to a lower than expected inclusion rate the timing of the assessments was 
adjusted to baseline (T0), directly post treatment (T1), and 4 (T2) and 8 months 
(T3) post treatment (see figure 1). All assessments took place in the rehabilitation 
institute where the patient was treated. Baseline assessments were performed 
by JK. From T1, all outcome assessments were performed by research assistants 
who were not involved in the administration of the interventions and who were 
blind to treatment allocation of the participants. When patients mentioned the 
content of their intervention to the assessor, this was reported and the subsequent 
assessment was performed by a different, still blinded assessor.
Randomization 
Stratified block randomization (block size 4) was performed by a randomization 
program for each participating rehabilitation institution separately. Main factors 
that were expected to affect outcomes were selected for minimization, i.e. 
rehabilitation institute and patients’ anxiety level (HADS–subscale Anxiety 
(HADS-A) ≤7 vs. > 7). As a result, for each participating institute, patients with 
high anxiety scores and those with low anxiety scores were equally allocated to 
either the experimental or control group.
Interventions 
Both interventions were administered during a 4-month time period, with 
a minimum of 13 and a maximum of 16 sessions. Each session consisted of 
two 20- to 25-minute blocks divided by a 10- to 15-minute break. Thus, each 
session lasted approximately one hour. The CBT intervention was administered 
by a certified healthcare psychologist (‘therapist’) who had ample experience 
in treating depression as well as with stroke rehabilitation in general. All 
therapists were additionally trained by JK to master the specific aspects of the 
current CBT intervention. Goals for attaining daily life activities were primarily 
set together by the patient and the therapist using pictures from the Activity 
Card Sort.21 Concurrently with the psychological sessions, the CBT intervention 
was augmented with three sessions of occupational therapy (OT) or movement 
therapy (MT). During these sessions, an occupational or movement therapist 
helped patients with establishing and attaining goals aimed at meaningful 
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activities and social participation. These goals were attuned to the content of 
the psychological sessions. In the case of a baseline HADS–A score > 7, the 
protocol was extended with an additional (fourth) OT/MT session aimed at 
training relaxation techniques as provided by the Dutch Heart Foundation.22 
To implement the recommendations made by Broomfield,10 therapists were 
continuously reminded to use concrete, repetitive, accessible, slow and structured 
communication strategies as proposed by Judd.23 A detailed description of the 
applied CBT intervention has been published elsewhere.14
We selected CCT as the comparative intervention to control for nonspecific 
(e.g. Hawthorne) effects. In a previous study, this type of training yielded high 
satisfaction scores.24 In the current study, CCT was largely self-administered, 
but either cognitive trainers or psychological assistants were present to assist 
the participants during the training. They were instructed not to engage in any 
conversation with the patients about topics other than the cognitive training. 
A desktop was set up with a headphone and a keyboard with colored patches 
attached to two keys. Patients could select any (or a combination) of four specific 
cognitive domains for training, i.e. attention, memory, executive functioning, 
and/or visual attention. As patients improved, the Cogniplus^ program adjusted 
the level of difficulty for each training task accordingly. In this way, each patient 
trained at his/her individual level and pace. 
Co-interventions
During the study, patients were requested to minimize co-interventions by other 
therapists and to refrain from starting new medication. Any existing (psycho)
pharmacological treatment was continued. All co-interventions were registered 
in a booklet at each assessment. 
Assessments
Baseline assessments consisted of the following characteristics: age (years), sex 
(male, female), employment (yes, no), time since stroke (months), stroke type 
(ischemic, hemorrhagic, other), affected hemisphere (left, right, other), mobility 
(Stroke Impact Scale-subscale Mobility)25, co-morbidity (Cumulative Illness Rating 
Scale),26 level of independence (Barthel Index),20 and cognition (MMSE).18 Except 
for co-morbidity, higher scores reflect better outcomes on the scales mentioned. 
The primary outcome was the severity of depressive symptoms as assessed with 
the HADS-D. The HADS has been specifically validated to assess depressive 
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symptoms in stroke patients.17 Secondary outcomes were HADS-A for symptoms 
of anxiety; the Post Stroke Depression Rating Scale (PSDRS) for assessing the more 
qualitative aspects of mood;27 coping assessed with the Utrecht Proactive Coping 
Competence scale (UPCC);28 quality of life assessed with the Stroke Specific 
Quality of Life (SSQoL) scale;29 social participation assessed with the Utrecht 
Scale for Evaluation of Rehabilitation - Participation (USERP;30 and subjective 
well-being assessed with a life satisfaction questionnaire (LS2).31 Except for HADS 
and PSDRS scores, higher scores reflect better outcomes.
Statistical analyses  
This study was originally powered on the HADS-D at 4 months post treatment 
(i.e., T2) without accounting for improved precision due to repeated measures 
(at T1 and T3). To obtain a power of 80% with an α-level of 5%, we originally 
aimed to include a total of 106 participants.13 In this calculation, adjustments for 
baseline values (i.e., T0) and post treatment values (i.e., at T2) and a drop-out 
rate of 15% were taken into account. Due to the lower than expected inclusion 
rate, we investigated whether accounting for the additionally repeated measures 
at T1 and/or T3 could provide sufficient power. Using the method as described 
by De Hoop,32 we calculated that including an extra post-treatment value (i.e., 
T1) would provide sufficient power with half the originally planned subjects. 
This was discussed with and approved by the medical-ethical committee. As a 
consequence, a minimal number of 53 participants was needed.
Median and ranges or numbers and percentages were used for descriptive 
statistics in the case of continuous and categorical variables, respectively. After 
confirming normal distribution of the dependent continuous variables, we used 
linear mixed models for repeated measures to study the differences between 
groups for each outcome (dependent variable). The independent fixed variables 
were group (CBT vs. CCT), baseline score, time point of measurement (T0-T3), 
the minimization factor HADS–A > 7, and the interaction term between point 
of measurement and group. The participating institute was treated as a random 
variable. We present the baseline-adjusted mean differences between groups at 
each time point with 95% confidence intervals. The effects of the intervention on 
the primary and secondary outcome measures were analyzed according to the 
intention-to-treat principle using SAS 9.2 for Windows and IBM SPSS Statistics 20 
for Windows. Data analysis was performed by an independent statistician who 
was blinded for group allocation.  
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Results
Participants
Figure 1 presents the patient flow throughout the study. Trial inclusion took place 
from January 2011 until August 2012, and ended according to prior agreements 
with the medical ethical committee. Out of 163 referred patients, 61 ultimately 
participated. Of these, 31 patients were assigned to the CBT and 30 patients to 
the CCT intervention. Incomplete interventions occurred once in the CBT group 
(change in protocol by psychologist) and four times in the CCT group (related 
to suicidal thoughts (n=1); dissatisfaction with intervention (n=2); no reason/not 
specified (n=1). Fifty-two patients completed the post treatment assessment, of 
whom 44 completed the last follow-up. Patient characteristics are listed in Table 
1. 
Table 1. Patient characteristics at baseline
CBT CCT
n Median(range) / n(%) n Median(range) / n(%)
Age (years) 31 61 (45;79) 30 61 (25;76)
TSS (months) 26 (2;243) 21.5 (2;138)
Men 31 19 (61.3) 30 19 (63.3)
Employed 31 9 (29) 30 13 (43.3)
Stroke type 28 28
Infarct 21 (75) 24 (85.7)
Hemorrhage/ other 7 (25) 2 (7.1)
Unknown 0 2 (7.1)
Stroke hemisphere 26 28
Left 15 (57.7) 9 (32.1)
Right 8 (30.8) 11 (39.3)
Other 3 (11.5) 8 (28.6)
SIS mobility 31 65 (13;98) 30 65 (25;100)
CIRS 31 3 (0:18) 30 5 (0;13)
Barthel Index 31 20 (17;20) 30 20 (12;20)
MMSE 31 30 (27;30) 30 30 (24;30)
HADS 31 30
Depression 12 (8;20) 12 (8;20)
Anxiety 9 (4;17) 10 (1;18)
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Control of bias
More than 95% of all assessments were performed according to the protocol.15 
Some exceptions were: extra pauses (T0, n=1); missing page in assessment 
booklet (T1, n=1); UPCC questionnaire too difficult to understand (T1, n=1); and 
UPCC and LS2 questionnaires filled in at home due to time constraints (T1, n=1). 
Assessor unblinding by the patient occurred in 13% of the T1 assessments, 10% 
of the T2 assessments, and 9% of the T3 assessments. In the CBT group, one 
patient had sought contact with a psychologist outside the trial for additional 
anxiety therapy (T1), and one patient had started antidepressants (T2). In the CCT 
group one patient commenced with antidepressants at T1.  
Interaction effects and group differences
Table 2 presents the primary and secondary outcomes by point of measurement 
for each group. Changes in HADS-D were never significant between groups (See 
also, Figure 2). No group differences after treatment were found for any of the 
primary or secondary outcomes. Therefore, a parallel line model is presented for 
all variables in Table 3.
Figure 2. Mean scores for CCT and CBT at all assessment time points
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Table 2. Observed median (range) of the primary and secondary outcomes by point of 
measurement by group
Baseline Post treatment 4-month follow up 8-month follow up
N Median (range) N Median (range) N  Median (range) N  Median (range)
HADS-D
CBT 31 12.0 (8.0;20.0) 24 8.00 (0.0;15.0) 24 9.0 (0.0;19.0) 23 8.0 (0.0;19.0)
CCT 30 12.0 (8.0;20.0) 28 9.00 (1.0;14.0) 24 8.5 (0.0;16.0) 20 7.5 (0.0;12.0)
HADS-A
CBT 31 9.0 (4.0;17.0) 24 6.5 (2.0;18.0) 24 6.0 (0.0;17.0) 23 5.0 (0.0;17.0)
CCT 30 10.0 (1.0;18.0) 28 7.5 (0.0;16) 24 7.0 (2.0;15.0) 20 6.0 (0.0;13.0)
PSDRS
CBT 30 14.0 (3.0;24.0) 23 10.3 (2.0;21.0) 24 8.0 (2.0;22.3) 22 8.2 (1.0;18.0)
CCT 30 12.0 (4.0;25.3) 28 9.0 (1.0;21.0) 24 8.5 (0.0;23.3) 20 7.5 (2.0;18.0)
UPCC
CBT 31 2.5 (1.5;3.2) 24 2.5 (1.4;3.8) 23 2.6 (1.7;3.5) 23 2.5 (1.7;3.6)
CCT 30 2.5 (1.5;3.8) 27 2.4 (1.7;4.0) 23 2.4 (1.5;3.8) 20 2.7 (1.8;4.0)
SSQoL
CBT 31 3.2 (2.1;4.7) 24 3.8 (2.2;5.0) 24 3.5 (2.1;4.9) 24 3.7 (2.2;5.0)
CCT 30 3.1 (2.0;4.7) 28 3.5 (1.9;4.8) 24 3.3 (2.2;4.7) 20 3.7 (1.8;5.0)
USERP freq part A
CBT 31 12.6 (5.0;30.0) 24 14.0 (5.0;35.0) 24 11.5 (5.0;25.0) 24 12.7 (5.0;30.0)
CCT 30 14.5 (5.0;50.0) 28 13.4 (5.0;45.0) 24 13.1 (0.0;35.0) 20 14.3 (0.0;45.0)
USERP freq part B
CBT 31 45.0 (7.5;82.5) 24 43.8 (20.0;77.5) 24 51.3 (27.5;70.0) 24 47.5 (17.5;77.5)
CCT 30 42.5 (15.0;80.0) 28 45.0 (5.0;70.0) 24 46.3 (12.5;72.5) 20 50.0 (17.5;70.0)
USERP satisfaction
CBT 31 56.3 (19.4;88.9) 24 66.3 (27.8;94.4) 24 68.1 (30.6;99.4) 24 63.9 (30.6;91.7)
CCT 31 51.4 (11.1;78.1) 28 62.5 (30.6;88.9) 24 62.5 (30.6;80.6) 20 63.9 (34.4;91.7)
USERP restriction
CBT 31 72.5 (50.0;94.4) 24 75.0 (43.6;100.0) 24 77.6 (55.0;94.4) 24 73.8 (52.8;100.0)
CCT 30 71.4 (46.9;100.0) 28 75.0 (50.0;94.4) 24 73.8 (50.0;96.9) 20 81.2 (52.8;100.0)
LS2
CBT 31 4.0 (2.0;11.0) 24 6.0 (3.0;13.0) 24 7.5 (2.0;13.0) 24 7.0 (0.0;13.0)
CCT 30 4.0 (2.0;12.0) 28 5.0 (3.0;11.0) 24 6.5 (2.0;13.0) 20 7.0 (3.0;13.0)
Abbreviations: HADS-D, Depression subscale Hospital Anxiety and Depression Scale (range 0-21); 
HADS-A, Anxiety subscale Hospital Anxiety and Depression Scale (range 0-21); PSDRS, Post Stroke 
Depression Rating Scale (range 0-45); UPCC, Utrecht Proactive Coping Competence list (range 1-4); 
SSQoL, short Stroke Specific Quality of Life Scale (range 1-5); USERP, Utrecht Scale of Rehabilitation – 
Participation, (USERP Frequency part A: Vocational activities, USERP Frequency part B: Leisure activities) 
(range 0-100, each subscale); LS2, two Life Satisfaction questions (range 2-13).
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Time effects
Table 3 depicts the estimated mean differences (MD) between points of 
measurement, adjusted for baseline values, for all outcomes and for both groups 
together. A post treatment effect was found for the primary outcome HADS-D 
(MD=-4.6, 95%CI=-5.7;-3.6). The overall time effect of HADS-D from post 
treatment to 8-months follow-up was not significant. Yet, HADS-D showed 
a significant increase from post treatment to 4-months follow-up (MD=1.1, 
95%CI=0.2;1.9), followed by a significant decline from 4-months to 8-months 
follow-up (MD=-1.4, 95%CI=-2.1;-0.7) for both groups. 
A post treatment effect was also observed for HADS-A (MD=-2.6, 95%CI=-3.6;-
1.5), PSDRS (MD=-3.4, 95%CI=-4.9;-2.0), USERP–subscale Satisfaction(MD=9.7, 
95%CI=5.4;14.1), SSQOL (MD=0.3; 95%CI=0.1;0.5), and LS2 (MD=1.3, 
95%CI=0.7;2.0), but not for UPCC. However, UPCC showed a significant change 
from post treatment to 8-months follow-up (MD=0.1, 95%CI=0.0;0.3) as did 
PSDRS (MD=-1.9, 95%CI=-3.1;-0.7) and LS2 (MD=0.6, 95%CI=0.0;1.3). 
Discussion
The aim of our study was to evaluate the effectiveness of individually tailored 
cognitive behavioral therapy for reducing depressive symptoms with or without 
anxiety after stroke. The results of our multicenter RCT indicate that there was 
significant and persistent improvement of depressive and anxiety complaints 
after treatment, although this was independent of the type of intervention. In 
addition, the subjective ratings of patients’ participation level (USERP-satisfaction) 
increased after treatment, as did quality of life (SSQoL) and life satisfaction (LS2). 
These results appear to be similar to those of Lincoln and Flannaghan10 even 
though our CBT was of longer duration and higher intensity, was augmented with 
occupational or movement therapy, was provided by well-trained psychologists, 
and took cognitive impairments and anxiety complaints into account. Like our 
study, Lincoln and Flannaghan10 found no differences between intervention 
groups (i.e., no intervention, attention placebo, CBT),33 although they did find 
a small decline (3-4 points) in median score on the Beck Depression Inventory 
(BDI; range 0-63) for each group directly after the intervention period. Notably, 
the relative improvements that were observed in the present study were larger 
(i.e., 3-4 points on HADS-D; range 0-21), which suggests that both treatments 
may have caused a beneficial effect. As our study lacked a ‘no intervention’ 
control group, it cannot be ruled out that any beneficial effect of either CBT 
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or CCT was non-specific or that HADS-D scores simply improved due to 
‘regression to the mean’. However, the observed improvements were relatively 
large, whereas recent literature shows that depressive symptoms post stroke 
(measured with the BDI) remain stable over the first two years.34 In addition, our 
Restore4Stroke consortium recently reported non-significant fluctuations in post 
stroke depressive symptoms (maximally 2 points change in HADS-D) over the 
first two years.35 These findings point toward the possibility that the observed 
decline in depressive symptoms after treatment in the present study may actually 
represent a beneficial effect of both CBT and CCT. This notion raises the question 
what the effective component of CCT might have been, as we took care that 
cognitive trainers and psychological assistants were instructed not to address 
issues other than the cognitive training. Interestingly, in a recent evaluation of 
CCT, Åkerlund and colleagues showed that patients with acquired brain injury 
who suffered from depressive complaints demonstrated mood improvements 
after CCT which suggests that cognitive training may improve mood through 
motivational mechanisms or perhaps through cognitive improvement.36 
Irrespective of the underlying mechanism, it may be that such effects occurred in 
our study. Unfortunately, at the initiation of our study, beneficial effects results of 
CCT on mood problems were not yet known. 
Quality of life scores as well as satisfaction with life and with participation 
equally and persistently improved in both groups after treatment as did anxiety 
level. Pro-active coping did not immediately respond after the intervention, but it 
improved during follow-up, together with life satisfaction and qualitative aspects 
of mood. In a recent study from our Restore4Stroke consortium, change in 
depression scores was associated with subjective experience of participation,37 
emphasizing that rehabilitation should focus on resuming occupational activities 
when treating depressive complaints after stroke. Although in the present study 
this approach was applied in the CBT intervention, it remains to be explained 
why we found no group differences for any of the secondary outcomes, and why 
CBT and CCT had similar effects. 
Limitations
Apart from the absence of a ‘no intervention’ control group, the main limitation 
of the present study is the relatively small patient sample and the recruitment 
through rehabilitation institutes, which limits the generalizability of our results. It 
is well known that recruiting patients with depressive symptoms for participation 
in research is notoriously difficult.38 Patients who did participate may have been 
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more motivated than those who did not, which may have led to selection bias. 
This too would limit the generalizability of our results. Although we did not reach 
the inclusion as originally planned, the risk of false negative outcomes for group 
by time interactions seems to be small because no trends were observed towards 
significant interactions. We were not able to directly compare our results to those 
of Lincoln and Flannaghan,10 as we used HADS-D instead of BDI as a primary 
outcome. This choice was determined by the intention to prevent overestimation 
of depressive symptoms due to general symptoms (e.g. fatigue) of stroke. Unlike 
the BDI, the HADS does not include fatigue as a symptom of depressed mood. 
Conclusion
This RCT showed persistent improvement of depressive symptoms, anxiety 
symptoms, quality of life, satisfaction with life and participation after both 
cognitive behavioral therapy and computerized cognitive training in patients 
with depressive complaints minimally three months after stroke. This finding 
implies that, for now, both types of interventions may be considered to improve 
depressive symptoms after stroke. Future research should determine whether 
both interventions are better compared to natural history and what underlying 
mechanisms are responsible for such effects.
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Abstract
Depressive and anxiety symptoms after stroke have a high impact on patients’ 
daily life functioning and their rehabilitation. These emotional consequences of 
stroke also have negative effects on caregivers’ well-being. 
Obective: We investigated the concomitant effects of two patient-directed 
interventions on caregivers’ well-being. The treatments that stroke patients 
received consisted of an augmented cognitive behavioural therapy (CBT) or a 
computerised cognitive training (CCT) to alleviate depressive symptoms post 
stroke. 
Design: Randomised controlled trial. Caregivers were assessed at baseline, post 
treatment, and 4 and 8 months post treatment. Linear mixed models for repeated 
measures were used for statistical analysis.
Subjects: Fifty caregivers of stroke patients that received either CBT (n=23) or 
CCT (n=27).
Outcome measures: Emotional burden (IEQ-BI), practical burden (CSI), mental 
health (GHQ), and emotional complaints (HADS). 
Results: Caregivers of patients who received CBT reported significantly higher 
GHQ levels and less worrying about patients’ well-being. In addition, there were 
positive time effects on IEQ-BI, particularly the subscales Worrying, Supervision 
and Tension.
Conclusion: The results suggest that augmented CBT aimed at improving patients’ 
emotional, behavioural and social functioning positively affects some aspects of 
caregivers’ well-being. Future studies should take into account the concomitant 
effects of patient-directed interventions on caregivers well-being as well as on 
their possible role in the implementation and effect of these interventions.
99Treating patients with post-stroke depressive symptoms: caregivers well-being?
Introduction
Stroke survivors are frequently left with physical, cognitive and emotional 
problems in the chronic phase of their illness.1,2 The majority of these patients 
are discharged home after a hospital stay, although they may still need practical 
support as they face limitations in daily routines. Their spouses are often 
obliged to adopt a caregiver-role. This may change the independent, pre-stroke 
relationship dramatically.3 Providing care at home for a patient after stroke requires 
considerable effort.4 According to Cameron and colleagues (2011), it is not so 
much the physical, but rather the psychological sequelae of stroke that influence 
caregivers’ well-being. Furthermore, stroke survivors’ depressive symptoms 
were found to be a ‘significant challenge’ for caregivers.2 Caregivers often 
experience negative effects on their own emotional stability. This is expressed 
by high prevalence rates of depression, anxiety and lower life satisfaction in 
caregivers.5-7 In patients with acquired brain injury, Geurtsen et al. showed that 
caregivers experience a high level of emotional burden, indicated by concern, 
worries and feelings of responsibility for the patients’ well-being.2,3,8-11 Geurtsen 
et al. proposed that caregivers’ emotional burden may be an ‘anticipatory 
construct’ that depends on expectations of patients’ emotions and functioning,12 
since they found that emotional burden was not associated with a more stable 
construct, mental health. Moreover, caregivers experience restrictions in their 
societal participation, for instance with regard to employment and recreational 
activities13,14 which may lead to social isolation and limited support from family 
and friends.15 Conversely, the well-being of caregivers may also influence the 
well-being of patients. Indeed, depressive symptoms in caregivers may worsen 
the post-stroke depressive symptoms in patients and negatively affect patients’ 
rehabilitation and well-being.16,17 
A small number of studies have investigated the effect of interventions specifically 
aimed at the caregivers of patients with stroke,18 but there are no clinical 
practice guidelines yet19,20 In their Brain Integration Program study, Geurtsen and 
colleagues showed that interventions for patients with acquired brain injury can 
have a concomitant positive effect on caregivers’ emotional burden and mental 
health.21 Their intervention was activity-focused and directed at balancing daily 
life activities with the practical and physical consequences of an acquired brain 
injury.21 Their study showed that a positive effect on caregivers’ worrying and 
mental health was already apparent during the waiting list phase, indicating that 
at least some changes in emotional burden were anticipatory and caused by 
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hopes and expectations of caregivers rather than by actual patient improvement.9 
We recently studied the effects of an augmented cognitive behavioural therapy 
compared to computerised cognitive training for post-stroke depressive 
symptoms in a randomised controlled trial.22 The cognitive behavioural 
therapy was aimed at ameliorating patients’ emotional, behavioural and social 
functioning, which was complemented (‘augmented’) with activity oriented goal 
attainment supported by a movement of occupational therapist.23 Interestingly, 
we found that both interventions were equally effective for reducing post-stroke 
depressive symptoms. Caregivers’ practical and emotional burden, mental health 
and emotional complaints were also assessed in this study. The results of these 
assessments are reported in the present paper. As opposed to cognitive training, 
cognitive behavioural therapy is directed at cognitive and behavioural change, 
which has a possible influence on caregivers’ well-being.2 Therefore, we will 
compare both caregiver groups in the current study. 
Methods
Participants and design
All patients participated in a randomised controlled trial, as part of the 
Restore4Stroke study in the Netherlands. For methodological details of the study 
design we refer to a previous publication.24 Sixty-one patients with stroke and 
with a baseline score >7 on the depression subscale of the Hospital Anxiety 
and Depression Scale (HADS)25 were included in the main trial.22 Patients were 
randomly assigned to either the experimental cognitive behavioural therapy (CBT) 
or to computerised cognitive training (CCT; Cogniplus) as a control intervention. 
For details of the CBT treatment protocol, we refer to another publication.23 Both 
interventions lasted 4 months.
All caregivers were invited to participate as well. At inclusion of the patients, 
all caregivers were informed by the primary researcher about the purpose of 
the study by means of a letter. They were considered eligible if they had a 
relationship with the patient at the moment of inclusion, were at least 18 years 
old, and had adequate knowledge of the Dutch language. After every patient 
assessment session, caregivers received questionnaires in hardcopy booklets 
which they returned by post. If necessary, they were reminded by phone in case 
the booklets were not returned within 2 weeks. Socio-demographic data were 
collected at inclusion: caregivers’ age, gender, education level, marital status, 
and financial situation. In addition, caregivers answered questions about the 
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type of relationship and frequency of contact with the patient, and about the 
presence of children in their household. Caregiver outcome data were collected 
at the same time points as patient outcome data were obtained at enrolment 
(before randomisation), directly after the intervention (after 4 months), and at 4 
and 8 months follow-up. The study was approved by the Committee on research 
involving Human Subjects, Nijmegen, The Netherlands and by all participating 
institutes. Written informed consent was collected from all caregivers at 
enrollment. 
Outcome measures
General Mental Health
The General Health Questionnaire (GHQ) is a 12-item self-report instrument and 
was used for the measurement of mental health with a Likert-scoring method.26 
Lower scores indicate that caregivers experience lower mental health.26 This 
scale has shown good internal consistency27 and test-retest reliability.28 
Emotional Burden 
Emotional burden was measured with the Involvement Evaluation Questionnaire 
for Brain Injury (IEQ-BI)9,29 This scale is a 31 item self-report questionnaire in 
Dutch, covering four subscales: tension, supervision, worrying, and urging. The 
subscale “tension” refers to a strained interpersonal atmosphere; “supervision” 
refers to control on a patient’s behaviour; “worrying” addresses painful 
interpersonal cognitions; and “urging” refers to any kind of action to stimulate 
the patient to undertake activities.30 All subscales were scored on a 5-point Likert 
scale. Lower scores indicate lower levels of caregiver burden. The IEQ-BI has 
shown good internal consistency, discriminant validity and responsiveness.31
Practical Burden
The Caregiver Strain Index (CSI) was used as a brief instrument to identify 
strain on caregivers.32 The CSI contains 13 items measuring the levels of stress 
experienced by caregivers. Questions can be answered with yes (1) or no (0). A 
score ≥ 7 indicates the existence of caregiver strain. The CSI has shown good 
internal consistency32 and test-retest reliability.33
Symptoms of Depression and Anxiety
Depressive and anxiety symptoms in caregivers were measured with the HADS. 
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The HADS consists of 14 items. Seven items constitute the subscale depression 
(HADS-D), while the other seven items form the subscale anxiety (HADS-A).25 
All items were rated on a four-point scale ranging from 0 to 3. A score 3 indicates 
the highest experienced level of emotional distress. The HADS has shown good 
internal consistency34 and good test-retest reliability.35
Statistical Analysis 
To analyse group differences for each of the outcome measures, we used linear 
mixed models for repeated measures with adjustment for baseline values. 
Analyses were performed using the intention-to-treat principle. The dependent 
variables were the outcome measures (i.e., IEQ-BI total; IEQ-BI supervision; IEQ-
BI tension; IEQ-BI worrying; IEQ-BI urging; CSI; GHQ; HADS-D; HADS-A). The 
independent variables were Treatment (CBT vs. CCT) and Time (4 time points, 
T0-T3). Treatment and Time effects are presented as mean differences (MD) 
with 95% confidence intervals (CIs). The level of significance was set at 0.05. 
Analyses were performed with SAS 9.2 for Windows and IBM SPSS Statistics 20 
for Windows. Data analysis was performed by an independent statistician who 
was blinded for group allocation.
Results
The 61 patients enrolled in the Restore4Stroke study had a median age of 61.5 
years, 62.9% were men, and 72.9% had suffered an ischemic stroke. Caregivers 
of 50 patients were included in the present study, of whom 23 were related 
to a patient who received CBT. The socio-demographic and psychological 
characteristics at baseline are displayed for each group in Table 1. Sixty-four 
percent of the total group were women and the median age of both sexes was 
58 years (range: 30-82). Due to patient drop-out, the data of 4 caregivers at 
4-month follow-up and of 7 caregivers at 8-month follow-up were lost. The post-
treatment data of 6 other caregivers were lost, either because their partners did 
not complete the treatment or because they were unwilling to continue. Table 2 
shows the median values and ranges for each of the outcome measures for both 
treatment groups at four time points. 
Table 3 shows the overall treatment effects on all outcome measures as well as 
the post-hoc analyses per point of measurement corrected for baseline values. 
The GHQ showed a significant overall treatment effect in favour of the CBT 
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group (MD=1.78; 95%CI=0.43 - 3.13, p=0.01; see Figure 1 for observed means). 
Post-hoc analyses showed significant group differences directly post treatment 
(MD=1.82; 95%CI=0.20 - 3.44, p=0.03) and at 4 months post treatment 
(MD=2.60; 95%CI=0.34 - 4.87, p=0.02), but no longer at 8-months follow-up 
(MD=1.59; 95%CI=-0.25 - 3.43, p=0.09). As for the IEQ-BI, a significant overall 
treatment effect in favour of the CBT group was found only for the subscale 
worrying (MD=1.9; 95%CI=0.56 - 3.24, p< 0.01; see Figure 2 for observed 
means). Post-hoc analyses showed significant group differences only at 8 months 
post treatment (MD=2.64; 95%CI=0.83 - 4.45, p< 0.01). No significant treatment 
effects were found for any of the other outcomes.
Table 1. Caregivers’ demographics and baseline characteristics
CBT CCT
Characteristics N median (min-max)/n (%) N median (min-max)/n (%)
Sex 23 27
Men 8 (34.8) 10 (37)
Women 15 (65.2) 17 (63)
Age (yrs) 27 58 (30-78) 23 58 (36-82)
Educational level* 23 27
High 9 (39.1) 2 (7.4)
Low 14 (60.9) 25 (92.6)
IEQ-BI
Total (0-108) 22 18.5 (3-45) 24 18.5 (4-54)
Tension (0-36) 24 7 (0-16) 23 6.5 (1-19)
Supervision (0-24) 24 1 (0-7) 23 1 (0-8)
Worrying (0-24) 27 5.5 (0-17) 22 6 (1-14)
Urging (0-32) 24 6 (0-21) 23 7.5 (0-20)
GHQ (0-12) 26 3 (0-10) 23 1 (0-11)
CSI (0-13) 27 7 (0-13) 23 6 (0-12)
HADS
Depression (0-21) 27 5 (0-13) 23 4 (0-11)
Anxiety (0-21) 27 7 (0-13) 23 6 (1-15)
*based on education system of Verhage. CBT: Cognitive Behavioural Therapy, CCT: Computerised 
Cognitive Training, IEQ-BI Total: Involvement and Evaluation Questionnaire - Brain Injury Total (0-108), 
IEQ-BI Tension: Involvement and Evaluation Questionnaire - Brain Injury tension subscale (0-36), IEQ-
BI Supervision: Involvement and Evaluation Questionnaire - Brain Injury supervision subscale (0-24), 
IEQ-BI Worrying: Involvement and Evaluation Questionnaire - Brain Injury worrying subscale (0-24), 
IEQ-BI Urging: Involvement and Evaluation Questionnaire - Brain Injury urging subscale (0-32), CSI: 
Caregiver strain index (0-13), GHQ: General Health Questionnaire (0-12), HADS-D: Hospital anxiety 
and depression scale depression subscale (0-21), HADS-A: Hospital anxiety and depression scale 
anxiety subscale (0-21).
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Table 2. Observed median (range) of the caregiver outcomes by point of measurement by 
group
Baseline Post treatment 4 month follow-up 8 month follow-up
Outcomes N median
(min;max)
N median
(min;max)
N median
(min;max)
N median
(min;max)
IEQ-BI Total
CBTl 23 17 (3;45) 18 14 (2;65) 15 12 (2;59) 16 9.5 (0;41)
CCT 24 18.5 (4;54) 24 17.5 (1;51) 20 12.5 (2;52) 15 14 (1;55)
IEQ-BI Tension
CBT 23 7 (0;16) 18 4 (0;27) 15 4 (0;27) 16 4 (0;17)
CCT 24 6.5 (1;19) 24 6 (0;20) 20 5 (1;18) 15 5 (0;17)
IEQ-BI Supervision
CBT 23 1 (0;7) 18 0.5 (0;7) 15 0 (0;8) 16 0 (0;3)
CCT 24 1 (0;8) 24 1 (0;5) 20 1 (0;4) 15 0 (0;3)
IEQ-BI Worrying
CBT 23 5 (0;17) 18 3.5 (0;21) 17 4 (0;19) 16 3 (0;9)
CCT 27 6 (1;14) 24 5.5 (0;16) 21 4 (1;15) 16 4.5 (0;13)
IEQ-BI Urging
CBT  23 6 (0;21) 18 5.5 (0;19) 15 8 (0;19) 17 4 (0;21)
CCT  24 7.5 (0;20) 24 5 (0;17) 20 4 (0;22) 15 5 (0;26)
GHQ
CBT 23 3 (0;10) 17 1 (0;9) 15 0 (0;10) 17 1 (0;9)
CCT 26 1 (0;11) 23 3 (0;12) 21 5 (0;12) 16 2.5 (0;10)
CSI
 CBT 23 7 (0;13) 20 5.5 (0;13) 19 5 (0;12) 17 6 (0;11)
CCT 27 6 (0;12) 24 6 (0;11) 21 6 (0;11) 16 5 (0;11)
HADS-D
CBT 23 5 (0;13) 18 5.5 (0;11) 16 3.5 (0;11) 17 5 (0;11)
CCT 27 4 (0;11) 24 6 (0;17) 21 6 (0;12) 16 4.5 (0;12)
HADS-A
CBT 23 7 (0;13) 18 6 (0;13) 16 5.5 (0;14) 17 5 (0;15)
CCT 27 6 (1;15) 24 6 (0;17) 21 7 (0;14) 16 5 (1;13)
CBT: Cognitive Behavioural Therapy, CCT: Computerised Cognitive Training, Involvement and 
Evaluation Questionnaire (IEQ-BI) - Brain Injury Total (0-108), IEQ-BI Tension subscale (0-36), IEQ-
BI Supervision subscale (0-24), IEQ-BI Worrying subscale (0-24), IEQ-BI Urging subscale (0-32), 
CSI: Caregiver strain index (0-13), GHQ: General Health Questionnaire (0-12), Hospital anxiety and 
depression scale (HADS) Depression subscale (0-21), HADS Anxiety subscale (0-21)
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Figure 1. GHQ Score (0-12). Differences between caregivers in CBT grou and CCT group. T0 
=at inclusion, T1 =post treatment, T2 =4 month post treatment, T3 =8 month post treatment. 
Figure 2. IEQ Worrying Score (0-24). Differences between caregivers in CBT group and CCT 
group. T0 =at inclusion, T1 =post treatment, T2 =4 month post treatment, T3 =8 month post 
treatment
Time effects
For both groups, a significant overall time effect was found on the IEQ-BI total 
score (MD=3.55; 95%CI=0.38 - 6.72, p=0.03), IEQ-BI supervision (MD=0.54; 
95%CI=0.01 - 1.08, p=0.05) and IEQ-BI worrying (MD=1.18; 95%CI=0.11 - 2.24, 
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p=0.03), IEQ-BI Tension (MD=1.71; 95%CI=0.43 - 3.00, p=0.01). The IEQ-BI 
urging, GHQ, CSI or the HADS did not show any significant time effects. 
Discussion
In the present study we evaluated the concomitant effects on caregivers’ well-
being when stroke survivors with depressive symptoms received either augmented 
cognitive behavioural therapy (CBT) or computerised cognitive training (CCT). 
Caregivers’ well-being was operationalised in terms of mental health, emotional 
burden, practical burden and depressive and anxiety symptoms. This study 
showed that caregivers reported better mental health and lower levels of worrying 
when their spouses received CBT compared to CCT. These findings suggest that 
an intervention for reducing depressive symptoms post stroke may indeed be able 
to influence caregivers’ well-being.2,36 Although the effects were small, they are 
remarkable since the results from this trial did not show differential intervention 
effects in terms of patient-related outcomes. That is, depressive symptoms of 
patients decreased over time regardless of the type of intervention they had 
received.22 This lack of group differences in patient-related outcomes raised the 
question whether we had found a non-specific (e.g. Hawthorne) effect, although 
both interventions brought about a similar level of ‘attention’. Indeed, the two 
interventions were similar in that they were weekly administered to the patient by 
a therapist or assistant in a rehabilitation centre.22,23 Yet, the interventions differed 
in their content. Whereas the CBT group received a psychological treatment 
complemented with activity oriented goal attainment supported by a movement 
of occupational therapist,23 the CCT group merely received supervised cognitive 
training modules on a computer. Moreover, the CBT augmented with specific 
goal attainment led to a vast amount of homework, which was not the case for 
CCT. Although the caregivers were not directly addressed in either intervention, a 
potential reason for the differential effects on caregivers in the present study may 
be related to interaction in the home situation. Having a partner that commits to 
homework to achieve activity oriented goals may have had concomitant positive 
effects on the caregiver. As providing such homework can easily be added to any 
type of psychological intervention, future research should take into account the 
concomitant effects of patient-directed interventions on caregivers well-being, 
particularly when such interventions include homework to achieve activity 
related goals. Caregivers may also play a supportive role in the implementation 
and effect of home-based interventions.
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The chronicity of patients’ impairments following stroke may play a role in the 
absence of other effects on the caregivers.1 Although emotional complaints 
of patients improved after treatment, their physical and cognitive impairments 
following stroke were still the same. These remaining impairments continued to 
limit patients in the performance of daily activities and to restrict them in their social 
participation. Hence, caregivers retained a ‘caregiver-role’ and their practical 
burden remained unchanged. This is a relevant consideration, as particularly the 
CSI is sensitive to practical burden which may explain why it did not show any 
change. Our pattern of results is congruent with the notion of Geurtsen et al.9 
and Davis et al.37 that practical burden, mental health and emotional burden 
are different constructs.9,37 Therefore, future intervention studies directed at 
the improvement of the emotional consequences of stroke should focus on all 
those constructs when their impact on caregivers is assessed. Evidence for the 
effectiveness of specific interventions primarily directed at caregivers of stroke 
patients is still lacking18,38 but, currently, the effects of a complex intervention 
program for caregivers of stroke survivors, taking into account both practical 
burden and mental health, are being investigated.19 
This study has several limitations. First, the analyses that were performed were 
not adjusted for multiple testing, as all caregiver-related measures were meant 
as secondary outcomes within the trial.22 Therefore, our results should be 
interpreted with caution and need replication including caregiver well-being as 
a primary outcome. Second, the absence of any effects on caregivers’ emotional 
complaints could be a consequence of using the HADS. The HADS was originally 
developed as a questionnaire for use in patients with somatic co-morbidity. As a 
consequence, the items of this questionnaire have not been validated to identify 
and monitor emotional complaints in a ‘healthy’ caregiver group.40 
In conclusion, our results suggest that augmented, activity-oriented CBT aimed 
at improving stroke patients’ emotional, behavioural and social functioning may 
positively influence relevant aspects of caregivers’ well-being. An alternative, 
current perspective on alleviating caregiver burden is to focus interventions 
directly on the problems and needs of the caregiver.41 Therefore, future 
intervention studies directed at the improvement of the emotional consequences 
after stroke need to take into account the caregivers as relevant targets for 
assessment, irrespective of whether the intervention itself is primarily aimed at 
patients or their caregivers.
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Abstract
Introduction: Stroke survivors encounter emotional problems in the chronic 
phase after stroke. Post-stroke depressive symptoms have major impact on health-
related quality of life (HRQol) and lead to increased hospitalization and therefore 
substantial healthcare costs. We present a cost-effectiveness and cost-utility 
evaluation of a cognitive behavioural therapy augmented with occupational and 
movement therapy to support patients with a stroke with depressive symptoms 
in goal-setting and goal attainment (augmented CBT) in comparison with a 
computerized cognitive training program (CogniPlus) as a control intervention.
Methods: A trial-based economic evaluation was conducted from a societal 
perspective with a time horizon of 12 months. Stroke patients (aged 18+ years) 
with signs of depression (Hospital Anxiety and Depression Scale (HADS) – 
subscale depression > 7) were eligible to participate. Primary outcomes were 
the HADS and Quality Adjusted Life Years (QALYs) based on the three-level 
five-dimensional EuroQol (EQ-5D-3L). Missing data were handled through mean 
imputation (costs) and multiple imputation (HADS and EuroQol), and costs were 
bootstrapped. Sensitivity analyses were performed to test robustness of baseline 
assumptions. 
Results: Sixty-one patients were included. The average total societal costs 
were not significantly different between the control group (€9,998.3) and the 
augmented CBT group (€8,063.7), with a 95% confidence interval (-5,284, 
1,796). The augmented CBT intervention was less costly and less effective from 
a societal perspective on the HADS, and less costly and slightly more effective 
in QALYs, in comparison with the control treatment. The cost-effectiveness and 
cost-utility analyses provided greater effects and fewer costs for the augmented 
CBT group, and fewer effects and costs for the HADS. Based on a willingness 
to pay (WTP) level of €40,000 per QALY, the augmented CBT intervention had 
a 76% chance of being cost-effective. Sensitivity analyses showed robustness of 
results.
Conclusion: The stroke-specific augmented CBT intervention did not show 
convincing cost-effectiveness results. In addition to other literature, this study 
provided new insights into the potential cost-effectiveness of an adjusted 
cognitive behavioural therapy intervention. However, as our study showed a 
76% chance of being cost-effective for one outcome measure (QALY) and did 
not provide convincing cost-effectiveness results on the HADS we recommend 
further research in a larger population.
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Introduction
Stroke is a leading cause of death and a source of persistent disability around the 
world.1 Annually, 6.7 million people die from stroke, representing 12% of all global 
deaths2 As a disease of aging, the prevalence of stroke is expected to increase 
significantly around the world in the years ahead as the global population older 
than 65 years of age continues to increase by approximately nine million people 
per year.3 Stroke survivors often encounter severe cognitive and emotional 
consequences.4 Post-stroke depressive symptoms occur frequently in the chronic 
phase after stroke.5-9 Recent data from the National Stroke Association (United 
Kingdom) show that approximately one-third of stroke survivors is affected by 
varying degrees of post-stroke depression amongst other symptoms.10 In addition, 
these symptoms often coincide with increased feelings of anxiety.11 Besides the 
major impact on health-related quality of life (HRQol),12 post-stroke depressive 
symptoms are associated with increased hospitalization and therefore substantial 
healthcare costs.13 
Stroke puts a high burden of disease on patients and their caregivers, as well as a 
considerable financial burden on society. Currently, approximately 3-4% of total 
healthcare expenditures in Western countries are spent on stroke.14 Even greater 
healthcare expenditures are likely in the near future, with expected increases 
in the elderly population and the availability of new and better treatments for 
stroke patients. As healthcare resources are limited and choices have to be 
made, interest in the economic aspect of stroke and cost-effective stroke-specific 
interventions has increased in the past few years.15 
Previous research has been used to evaluate different interventions focusing 
on the treatment of post-stroke depressive symptoms, such as pharmacological 
interventions16,17 yet evidence for the effectiveness of stroke-specific psychological 
interventions is limited.18 This is mainly related due to possible lack of efficacy 
of the interventions under investigation, but also caused by poor study design.19 
There are, however, indications that the use of cognitive behavioural therapy 
(CBT) might be both effective and cost-effective, based on the treatment of 
other chronic conditions.20-25 Psychological interventions, such as CBT, seem 
promising in terms of effectiveness because they result in fewer side effects 
than medication and have a stronger effect on preventing relapse of symptoms 
than pharmacotherapy.20,26-29 With respect to psychological interventions, fewer 
side effects and reduction in relapse are potentially strong indicators for cost-
effectiveness. Furthermore, the characteristics of CBT seem to suggest it ought to 
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be an especially good fit to meet the needs of people who suffer from post-stroke 
depression.17 Depressed stroke survivors endorse significantly more negative 
conditions than non-depressed stroke survivors.30,31 In addition, there is good 
evidence that remaining active, expressing emotion and finding positive meaning 
ensures good psychological adjustment in other chronic illnesses.32
The current study describes the cost-effectiveness and cost-utility of a cognitive 
behavioural therapy augmented with occupational and movement therapy 
to support stroke patients with depressive symptoms in goal setting and goal 
attainment (augmented CBT) for stroke patients suffering from post-stroke 
depressive symptoms, in comparison with a computerized cognitive training 
program (CogniPlus) as a control intervention. Our aim was to determine the 
cost-effectiveness of both interventions from a societal perspective.
Methods
Guidelines
The current study and economic evaluation were performed according to the 
Consolidated Health Economic Evaluation Reporting Guidelines (CHEERS).33
Design
The current study describes an economic evaluation which was linked to the 
Restore4stroke CBT study: a multi-centre randomized controlled trial (RCT) 
conducted in five rehabilitation centres and in the rehabilitation department of 
one general hospital in the Netherlands. The Medical Ethics Committee of the 
Radboud University Medical Centre and the executive boards of the participating 
institutes approved the study. The inclusion of participants took place between 
February 2012 and October 2013. All patients provided written informed 
consent. The RCT was registered in the Dutch Trial Register as NTR2999. 
Detailed information on the methods of this RCT and the current study can be 
found elsewhere.15,34
Eligibility criteria
Patients where included if they: (1) suffered any type of stroke in the last three 
months and complaints in mood (indicating possible symptoms of anxiety or 
depression) occurred post stroke, (2) were 18 years or older, (3) scored >7 on the 
HADS depression subscale (HADS-D),35 (4) mastered the Dutch language, and (5) 
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had sufficient communication skills based on the Mini-Mental State Examinate36 > 
27 and had normal score (> 0) on communication items of the National Institutes 
of Health Stroke Scale items.37 Patients were excluded if they: (1) scored < 19/20 
on the Barthel Index5 indicating premorbid disabilities, (2) were staying in an 
in-patient setting, (3) suffered from co-morbidity that might affect outcomes (e.g. 
cancer or major psychiatric illnesses for which psychological treatment was being 
given at the moment of inclusion), (4) were diagnosed with a major depression 
requiring medication, or (5) were diagnosed with a pre-morbid depression or had 
received psychiatric care for depression. 
Interventions
The augmented CBT intervention was individually administered and tailored 
according to specific subjects-own activity-related goals. These goals could 
capture domains as e.g. self-care, leisure, household, work, and improvement of 
mobility-related goals such as movement and walking. The CBT treatment program 
consisted of 10–12 sessions with a certified healthcare psychologist, experienced 
in the treatment of depression and stroke rehabilitation. The augmentation part 
of the intervention was specifically aimed at supporting patients in goal setting 
and goal attainment. This part consisted of three sessions of occupational therapy 
(OT) or movement therapy (MT) provided by an occupational or movement 
therapist. Each of these sessions was comprised of 20-25 minutes blocks divided 
by a 10-15 minute break. If a patient’s score on the HADS subscale anxiety 
(HADS-A) was > 7, the protocol was expanded with an additional (fourth) OT/
MT session.38 All treatments were provided at the closest participating centre and 
the complete program was executed within four months.
The control group was provided with an individual, patient-tailored computerized 
cognitive training program (CogniPlus).39 In specific self-determined cognitive 
domains (e.g. attention, memory, executive functioning, and visual attention) 
patients executed computer tasks on their own performance level. This impairment-
oriented intervention consisted of 13-16 sessions provided at participating centres 
under the supervision of a research assistant or psychological assistant, for a 
period of four months. We chose to compare the augmented CBT intervention 
to an ‘active’ intervention (and not usual care) to control for Hawthorne effects. 
Evidence from Spikman et al.40 showed that a similar control group did not 
improve in executive functioning, and that generalisation of what was assessed 
in the control intervention to daily life did not occur. Further information on the 
justification of both interventions can be found elsewhere.15,34 
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Procedure
Treating physicians and healthcare psychologists of the participating institutes 
were informed about the inclusion and exclusion criteria of the study. Accordingly, 
they recruited eligible patients at participating centres. Potential participants were 
contacted by the primary researcher (JK) and informed about the intervention. 
In case of a positive reply, an individual appointment was made to confirm the 
inclusion and exclusion criteria, to obtain written consent, and to conduct the 
baseline assessment. Patients were randomly allocated to either the augmented 
CBT group or control group. Stratified block randomization (block size four) was 
conducted, in which level of anxiety was a minimization factor (HADS-A > 7 
vs ≤ 7). Follow-up assessments took place at the nearest participating centre 
for each patient and were conducted by a research assistant who was blinded 
to the type of intervention provided to the patient. Prior to each assessment, 
the assessor explicitly asked patients not to talk about the content of their 
intervention. The success of assessor blinding was ensured with a short self-
constructed questionnaire at the end of each assessment. 
Time horizon
Patients were randomly allocated to one of the interventions after the baseline 
assessment (T0). Assessments took place post treatment (T1), at eight months 
follow-up (T2) and at twelve months follow-up (T3). 
Sample size
Based on a minimal detectable effect size of 0.6 the standard deviation (SD) on the 
HADS (α=0.05; β=0.80), a minimum of 45 participants per group was required. 
With an expected dropout of 15%, 106 participants needed to be recruited. 
However, due to recruitment difficulties we were not able to include the minimum 
amount of participants necessary. Reconsidering the proposed analysis of the 
Restore4stroke CBT study, it was decided to add the T1 measurement next to T2 
to estimate the effect of treatment outcomes. These repeated measures at T1 and 
T2 would reduce variance, double the power and reduce the required sample 
size. Therefore, a new power (n=53; α=0.05; β=0.80) allowed us to continue 
with fewer participants than originally planned. The Medical Ethics Committee 
approved an amendment containing these changes.
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Outcome measures
The main outcome for the cost-effectiveness analysis (CEA) was depression and 
anxiety, assessed by the HADS (total score). The HADS is a 14-item questionnaire 
(seven questions concerning ‘depression’ and seven questions concerning 
‘anxiety’) on a 4-point scale. Higher scores on the HADS indicate greater levels 
of depression and/or anxiety. The validity and reliability of the HADS has been 
determined in previous research,41 
The main outcome for the cost-utility analysis (CUA) was health-related quality of 
life (further referred to as QoL), as measured by with the five-dimensional three-
level EuroQol (EQ-5D-3L).42 The five EuroQol dimensions are mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression. To estimate the utility of 
health states described by patients, we used the Dutch tariff.43 Quality adjusted 
life years (QALYs) were calculated by means of the area under the curve method. 
Higher QALYs indicate more improvement in QoL.
Resource use and costs
A 19-item self-report cost-questionnaire was constructed to collect cost data from 
a societal perspective, based on the steps described by Thorn.44 The validity and 
feasibility of generic self-report questionnaires has been investigated elsewhere.45 
As a societal perspective is a broad perspective in which all relevant costs for the 
whole population are incorporated,46 we included four main cost categories in 
this study: intervention, healthcare, patient- and family-related, and productivity 
costs. A bottom-up approach was used to determine intervention costs (e.g. 
intervention materials, consultation hours with a psychologist). Healthcare 
costs covered care provider utilization (e.g. general practitioner and medical 
specialist consultations), complementary medicine, home care and medication. 
As a guideline for calculating healthcare costs we used the Dutch Manual for 
Costing.47
Medical and personal aids were based on costs per user within the aid category 
provided by the Dutch care institute48 and the costs of prescription medicines 
were valued by the price per dosage for drug costs in the Netherlands.49,50 
Travel costs and costs of informal care were included as patient- and family 
costs. Travel costs were calculated by multiplying the average distance with 
standard price weights provided by The Dutch Manual for Costing,47 corrected 
for the costs of public transport and parking costs. Shadow prices were used to 
determine the costs of informal care, which were equal to the hourly wage rates 
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of professional caregivers (i.e. housekeepers). Productivity costs were valued 
according to the human capital approach. This approach states that productivity 
costs are calculated by multiplying the number of sick days by the costs of 
labour, corrected for different age categories. The human capital approach is the 
international standard in calculating productivity costs, whereas its counterpart, 
the friction cost method, is subject to variability in the national economic 
cycles.51,52 Furthermore, due to changes in Dutch legislations, it is unlikely for 
employees that they are being replaced, making it imperative to include long-
term absenteeism as well. 
Currency, price date and conversion
All costs reported in this study were expressed in Euro’s (€). Consumer price 
indices were used to adjust all costs to the index year 2012.53 Discounting was 
not necessary since the follow-up period of the current study did not exceed one 
year. 
Analytic methods
Intention-to-treat was used to analyse data. Missing values for resource use 
were handled by individual mean imputation, the recommended imputation 
methods on dealing with intermittent data in economic evaluation studies.54 
Missing data on the main outcomes were handled by multiple imputation (MI). 
MI is a technique often used to analyse data sets with missing values; it is the 
process of replacing each missing data point with a set of plausible values to 
generate complete data sets.55 Since baseline utility measurements are included 
when calculating QALYs we consider any baseline difference in utility scores as 
a potential bias, regardless of whether or not this difference is significant or not. 
Therefore, we used a regression based correction method to correct for baseline 
differences in utility scores.56 
An incremental cost-effectiveness ratio (ICER) was calculated by dividing the 
incremental costs by the incremental effects, and an incremental cost-utility 
ratio was calculated by dividing the incremental costs by the differences in 
QALY. We used non-parametric bootstrapping (5000 replications) to estimate 
the uncertainty surrounding the ICER, due to the highly skewed cost distribution. 
Bootstrapped cost-effectiveness and cost-utility pairs were presented in cost-
effectiveness planes (CE-planes). Statistically significant differences in costs were 
determined by means of a 95% confidence interval (further referred to as CI). If 
121An economic evaluation of an augmented CBT intervention
the CI entailed a ‘0’ value, no statistical differences in costs were found.
Furthermore, a cost-effectiveness acceptability curve (CEAC) was made to 
express the probability of the augmented CBT intervention being a cost-effective 
alternative in comparison with the control intervention. A CEAC shows the 
probability of an intervention to be a cost-effective alternative for a certain 
threshold; the amount of money society is willing to pay (WTP) to gain one 
unit of effect (e.g. a one-point improvement on the HADS or one QALY). For 
the HADS, the WTP threshold is an unknown quantity. A previous study on 
manual psychological therapy for dementia patients used a WTP level of €500 
per one-point improvement on the HADS.57 The minimal important difference 
of the HADS has not been established, but in patients with chronic obstructive 
pulmonary disease (COPD) a minimal important difference of 1.6 was found.58 
The WTP threshold for a QALY differs per country or even within countries. In 
the Netherlands, the Dutch Council of Public Health and Care published a report 
in 2006 regarding the burden of disease in the Netherlands, estimating a QALY 
threshold for stroke at €40,000 Euros.59 All statistical analyses were performed 
using the Statistical Package for the Social Sciences (SPSS) version 21 or Microsoft 
Excel (bootstrapping).
Sensitivity analyses
To test the robustness of assumption made in the base case analyses, we conducted 
four one-way sensitivity analyses. First, the price for a rehabilitation day treatment 
was decreased to €117, equal to a regular rehabilitation consultation. Second, the 
friction cost method was used to calculate productivity costs instead of the human 
capital approach.47 Third, we compared our base case societal perspective for 
calculating costs with a healthcare perspective. Finally, as different sets of tariffs 
exist to calculate utilities, we analysed the impact of the use of Dutch tariffs 
versus United Kingdom (UK) tariffs.60
Results
Sample
One hundred sixty-three patients were assessed regarding their eligibility for 
participation in this study (Figure 1). Eighty-three patients were found ineligible 
based on their HADS-D score (≤7) and 15 patients did not meet other inclusion 
criteria. After baseline measurement, four patients dropped out due to various 
reasons. Thus, a total of 61 patients were included in this study (Table 1). Thirty-
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one patients (52%) were allocated to the augmented CBT group and 30 patients 
(48%) to the control group. As presented in figure 1, the percentage of missing 
data at T1 was 15% (n=9), at T2 was 21% (n=13) and at T3 was 28% (n=17).
Table 1. Baseline patients’ characteristics (n=61)
Augmented CBT (n=31) CogniPlus (n=30)
Demographic characteristics n M(SD) / % n M(SD) / %
Mean age in years 31 62.2 (8.3) 30 60.0 (10.5)
Gender (men) 31 61.3 30 63.3
Paid work 31 29 30 43.3 
Hours worked/week 31 2.3 (5.6) 30 5.5 (12.8)
Stroke characteristics
Time since stroke in months 31 43.9 (51.1) 30 40.2 (41.9)
Type of stroke (infarction) 28 75 28 85.7
Affected hemisphere (right) 28 30.8 26 39.3
Outcome measures
Effects
HADS Total 31 22.3 (6.2) 30 22.3 (6.7)
HADS Anxiety 31 9.9 (4.1) 30 10.0 (4.4)
HADS Depression 31 12.5 (3.3) 30 12.33 (3.4)
Utility 31 0.58 (0.27) 30 0.47 (0.30)
Costs
Healthcare costs (€) 31 2,213.4 (880.9) 30 2,051.8 (501.6)
Non-healthcare costs (€) 31 2,528.3 (712.4) 30 1,962.3 (518.1)
Total societal costs (€) 31 4,717.7 (1,203.9) 30 4,038.4 (853.7)
Cost analysis
The average total societal costs were greater for the control group (€9,998) in 
comparison with the augmented CBT group (€8,064), but this difference between 
the two groups was not significant (CI: -5284, 1,796). Healthcare costs were also 
greater for the control group (€5,055 compared to €3,771), but this difference 
was not significant either (CI: -3,039, 465). Specialist visits was the only cost 
category within healthcare costs that showed significantly greater costs for the 
control group (€993) in comparison with the augmented CBT group (€539) (CI: 
-868, -38). The non-healthcare costs were also in favour of the intervention group 
(€4,926 in comparison with €4,333 in the control group), however, no significant 
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difference was found (CI: -2,778, 1,551). Both the productivity costs (CI: -3,065, 
-93) and the productivity costs of the caregiver (CI: -1,354, -27) were significantly 
greater for the control group. As expected, intervention costs were greater for 
the augmented CBT group (€1,130 in comparison with €592). Further details are 
presented in Table 2.
Cost-effectiveness and cost-utility
The CEA for the HADS showed that the augmented CBT group induced fewer 
costs (-€1,913) but also fewer effects (-0.8), resulting in an ICER of €2,395 (Table 
3). The majority of bootstrapped ICERs (58%) were located in the southwest 
(SW) quadrant of the CE-plane (Figure 2) indicating fewer costs and fewer effects 
for the augmented CBT intervention, and 29% of the bootstrapped ICERs were 
located in the dominant southeast (SE) quadrant indicating greater effects and 
fewer costs for the augmented CBT intervention. 
Patients in the augmented CBT group gained slightly more QALYs (mean: 0.01) 
compared to control group patients. More QALYs gained combined with fewer 
societal costs (-€1,913) induced by the augmented CBT group resulted in a 
dominant ICER. As presented in Figure 3, 31% of the bootstrapped ICERs were 
located in the SW quadrant (fewer costs and effects) of the CE-plane and 55% of 
the bootstrapped ICERs were located in the dominant SE quadrant (fewer costs 
and greater effects). 
The cost-effectiveness acceptability curves (CEACs) of the HADS and QALY are 
also presented in Figures 2 and 3. The slope of the HADS CEAC indicates that with 
a WTP threshold of €2,500, the probability of the augmented CBT intervention 
being cost-effective was 49%. Furthermore, greater WTP levels showed an 
increasing decline in the probability of the augmented CBT intervention being 
cost-effective. In the Netherlands, there is no fixed WTP threshold for a QALY, 
but the threshold is dependent on the burden of disease.59 Based on the burden of 
stroke, a WTP level of €40,000 was considered acceptable.59 Using this threshold, 
the QALY CEAC indicates that there is a 76% chance that the augmented CBT 
intervention will be cost-effective.
Sensitivity analysis
A sensitivity analysis was performed to estimate the impact of reducing the price 
of a rehabilitation treatment day, on the cost-effectiveness results. The analysis 
proved robustness of the base case assumption for this parameter for both the 
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Figure 2. Cost-effectiveness plane HADS and cost-effectiveness acceptability curve HADS.
Figure 3. Cost-effectiveness plane QALY and cost-effectiveness acceptability curve QALY.
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HADS and QALY, as it resulted in a slightly lower ICER and no major changes in 
distributions on the CE-plane (Table 4). Calculating productivity costs by means 
of the friction cost method resulted in a much lower ICER for both the HADS and 
QALY and major shifts in distributions on the CE-plane to both ‘west’ quadrants 
(indicating fewer costs for the augmented CBT group). Estimating total costs from 
a healthcare perspective resulted in lower ICERs for both outcome measures; this 
was due to fewer cost categories being included. A major shift on the CE-plane 
of the QALY is noticeable towards the northeast (NE) quadrant (greater costs 
and greater effects). Finally, UK tariffs were used to calculate QALYs resulting in 
a decrease in ICER, and again, a shift on the CE-plane towards the SE quadrant.
Discussion
To our knowledge, this is the first cost-effectiveness analysis performed on a 
prospective randomized comparison of an augmented CBT intervention versus 
computerized cognitive training (CogniPlus) for post-stroke depressive symptoms.
The results of this study provides evidence that, using the HADS as an outcome, 
the augmented CBT intervention for stroke patients was less costly and less 
effective from a societal perspective and less costly and slightly more effective 
in terms of QALYs, compared to the control treatment. Cost differences between 
the two groups could be explained by costs of admission to a hospital, specialist 
consultations and home adjustments, but the larger part of the difference in 
total costs was due to productivity costs of both the patient and the caregiver 
which were both significantly less in the augmented CBT group. The fact that, 
at baseline, 43.3% of the control group had paid work, in comparison with only 
29% of the augmented CBT group, and that patients in the control group worked 
more than twice the number of hours per week might explain this difference. 
The results of the cost-effectiveness analysis showed that the probability of the 
augmented CBT intervention being cost effective was 49% for a WTP of €2,500. 
No fixed WTP threshold for the HADS exists, but previous research used a WTP 
of €500 per point improvement on the HADS based on expert opinion.57 A 
dominant ICER for the QALY was found, indicating greater effects and fewer 
costs for the augmented CBT group. Combined with a high probability of the 
augmented CBT intervention being cost-effective, the results from the cost-utility 
analysis were in favour of the augmented CBT intervention. However, due to the 
minimal difference in effects (mean: 0.1), these results should be interpreted with 
caution.
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In general, the sensitivity analyses showed robustness of results. For the HADS, 
a distinct shift in the distribution of bootstrapped ICERs was noticeable when 
calculating productivity costs with the friction method. This might be expected, 
since the friction cost method accounts for a shorter period of productivity losses 
resulting in fewer costs, and a lower ICER with the same difference in HADS 
score and a slightly greater probability of the augmented CBT intervention being 
cost-effective. This was also observed for the friction method, employed as a 
sensitivity analysis with regard to QALYs. A major shift was noticeable when 
conducting the cost-utility analysis from a healthcare perspective instead of the 
societal perspective. It appeared that the augmented CBT group induced both 
greater costs and greater effects leading to a shift on the CE plane towards the NE 
quadrant. This, and the fact that the difference in effect was minimal, indicated 
that the majority of total costs for the control group were accounted for by non-
healthcare costs.
To our knowledge, this current study provides new but preliminary evidence 
on the cost-effectiveness of a stroke-specific augmented cognitive behavioural 
therapy. Four previous studies investigating a comparable intervention in different 
populations showed similar results.22-24,27 More precisely, recent research on the 
effectiveness of an online CBT intervention for depressive patients found greater 
costs for CBT group and a cost per QALY gained of €23.857, which is below 
the acceptable UK threshold of €27.784 per QALY.21 Although this study was 
conducted from a National Health Services (NHS) perspective and the CBT 
intervention was compared with care as usual, the conclusions drawn from 
this study where in line with the current study results, indicating the potential 
cost-effectiveness of CBT. Another study evaluating the effectiveness of CBT for 
depressive patients in a non-stroke population reported greater costs and greater 
effects in terms of QALYs, resulting in a base case ICER of €20.714.25 Two other 
studies on the cost-effectiveness of CBT for patients with low-back pain and 
for people with schizophrenia-spectrum disorder also showed the possible cost-
effectiveness of cognitive behavioural therapy.22,24 It is important to note that 
these previous studies chose ‘care as usual’ as comparator, whereas the current 
study chose a computerized training (CogniPlus). The choice of comparator is 
a critical design parameter in economic evaluation research and may influence 
study results.61 
Strengths and limitations 
To our knowledge, there has been no previous economic evaluation research on a 
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stroke-specific cognitive behavioural therapy. Furthermore, the cost-effectiveness 
and cost-utility analyses in this study were conducted from a societal perspective, 
which is also considered to be a strength because it provides extensive evidence 
on a broad range of costs. Finally, both the outcome assessors and research 
assistants were blinded for the randomised treatment.
The current study was also subject to several limitations. First, due to recruitment 
difficulties we were not able to include the desired amount of participants, which 
was the reason for performing a new power calculation. Still, the current study 
results must be interpreted with caution due to the small sample size. Next, we 
had to deal with a considerable number (n=17; 28%) of missing values on T3 
measurement concerning the HADS and EQ-5D-3L. A multiple imputation (MI) 
method was used to handle these missing values.55 There are alternative methods 
for imputation, such as linear mixed models, but since cost-effectiveness analysis 
requires individual patient data we believe that MI was the best method for the 
analyses performed in the current study. Also, productivity costs of the caregivers 
were estimated with a mean hourly wage and a mean age, since information 
with respect to the employment of caregivers was limited. Finally, we found and 
measured differences between interventions within the time horizon chosen for 
this study. However, with progressing insight, we would argue that it would be 
interesting to expand the time horizon, by adding extra follow-up measurement 
moments or using modelling techniques in further research in order to identify 
the long-term effects of both interventions in comparison to each other.
Concluding remarks
Taking into account the limitations of the current study, we conclude that the 
preliminary results of the cost-effectiveness of the stroke-specific augmented 
CBT intervention under investigation were not convincing. As our study showed 
a 76% chance of being cost-effective for one outcome measure (QALY) and did 
not provide convincing cost-effectiveness results on the HADS. However, other 
studies showed the potential for the augmented CBT intervention to be cost-
effective in treating depression. Although we have argued why we have chosen an 
‘active’ control intervention, it would be very interesting to investigate the effect 
of including a care as usual group as third study arm in future research. Also, in 
addition to other literature, this study provided new insights into the potential 
cost-effectiveness of an adjusted cognitive behavioural therapy intervention. 
Therefore, for further research we would recommend recruitment of a larger 
stroke population, i.e. in multiple sites.
132 Chapter 7
References
1. Jaracz K, Grabowska-Fudala B, Kozubski W: Caregiver burden after stroke: towards a structural 
model. Neurol Neurochir Pol 2012, 46(3):224-232.
2. World Health Organization [http://www.who.int/topics/cerebrovascular_accident/en/] WHO: 
World Health Report: Changing History. In.: World Health Organization; 2004.
3. Rasquin SM, Van De Sande P, Praamstra AJ, Van Heugten CM: Cognitive-behavioural 
intervention for depression after stroke: five single case studies on effects and feasibility. 
Neuropsychol Rehabil 2009, 19(2):208-222.
4. Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A: A comparative study into the one year 
cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg 
Psychiatry 2003, 74(5):581-585.
5. De Wit L, Putman K, Baert I, Lincoln NB, Angst F, Beyens H, Bogaerts K, Brinkmann N, Connell 
L, Dejaeger E et al: Anxiety and depression in the first six months after stroke. A longitudinal 
multicentre study. Disabil Rehabil 2008, 30(24):1858-1866.
6. Gainotti G, Azzoni A, Lanzillotta M, Marra C, Razzano C: Some preliminary findings 
concerning a new scale for the assessment of depression and related symptoms in stroke 
patients. Ital J Neurol Sci 1995, 16(7):439-451.
7. van Mierlo ML, van Heugten CM, Post MWM, Lindeman E, de Kort PLM, Visser-Meily JMA: A 
longitudinal cohort study on quality of life in stroke patients and their partners: Restore4Stroke 
Cohort. International Journal of Stroke 2014, 9(1):148-154.
8. Wilkinson PR, Wolfe CD, Warburton FG, Rudd AG, Howard RS, Ross-Russell RW, Beech RR: 
A long-term follow-up of stroke patients. Stroke 1997, 28(3):507-512.
9. Post-Stroke Depression [http://www.stroke.org/we-can-help/survivors/stroke-recovery/post-
stroke-conditions/emotional/depression]
10. Lincoln NB, Brinkmann N, Cunningham S, Dejaeger E, De Weerdt W, Jenni W, Mahdzir A, 
Putman K, Schupp W, Schuback B et al: Anxiety and depression after stroke: a 5 year follow-
up. Disabil Rehabil 2013, 35(2):140-145.
11. Rastenyte D, Kranciukaite D: [Poststroke depression and its impact on quality of life]. Medicina 
(Kaunas) 2007, 43(1):1-9.
12. Husaini B, Levine R, Sharp L, Cain V, Novotny M, Hull P, Orum G, Samad Z, Sampson U, 
Moonis M: Depression increases stroke hospitalization cost: an analysis of 17,010 stroke 
patients in 2008 by race and gender. Stroke Res Treat 2013, 2013:846732.
13. Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos GA: Future costs of 
stroke in the Netherlands: the impact of stroke services. Int J Technol Assess Health Care 2006, 
22(4):518-524.
14. van Eeden M, van Heugten CM, Evers SM: The economic impact of stroke in The Netherlands: 
the euro-Restore4Stroke study. BMC Public Health 2012, 12:122.
15. Hackett ML, Anderson CS: Predictors of depression after stroke: a systematic review of 
observational studies. Stroke 2005, 36(10):2296-2301.
16. Hackett ML, Anderson CS, House A, Halteh C: Interventions for preventing depression after 
stroke. The Cochrane database of systematic reviews 2008(3):CD003689.
17. Broomfield NM, Laidlaw K, Hickabottom E, Murray MF, Pendrey R, Whittick JE, Gillespie DC: 
Post-stroke depression: the case for augmented, individually tailored cognitive behavioural 
therapy. Clin Psychol Psychother 2011, 18(3):202-217.
18. Hackett ML, Anderson CS, House A, Halteh C: Interventions for preventing depression after 
stroke. Cochrane Database Syst Rev 2008(3):CD003689.
19. Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G: Efficacy of cognitive-behavioural 
therapy and other psychological treatments for adult depression: meta-analytic study of 
publication bias. Br J Psychiatry 2010, 196(3):173-178.
20. Hollinghurst S, Peters TJ, Kaur S, Wiles N, Lewis G, Kessler D: Cost-effectiveness of therapist-
delivered online cognitive-behavioural therapy for depression: randomised controlled trial. Br 
J Psychiatry 2010, 197(4):297-304.
21. Lamb SE, Hansen Z, Lall R, Castelnuovo E, Withers EJ, Nichols V, Potter R, Underwood MR: 
133An economic evaluation of an augmented CBT intervention
Group cognitive behavioural treatment for low-back pain in primary care: a randomised 
controlled trial and cost-effectiveness analysis. Lancet 2010, 375(9718):916-923.
22. McCrone P, Ridsdale L, Darbishire L, Seed P: Cost-effectiveness of cognitive behavioural 
therapy, graded exercise and usual care for patients with chronic fatigue in primary care. 
Psychol Med 2004, 34(6):991-999.
23. van der Gaag M, Stant AD, Wolters KJ, Buskens E, Wiersma D: Cognitive-behavioural therapy 
for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-
effectiveness analysis. Br J Psychiatry 2011, 198(1):59-65, sup 51.
24. Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, 
Odondi L et al: Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as 
an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT 
randomised controlled trial. Health Technology Assessment 2014, 18(31):1-167, vii-viii.
25. Anson K, Ponsford J: Coping and emotional adjustment following traumatic brain injury. J 
Head Trauma Rehabil 2006, 21(3):248-259.
26. Anson K, Ponsford J: Evaluation of a coping skills group following traumatic brain injury. Brain 
injury 2006, 20(2):167-178.
27. Bedard M, Felteau M, Mazmanian D, Fedyk K, Klein R, Richardson J, Parkinson W, Minthorn-
Biggs MB: Pilot evaluation of a mindfulness-based intervention to improve quality of life among 
individuals who sustained traumatic brain injuries. Disabil Rehabil 2003, 25(13):722-731.
28. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L: Evaluation of cognitive behavioural treatment 
for depression after stroke: a pilot study. Clin Rehabil 1997, 11(2):114-122.
29. Nicholl CR, Lincoln NB, Muncaster K, Thomas S: Cognitions and post-stroke depression. Br J 
Clin Psychol 2002, 41(Pt 3):221-231.
30. Vickery CD, Sepehri A, Evans CC: Self-esteem in an acute stroke rehabilitation sample: a 
control group comparison. Clin Rehabil 2008, 22(2):179-187.
31. de Ridder D, Geenen R, Kuijer R, van Middendorp H: Psychological adjustment to chronic 
disease. Lancet 2008, 372(9634):246-255.
32. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, 
Briggs AH, Mauskopf J, Loder E: Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic 
Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013, 
16(2):231-250.
33. Kootker J, Fasotti L, Rasquin S, van Heugten C, Geurts A: The effectiveness of an augmented 
cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): 
the Restore4Stroke-PSDA trial. BMC Neurol 2012, 12(1):51.
34. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 
67(6):361-370.
35. O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA: 
Detecting dementia with the mini-mental state examination in highly educated individuals. 
Arch Neurol 2008, 65(7):963-967.
36. Meyer BC, Hemmen TM, Jackson CM, Lyden PD: Modified National Institutes of Health 
Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke 2002, 
33(5):1261-1266.
37. van Erp J: Relaxation exercises (ontspanningsoefeningen; bodyscan, aandacht voor uw 
lichaam). De Hart&Vaat groep 2010.
38. CogniPlus [http://www.psychologischtesten.nl/c-561271/cogniplus/]
39. Spikman JM, Boelen DH, Lamberts KF, Brouwer WH, Fasotti L: Effects of a multifaceted 
treatment program for executive dysfunction after acquired brain injury on indications of 
executive functioning in daily life. J Int Neuropsychol Soc 2010, 16(1):118-129.
40. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM: A validation 
study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch 
subjects. Psychol Med 1997, 27(2):363-370.
41. Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, Pickard AS: Validity of 
EQ-5D-5L in stroke. Qual Life Res 2015, 24(4):845-850.
134 Chapter 7
42. Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV: The Dutch tariff: 
results and arguments for an effective design for national EQ-5D valuation studies. Health 
Econ 2006, 15(10):1121-1132.
43. Thorn JC, Coast J, Cohen D, Hollingworth W, Knapp M, Noble SM, Ridyard C, Wordsworth 
S, Hughes D: Resource-use measurement based on patient recall: issues and challenges for 
economic evaluation. Appl Health Econ Health Policy 2013, 11(3):155-161.
44. Noben CY, Evers SM, Nijhuis FJ, de Rijk AE: Quality appraisal of generic self-reported 
instruments measuring health-related productivity changes: a systematic review. BMC Public 
Health 2014, 14:115.
45. Jonsson B: Ten arguments for a societal perspective in the economic evaluation of medical 
innovations. Eur J Health Econ 2009, 10(4):357-359.
46. Oostenbrink JB, Koopmanschap, M.A & Rutten F.F.H.: Handleiding voor Kostenonderzoek. In. 
Edited by Adang EMM: Institute for Medical Technology Assessment; 2010: 126.
47.  [http://www.gipdatabank.nl]
48. Farmacotherapeutisch Kompas: Medisch farmaceutische voorlichting [http://www.fk.cvz.nl/]
49. Drug costs in the Netherlands [http://www.medicijnkosten.nl/]
50. Hutubessy RC, van Tulder MW, Vondeling H, Bouter LM: Indirect costs of back pain in the 
Netherlands: a comparison of the human capital method with the friction cost method. Pain 
1999, 80(1-2):201-207.
51. Johannesson M, Karlsson G: The friction cost method: a comment. J Health Econ 1997, 
16(2):249-255; discussion 257-249.
52. CBS) CBvdS: Indexcijfers. In.; 2012.
53. Hendriks MRC, Al MJ, Bleijlevens MHC, van Haastregt JCM, Crebolder HFJM, van Eijk JTM, 
Evers SMAA: Continuous versus Intermittent Data Collection of Health Care Utilization. 
Medical Decision Making 2013.
54. Sinharay S, Stern HS, Russell D: The use of multiple imputation for the analysis of missing data. 
Psychological methods 2001, 6(4):317-329.
55. van Mastrigt GAPG: Outcome assessment and economic evaluation of short-stay intensive 
care for coronary artery bypass patients. Maastricht: Maastricht University; 2009.
56. Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M: Cognitive 
stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry 2006, 
188:574-580.
57. Puhan M, Frey M, Buchi S, Schunemann H: The minimal important difference of the hospital 
anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health 
Qual Life Outcomes 2008, 6(1):46.
58. Zorg RvV: Zinnige en duurzame zorg. In. Zoetermeer; 2006.
59. Kind P, Hardman G, Macran S: UK Population Norms for the EQ-5D. The University of York: 
Centre for Health Economics 1999.
60. Wagner M, Melnyk P, Rindress D: Systematic review of guideline recommendations on 
comparator selection in health economic evaluations. In: 2012; Montreal, Quebec, Canada: 
BioMedCom Consultants Inc.; 2012.


Chapter 8
Summary and general discussion 
138 Chapter 8
Summary
Post-stroke depressive symptoms with or without anxiety are common in the 
chronic phase of stroke and have a negative impact on rehabilitation, social 
reintegration, and quality of life. Currently, there is no evidence-based treatment 
available for reducing these emotional problems post stroke. The main aim of 
this thesis was to develop and evaluate a new, augmented cognitive behavioural 
therapy (CBT) protocol for the treatment of post-stroke depressive symptoms, 
with or without symptoms of anxiety, in comparison to a (presumably ineffective) 
control treatment (i.e., computerized cognitive training, CogniPlus). The individual 
CBT was augmented with individual sessions of occupational or movement 
therapy to attain specific, practical goals in daily life. In chapter one, the physical 
and psychological consequences of stroke were introduced, together with current 
treatment options for post-stroke depressive symptoms and the underpinnings 
for choosing a psychological treatment approach in this thesis. Thereafter, the 
outline of this thesis was presented based on the following research questions:
 
1. Are psychological determinants important risk factors for depressive 
symptoms post stroke? 
2. What components should be part of an augmented CBT protocol for 
depressive symptoms, taking into account the physical, cognitive and 
emotional sequelae of stroke? 
3. Is such an augmented CBT effective to reduce depressive symptoms and 
improve social participation and quality of life of patients in the chronic 
phase after stroke?
4. Is such an augmented CBT also beneficial with respect to the perceived 
burden by caregivers? 
5. Is such an augmented CBT for patients with depressive symptoms post 
stroke effective from an economical perspective? 
In chapter two, the first research question was addressed. A longitudinal cohort 
study (based on the Restore4Stroke cohort study) provided data to determine the 
importance of psychological risk factors for developing depressive symptoms 
and symptoms of anxiety one year after stroke. Depressed mood and anxiety are 
the most commonly reported emotional disorders after stroke. Better knowledge 
of their risk factors will aid in developing adequate prevention and treatment 
strategies. Previous studies on risk factors for post-stroke depressive symptoms 
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and anxiety have generally focused on socio-demographic, premorbid and stroke-
related patient characteristics. Some studies took into account psychological 
patient characteristics as potential risk factors as well, but these studies were 
either small sized, used a cross-sectional design, or regarded a limited set 
of psychological characteristics. Moreover, none of these studies provided 
quantitative values for the predictive strength of the identified risk factors, 
limiting the clinical application of their findings. In chapter two, we investigated 
the relative importance of socio-demographic, premorbid, stroke-related, and 
psychological patient characteristics for developing depressive symptoms and 
anxiety at one year post stroke in a large cohort of Dutch subacute patients 
(N=331) recruited in six general hospitals with a stroke unit. We conducted a 
longitudinal study to calculate predictive models for both depressive symptoms 
and anxiety one year after stroke, providing nomograms that can be used to 
estimate the predictive strength of each identified risk factor. Patients were 
included at stroke onset and followed up 2 and 12 months after stroke. Socio-
demographic and premorbid/stroke-related information was recorded during 
hospital admission, whereas psychological characteristics were determined with 
postal questionnaires 2 months post stroke. Symptoms of depression and anxiety 
were assessed with the Hospital Anxiety and Depression Scale (HADS) 2 and 12 
months post stroke. Multivariable logistic analysis was performed to analyze the 
influence of socio-demographic, premorbid/stroke-related, and psychological 
characteristics on depressive symptoms (depression subscale of HADS >7) and 
symptoms of anxiety (anxiety subscale of HADS >7) one year after stroke. The 
results showed that early depression, stroke severity, posterior cerebral artery 
stroke, and neuroticism independently explained the variance of depressive 
symptoms one year post stroke. Neuroticism and early anxiety independently 
explained the variance of symptoms of anxiety one year post stroke. We 
concluded that psychological characteristics appear to be stronger risk factors for 
post-stroke depressive symptoms and anxiety than previously determined socio-
demographic and pre-morbid or stroke-related factors, which has clear clinical 
implications for the prevention and treatment of post-stroke mood disorders. 
The results from chapter two support a psychological approach to the prevention 
and treatment of post-stroke depressive symptoms. Currently, no evidence-based 
treatment is available for mood problems after stroke. Chapter three addressed 
the second research question and presented a new, psychological intervention for 
post-stroke depressive symptoms. In earlier research on depression in the general 
population it has been shown that depressive symptoms can be ameliorated by 
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CBT. The intervention we developed was based on CBT principles and was 
shown feasible in a pilot study. In order to meet the specific needs of stroke 
patients (considering sensorimotor, cognitive, as well as behavioral problems), 
we incorporated motivational interviewing, grief resolution, and psycho-
education in the treatment. In addition, we emphasized for each session to take 
into account the cognitive deficits of the patients (i.e. to be concrete, accessible, 
structured, specific, and to repeat information). Moreover, we augmented the 
psychologist-administered therapy with the contribution of an occupational or 
movement therapist aimed at facilitating patients’ goal setting and attainment in 
daily life. The intervention consisted of 12 one-hour sessions with a psychologist 
and three to four one-hour sessions with an occupational or movement therapist. 
This psychological treatment protocol is innovative, as it applies CBT in a stroke-
specific manner and supports goal attainment by incorporating occupational or 
movement therapy sessions.
The effectiveness of the CBT intervention was evaluated in a randomized 
controlled trial (RCT). In chapter four, the research protocol of this part of the 
Restore4Stroke study was described in detail. It was hypothesized that patients 
treated with augmented CBT, tailored to their individual needs, would show a 
larger decrease in depressive symptoms as assessed with the HADS (depression 
subscale) than those receiving computerized cognitive training (CCT). Additionally, 
the effects on various secondary outcome measures, among which quality of 
life (Stroke Specific Quality of Life scale), social participation (Utrecht Scale 
for Evaluation of Rehabilitation – Participation), and anxiety (HADS – anxiety 
subscale) were evaluated. Furthermore, it was hypothesized that the augmented 
CBT would be more beneficial with respect to alleviating the perceived burden 
(emotional as well as practical) of caregivers. To this aim, a multi-center, assessor-
blinded, RCT was conducted. A sample of patients with depressive symptoms 
(HADS depression subscale >7) in the chronic phase of stroke was recruited 
and randomly allocated to either an experimental (augmented CBT) or a control 
(CCT) group. Outcomes were assessed at baseline, immediately post intervention, 
and at 4 and 8 months follow-up. This study is the first RCT that evaluates the 
(maintenance of) effects of augmented CBT on post-stroke depressive symptoms 
with or without symptoms of anxiety. 
Chapter five reported the results of the study as outlined in chapter four. Sixty-
one patients were randomized to either the CBT (n=31) or CCT (n=30) group. 
The analysis was performed with linear mixed models for repeated measures 
and showed a significant and persistent time effect on the subscale depression of 
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the HADS as well as on anxiety, social participation, and quality of life in both 
groups. However, there was no significant group x time effect for any of the 
outcome measures. These result imply that the augmented CBT intervention was 
not superior to CCT for the treatment of mood disorders after stroke based on 
patient-related outcomes. 
The fourth research question was addressed in chapter six. As emotional 
symptoms of stroke survivors may also have negative effects on caregivers’ well-
being, we invited patients’ caregivers to participate in the Restore4Stroke study as 
well. We investigated whether the applied interventions (CBT or CCT) influenced 
caregivers’ emotional burden (Involvement Evaluation Questionnaire for Brain 
Injury / IEQ-BI), practical burden (Caregiver Strain Index), mental health (General 
Health Questionnaire), and emotional symptoms (HADS). In total, 50 caregivers 
were assessed at baseline, immediately post treatment, and at 4 and 8 months 
follow-up. As in the patient trial, linear mixed models for repeated measures 
were used for statistical analysis. In contrast to the patients, caregivers of patients 
who received CBT reported significantly higher levels of mental health and less 
worrying about patients’ well-being after the intervention, corrected for baseline 
values. In addition, there were positive time effects on IEQ-BI, particularly on its 
subscales Worrying, Supervision and Tension. These results are remarkable as 
the patient trial did not show specific groups effects and suggest that augmented 
CBT aimed at improving patients’ emotional, behavioral and social functioning 
may positively affect some aspects of caregivers’ well-being. 
The final research question was addressed in chapter seven, in which the 
cost-effectiveness and cost-utility of the RCT (chapter six) were presented from 
a societal perspective. As post-stroke depressive symptoms may have major 
impact on health-related quality of life (HRQol) and may lead to increased 
hospitalization and, therefore, substantial healthcare costs, a trial-based 
economic evaluation was conducted from a societal perspective with a time 
horizon of 12 months. In this study the primary outcomes were the HADS and 
Quality Adjusted Life Years (QALYs) based on the three-level five-dimensional 
EuroQol (EQ-5D-3L). Missing data were handled through mean imputation (costs) 
and multiple imputation (HADS and EuroQol), and costs were bootstrapped. 
Sensitivity analyses were performed to test robustness of baseline assumptions. 
The average total societal costs were not significantly different between the CCT 
group (€9,998.3) and the augmented CBT group (€8,063.7). The augmented 
CBT intervention was, however, less costly and less effective from a societal 
perspective based on the HADS, and less costly and slightly more effective in 
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terms of QALYs, in comparison with CCT. The cost-effectiveness and cost-utility 
analyses provided greater effects and fewer costs for the augmented CBT group, 
and fewer effects and costs on the HADS. Based on a willingness to pay (WTP) 
level of €40,000 per QALY, the augmented CBT intervention had a 76% chance 
of being cost-effective. Sensitivity analyses showed robustness of results. Overall, 
we concluded that our stroke-specific augmented CBT intervention did not show 
convincing cost-effectiveness. 
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General Discussion 
This thesis describes the results of a study on augmented cognitive behavioral 
therapy for depressive symptoms after stroke. The study was embedded in a 
larger, more comprehensive research program entitled Restore4Stroke, that 
was focused on social reintegration and quality of life after stroke. This chapter 
discusses the present manuscript in the light of its field of research and clinical 
practice from three different perspectives. First, the profile of the patient with 
depressive symptoms after stroke is discussed. Second, I elaborate on how to 
treat patients with depressive symptoms after stroke. Third, this chapter focuses 
on how to assess and evaluate treatment results. Lastly, some methodological 
considerations are discussed, followed by future perspectives in the field of 
depressive symptoms after stroke. 
Is there a profile of patients with depressive symptoms after stroke?  
As stroke occurs without warning, there is little time to adjust to its consequences 
in daily life. Both stroke survivors and caregivers suddenly experience the effects 
that physical and cognitive impairments may have on daily life. These impairments 
limit their daily routines and hamper their ability to engage in meaningful or 
pleasurable activities, which has consequences for mood. Behavioral theories 
of depression suggest that engaging in pleasurable activities that bring a sense 
of mastery or pleasure influences mood positively.1 To help patients engage 
in meaningful activities requires creativity and flexibility of therapists. Goal 
attainment data of patients in the experimental (cognitive behavioral therapy; 
CBT) condition of our trial showed that meaningful or pleasurable activities of 
patients after stroke may vary greatly. For instance, patients reported activities 
such as baking cookies with grandchildren, playing petanque, attending a football 
match, or babysitting grandchildren (Figure 1). In a qualitative study of Ekstam, 
Uppgard, Von Koch and Tham (2007), stroke survivors reported loss of a variety 
of pleasurable activities that they were used to undertake in their pre-stroke life, 
such as traveling, car driving, gardening, and reading. Not participating in these 
daily life activities had negative effects on mood.2 Of the 27 people Ekstam and 
colleagues interviewed, the majority reported dissatisfaction even with life as a 
whole. 
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Figure 1. Word cloud of goal-keywords that were set by patients in the CBT group.
In addition to participation restrictions, cognitive impairments may influence 
mood as they impact on the way people think. Stroke survivors are often less 
flexible, less accurate, and struggle with problem solving. As a consequence, 
they are prone to interpret events and circumstances negatively, which makes it 
difficult to revalue tasks at hand, find other meaningful activities, or change the 
way they are used to undertake activities. Since cognitive processes are often 
compromised following stroke, patients may linger on and focus on negative 
information and thoughts, which is a risk for developing depressive symptoms. In 
addition, patients after stroke regularly misinterpret their bodily sensations, which 
induces fear and anxiety.3 For instance, during normal cycling they may interpret 
an increased heart rate as a sign of an upcoming recurrent stroke. Moreover, stroke 
survivors are often elderly adults, in which non stroke-related comorbidities are 
common.3 In summary, stroke survivors are less likely to participate in daily life 
activities than they did during their pre-stroke life and often suffer from negative 
thoughts, which has detrimental consequences for their activity level and mood. 
How to diagnose or define ‘depressive symptoms post stroke’ appears to be 
intricate. According to the criteria of the Diagnostic and Statistical Manual of 
mental disorders (DSM-V), post-stroke mood disorders may be (i) a ‘mood disorder 
due to stroke with depressive features’, (ii) a ‘major depression-like episode’, or 
(iii) ‘mixed mood features’.4 For a ‘major depression-like episode’, a depressed 
mood or a loss of interest or pleasure must be present for at least two weeks, 
along with at least four other symptoms of depression (e.g., daily insomnia or 
hyper insomnia; weight loss without dieting, weight gains, or loss of appetite; loss 
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of energy or fatigue). A ‘mood disorder due to stroke with depressive features’ 
must entail depressed mood or loss of interest or pleasure along with less than 
five other symptoms of depression.4 Based on the earlier DSM version (DSM-IV), 
depression could only be assessed in patients without an acute brain condition.5 
Thus, the adjusted criteria in the more recent version (DSM-V) indicate that the 
professional opinion on the presence and the definition of depressive symptoms 
post stroke has changed.  
In the scientific literature there is also a debate about how to distinguish 
‘(major) depression’ from ‘post-stroke depressive symptoms’ or from ‘post-stroke 
depression’.6-8 Evident commonalities between these diagnoses are feelings of 
sadness and behavioral-depressive changes. A critical difference from a major 
(endogenous) depression is that patients with post-stroke depressive symptoms 
show more reactive diurnal mood variations and emotionalism, absence of guilt, 
and rarely present with suicidal thoughts.6 There is a chance of overestimating 
mood problems after stroke if somatic symptoms, such as fatigue, are regarded 
as depressive symptoms. According to the DSM-V, chronic fatigue is a symptom 
of depression, but in the stroke population chronic fatigue may be a direct result 
of the brain damage. As the majority of stroke survivors experience chronic 
fatigue, the severity of depressive symptoms may be overestimated. Yet, recent 
research claims that somatic complaints do fit in a post-stroke screening for 
depression, because fatigue severity may be aggravated by depressed mood.7 
Some researchers even mention ‘distress’ post stroke as a relevant mood 
disorder9 which indicates that, although the severity of depressive symptoms 
after stroke may vary greatly, many patients suffer from some form of mood 
or emotional disorder that may require clinical attention or treatment. In this 
thesis, we purposely and consistently used the wording ‘depressive symptoms’ 
to refer to post-stroke mood disorders, acknowledging the distinction with major 
depression. 
How depressive post-stroke symptoms develop over time is not clear as 
increasing,10 decreasing,11 and dynamic12 incidence rates have been reported in 
the literature. Up till now, two studies aimed at identifying different post-stroke 
depression profiles describing the course of the symptoms over time.13,14 White 
and colleagues identified four trajectories based on a longitudinal qualitative 
analysis: (i) ‘resilience’, a group of patients that appear to be able to adjust to 
major changes in life; (ii) ‘ongoing crisis’, a group that experiences stroke as an 
additional burden to already existing life stress; (iii) ‘emergent mood disturbance’, 
a small group with depressive symptoms in the long term after stroke, occurring 
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after comorbidities or social issues independent of stroke; and (iv) ‘recovery 
from mood disturbance’, a group that reports initial fear of stroke recurrence 
but gradually regains a feeling of control over their life. In the latter group 
(‘recovery’ profile), independence, participation and self-efficacy was associated 
with the outcome of rehabilitation. Ayerbe and colleagues described four 
different trajectories based on a quantitative study of patients’ Hospital Anxiety 
and Depression Scale (HADS) scores: (i) ‘no depression’, in which depression 
never develops, (ii) ‘mild depression’, and (iii) ‘moderate depression', both with 
increasing depressive symptoms over time, and (iv) ‘severe depression’, in which 
initially symptoms may decline but then increase in the long term. The ‘ongoing 
crisis’ profile from the qualitative study on the one hand, and the third and 
fourth categories of Ayerbe et al. on the other hand seem to reflect the patient 
group included in the present thesis. Although both studies describe profiles 
from a different perspective, they provide important information about the stroke 
population covering multiple time points, indicating that we should attend to the 
mood problems of patients with a long-term perspective. 
Taken together, there is an ongoing debate on what ‘post-stroke depression’ 
entails and on what point in time after stroke depressive symptoms occur, change, 
persist, or should be treated. Comparing our patient group with the profiles 
presented above, there are similarities with the ‘ongoing crisis’ and ‘emergent 
mood disturbance’ profiles from the qualitative study,13 and with the ‘moderate’ 
and ‘severe depression’ group of Ayerbe and colleagues.14 More knowledge on 
how post-stroke depression profiles vary and how they should be identified is 
of great importance. For instance, as the profiles show fluctuations in symptom 
severity over time, regular assessments are necessary in the chronic phase to 
prevent overlooking depressive symptoms that appear later after stroke. It is also 
necessary to reduce the heterogeneity of clinical mood assessments post stroke 
and to obtain more knowledge of causative and other risk factors for effective 
prevention and targeted treatment. 
There is quite some controversy concerning the risk factors for ‘post-stroke 
depression’, mainly because there is huge heterogeneity in the study methodology 
and the populations included.15-18 A recent meta-analysis of Shi and colleagues 
(2017) that analyzed 36 risk factor studies (including the study of chapter 2 of 
this thesis) showed that a history of mental illness was the most critical risk 
factor for ‘post-stroke depression’. Other risk factors were sex (female), higher 
age, neuroticism, family history of depression, severity of stroke, and severity 
of participation restrictions.18 In chapter 2, we already showed the importance 
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of early signs of depression, neuroticism, and stroke severity. From a behavioral 
perspective, it is not surprising that severity of stroke plays an important role in 
the occurrence of ‘post-stroke depression’, as higher levels of impairment have a 
greater impact on daily life activities and on role fulfillment. Next to that, the way 
patients cope with physical and cognitive changes appears to play a mediating 
role in experienced mood. In chapter 2, we emphasized that few studies have 
included psychological factors in their risk analysis. The Restore4Stroke Cohort 
study by Van Mierlo et al. has shown that early depressive symptoms, one of the 
risk factors for long-term depressive symptoms post stroke, were highly associated 
with other psychological factors such as passive coping, lack of optimism, and 
lack of acceptance.19 In the aforementioned qualitative study of trajectories of 
depressive symptoms post stroke, White and colleagues also emphasized that 
an external locus of control was apparent in the trajectories that most fitted our 
patient group.13 This implies that the way patients adjust to sudden physical and 
cognitive impairments after stroke has influence on the development of mood 
disorders. This is an important clinical finding, as coping and acceptance may be 
amenable to psychological interventions.
Depressive symptoms after stroke, what to do? 
Depressive symptoms post stroke are associated with increased mortality, 
greater disability, and poorer quality of life. They also hamper rehabilitation, 
prolong hospitalization and, with that, enhance healthcare costs.20-23 Even when 
depressive symptoms diminish over time, the associated risks seem to remain. 
Although there is a lack of consensus on how to describe and identify the 
patients with depressive symptoms post stroke, the majority of studies highlights 
that most patients experience enhanced emotional strain, stressing the need for 
an appropriate treatment that remains helpful in the long term. 
Since the aforementioned risk analysis studies indicate that psychological factors 
play an important role, a psychological treatment approach seems warranted. 
The effects of CBT in related and other patient groups showed reduction of 
complaints, a lower relapse rate, and fewer side effects than pharmacotherapy 
which implies that, from a societal perspective, CBT is a potentially cost-effective 
intervention.3,24-28 Because stroke patients’ cognitive functions (e.g., attention, 
memory, executive functioning, flexibility) may be impaired, a psychological 
intervention should take into account these impairments and not be too 
strenuous.3 CBT focuses on changing both behavior and (negative) cognitions, 
however, CBT as applied in the healthy population may be too demanding for 
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patients after stroke, as it does not take into account the grief element after 
stroke, or concomitant physical or psychological consequences.29 We, therefore, 
designed an adjusted psychological intervention, taking into account individual 
cognitive impairments and grief, so that each patient could comprehend all of 
its content. The treatment focus was on achieving goals related to meaningful or 
pleasurable activities, an objective supported (‘augmented’) by individual sessions 
of occupational or movement therapy. Unfortunately, our trial (chapter 5) yielded 
no differences in improvement of HADS scores between the experimental group 
receiving CBT interventions and the control group receiving an equal amount of 
computerized cognitive training (CCT). We did, however, observe a significant 
improvement across time for both groups. Both interventions were administered 
during a similar time period and had a comparable intensity in terms of the 
duration of sessions. The CBT intervention was administered by a certified 
healthcare psychologist, who had ample experience with treating depressive 
and anxiety symptoms as well as with stroke rehabilitation in general. Although 
CCT was largely self-administered, either cognitive trainers or psychological 
assistants were continuously present to assist the participants during the training. 
In chapter 5, we already discussed whether the improvements in both groups 
could have been due to a nonspecific influence of time or attention, for instance 
a ‘Hawthorne effect’. At that point in our research, we had not yet analyzed 
the caregiver data nor evaluated the trial from an economical perspective. 
Remarkably, chapter 6 showed higher levels of mental health and less worrying 
about patients’ wellbeing for the caregivers of the CBT group. Moreover, results 
from the economic evaluation (chapter 7) showed that, in comparison to CCT, 
the CBT intervention was favorable based on the HADS total score and the 
QALY analysis.30 Although the effect sizes of these results were relatively small, 
it is important to interpret all patient, caregiver, and economic data to provide 
directions for more effective treatments from a holistic and societal perspective. 
A potential reason for the differential effects of the applied treatments on the 
caregivers may be related to the interaction in the home situation, as caregivers 
did not attend the therapy sessions. The two interventions were different in that 
the CBT included (activity-related) individual goal setting (see figure 1). These 
goals provided guidance to the content of the psychological sessions, while an 
occupational or movement therapist helped patients with attaining their goals. 
The CBT intervention coincided with a substantial amount of homework directed 
at either goal attainment or working with cognition schemes to investigate the 
relationships between thoughts, feelings and actions (chapter 4). Possibly one of 
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these components may have had a positive influence on the caregivers as well. 
For instance, having a partner that either commits to homework to achieve an 
activity related goal or, as a caregiver, being included in the goal itself (figure 
1) may have had concomitant positive effects on the caregiver (chapter 5). As 
providing homework is often part of a psychological intervention, future research 
should take into account the concomitant effects of patient-directed interventions 
on caregivers’ well-being, particularly when such interventions include home 
assignments to achieve activity related goals. Moreover, caregivers may also 
play a supportive role in the implementation and the effects of home-based 
interventions.31
From the Restore4Stroke cohort study by Van Mierlo et al. we were able to 
infer that post-stroke depressive symptoms may fluctuate approximately 2 points 
on the HADS-D over a two-year course.32 As the reduction (improvement) in 
depressive symptoms observed in both patient groups of our trial was much 
larger (i.e., >4 points on HADS-D), we concluded that both CBT and CCT had 
beneficial effects on mood. The CBT protocol (chapter 4) was ‘augmented’ 
with several non-CBT components, making it difficult to indicate the exact 
components that may have had a beneficial effect or not.33 It may even be that 
tentative positive effects of, for example, goal attainment were neutralized by 
too strenuous thought-mediating psychological treatment. Therefore, in order to 
provide directions for future treatment, it is important to understand what may 
have caused the positive effects of CCT on mood. During the trial, some patients 
reported that they hoped to participate in the ‘new computerized treatment’, 
reflecting favorable expectations that may have positively affected their mood.34 
Interestingly, in a study on the improvement of executive functioning in patients 
with acquired brain injury,35 a similar computerized cognitive training was 
reported to be ineffective, but with trainees showing a high satisfaction rate. 
Indeed, CCT provides immediate (positive) feedback on performance. Attaining 
high levels of (improved) performance may have led to personal satisfaction 
and improved self-efficacy with concomitant, positive effects on mood.36 
Summarizing, our investigation shows that the results of the patient trial do not 
indicate that CBT is more effective than CCT to improve depressive symptoms 
after stroke.33 Yet, based on the caregiver data (chapter 6) and from a societal 
perspective, it appears that CBT has some advantage over CCT.30 
As mentioned above, challenging negative or irrational thoughts may be hard for 
patients with cognitive impairments due to stroke. Limited cognitive flexibility 
and impaired attention and memory may make it hard to learn alternative ways 
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of thinking and behavior. Acceptance and commitment therapy (ACT) (e.g., third 
wave of behavioral therapy) may, therefore, be an interesting alternative approach 
to treat post-stroke depressive and anxiety symptoms. ACT does not focus on 
changing cognitions regarding individual experiences, but rather concentrates on 
the affective ‘relationship’ one has with one’s experiences. ACT teaches patients 
to remain active whilst accepting their limitations in a ‘mindful’ way. In ACT six 
interlinked components are reflected in a hexaflex: (i) cognitive defusion, (ii) 
acceptance, (iii) contact with the present moment, (iv) self as context, (v) values, 
and (vi) committed action.37 This approach seems promising for patients with 
brain injury. Trials investigating ACT as a means of psychological adjustment after 
traumatic brain injury have recently commenced.38 As this psychotherapeutic 
approach does not entail changing the way stroke patients think and feel, it may 
be easier to apply with possibly beneficial effects on mood.39
Although ACT may be promising for patients that are capable to talk about 
their problems, the application of any form of psychotherapy is problematic in 
severely impaired stroke patients, such as those with severe aphasia or apathy. 
Currently, the BEADS study investigates whether simple ‘behavioral activation’ 
can treat depressive symptoms post stroke.40 In the augmented CBT protocol 
as presented in chapter 4, behavioral activation was instigated by use of the 
Activity Card Sorting task (ACS) for goal setting.41 ACS was aimed at facilitating 
the conversation about goal setting and overcome communicative problems due 
to the passive state patients with (severe) depressive symptoms might be in. Yet, 
the use of the ACS may serve as an aid in the activation of aphasic stroke patients 
as well, and is useful for behavioral treatment such as the BEADS intervention.40
Severely impaired stroke patients may also benefit from other treatment 
approaches, such as ‘non-invasive brain stimulation’ (NIBS). Indeed, recent NIBS 
studies have shown promising effects in reducing depressive symptoms in healthy 
subjects.42 For instance, transcranial direct current stimulation (tDCS), a non-
invasive brain stimulation technique that applies a relatively weak current through 
the skull, is able to induce cortical plasticity. It is assumed to have the potential 
to modulate (pathological) plasticity and improve cognition in mood disorders. 
The first-ever randomized controlled trial of tDSC in ‘post-stroke depression’ has 
revealed promising results.43 In addition, clinicaltrials.gov shows that it is currently 
investigated in a large RCT whether repetitive transcranial magnetic stimulation 
(rTMS) and/or aerobic exercise training (AET) may be beneficial for ‘post-stroke 
depression’.44 Since AET and rTMS are both stand-alone treatments applied to 
non-stroke related depression, it is important to also investigate their effects in 
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the stroke population. Both interventions can be applied to many types of stroke 
patients with depressive symptoms, independent of their cognitive impairments. 
Taken together, there are several studies investigating which treatment options 
are effective in improving depressive symptoms after stroke. These studies 
describe either a behavioral-psychological, physiological, or combined 
approach to search for a safe and effective treatment. Also, a first step towards 
the identification of different ‘post-stroke depression profiles’ has been taken.14 
Hopefully more knowledge about such profiles will lead to more effective and 
better individualized treatments for mood disorders after stroke. Regarding the 
many studies investigating what intervention to provide for whom, we may in the 
future be able to select a behavioral (only) intervention for cognitively impaired 
patients or consider NIBS, whereas we may choose ACT for patients with mild 
cognitive impairments or with low flexibility. 
Treatment for post-stroke depressive symptoms: how to assess and evaluate? 
In the present thesis we assessed depressive symptoms and symptoms of 
anxiety with the Hospital Anxiety and Depression Scale. The cut-off score that 
we used for depressive symptoms as an inclusion criterion (HADS-Depression 
subscale >7 at one point in time) did not correspond to the DSM definition of 
major depression.45 We purposively excluded patients with a major depression 
requiring medication, as well as patients with major depression in their pre-stroke 
history, as both groups were expected to be less receptive to a psychological 
intervention. We started the Restore4Stroke trial in the year 2010, assuming 
that the assessment of chronic fatigue would lead to an overestimation of 
mood problems. Therefore, we used the HADS as an assessment tool both for 
inclusion purposes and for evaluating the primary outcome of our trial, as it is not 
sensitive to chronic fatigue.46 De Man-Ginkel and colleagues7 used the Patient 
Health Questionnaire-9 as an assessment tool, with fatigue represented in an 
‘energy’ subscale.47 The large cohort study of De Man-Ginkel and colleagues 
provided not only clinical profiles of patients based on different cut-off scores 
on the PHQ-9, but also produced psychosocial profiles of non-depressed stroke 
patients, of depressed patients with symptomatic atherosclerotic diseases other 
than stroke, and of depressed patients in general practice. This makes the PHQ-9 
more appropriate as a diagnostic screening tool for research and practice than 
the HADS, as it even includes more somatic symptoms such as loss of appetite 
and sleep.7,48 In addition to the HADS, we used the Post Stroke Depression Rating 
Scale (PSDRS) as one of the secondary outcomes.49 The PSDRS is a scale that 
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assesses psychological, physical, and vegetative aspects of depressive symptoms 
after stroke. It provides important phenomenological information on how a 
patient experiences mood after stroke, based on questions about how he/she 
would react to specific situations, for example ‘when your team wins’, ‘when you 
watch an intimate scene on television’, or ‘when a little child walks in’. During 
the assessments, many of our patients recognized such situations and indicated 
that how they felt in these situations had changed, but that they hardly ever 
talked about it. The PSDRS seemed a valid addition to the HADS, but it had not 
yet been applied to the assessment of depressed mood in a research setting. If, 
in future research, we are able to stratify patients based on different psychosocial 
profiles and their expected response to different treatment options, it may be 
useful to add assessment tools that provide more qualitative information on how 
patients perceive and manage specific situations, and to improve the diagnostic 
accuracy of these ‘future’ profiles. The PSDRS may be useful in this respect. The 
HADS appeared to be a useful screening tool to distinguish between profiles 
in the study of White and colleagues.14 Yet, the qualitative study of White and 
colleagues13 showed that the locus of control (internal or external), coping and self-
efficacy seemed important indicators to establish profiles. The illness cognition 
questionnaire (ICQ, used in chapter 2) may also be of relevance, as it assesses 
feelings of helplessness, acceptance, and perceived benefits around illness.50 
Future research may use these assessment tools when validating psychosocial 
profiles of post-stroke depressive symptoms. 
In chapter 2 we investigated the factors that contribute to depressive symptoms 
one year after stroke. The results showed that psychological factors such as 
neuroticism and coping were important contributors. Yet, we did not include 
caregiver characteristics that may have played a role in the development 
of depressed mood in stroke patients. Kruithof and colleagues51 showed that 
both caregiver and patient characteristics in the sub-acute post stroke phase 
predicted caregiver outcomes one year later. Caregivers’ burden, anxiety and 
depressive symptoms, together with patients’ anxiety symptoms, were predictors 
of caregivers’ burden and anxiety symptoms one year after stroke. The authors 
stressed that professionals should pay attention to whether and how caregiver 
and patient influence each other and that they should be regarded from a dyadic 
perspective. Should assessment of depressive and anxiety symptoms after 
stroke therefore include caregivers as well? It would indeed be interesting to 
investigate the role of caregiver characteristics in the development of depressive 
symptoms and symptoms of anxiety in patients after stroke. This would have clear 
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implications for the role of caregivers in the treatment of emotional problems 
in these patients. Involvement in treatment or treatment for caregivers’ mood 
problems may have a positive influence on patients’ rehabilitation.  
Methodological considerations
We investigated patients with depressive post-stroke symptoms that were willing 
to participate in a trial. The original inclusion phase of one year was extended with 
another six months, because the inclusion rate was lower than we had expected. 
Therefore we cannot exclude that some eligible patients with depressive symptoms 
might have been too passive in terms of their behavior to be willing to participate 
in a trial, which would imply selection bias and limit the generalizability of our 
results. This general drawback of RCTs may have been relatively strong in our 
study, as we specifically aimed at patients with depressed mood. Regarding the 
design our trial, it would have been preferable to also include a no-treatment 
condition. Now, we had to descriptively compare both intervention groups to 
the results of the Restore4Stroke cohort study data from van Mierlo et al32 to 
estimate ‘spontaneous’ mood changes, but a valid comparison within our trial 
was not possible. However, enrolling patients in a no-intervention condition was 
problematic for ethical reasons, as eligible patients experienced severe distress 
and many of them were in need of some form of treatment. Inclusion of a no-
treatment arm might also have further slowed down the inclusion rate, as patients 
might not have accepted the possibility to be randomized to a no-intervention 
group and, thus, might have refused participation. We also might have included 
a waiting list control group who would have been randomized to either CBT or 
CCT after a no-intervention period. However, the duration of the current trial 
was already long for several reasons. Adding a waiting list period might, thus, 
have jeopardized the overall feasibility of the trial. 
Apart from the absence of a no-intervention control group, the main limitations 
of the present trial are the relatively small sample size and the recruitment 
through rehabilitation institutes, which may further limit the generalizability of 
our results. Next to that, because we expected that CBT would be favorable over 
CCT, the analyses in chapter 7 were aimed at the effects of the CBT intervention. 
Therefore, we provide only a societal perspective on the effects of CBT, not of 
CCT. Moreover, therapists from six different rehabilitation centers carried out our 
treatments, making monitoring of individual therapy sessions hard to accomplish. 
We provided training to all therapists and only experienced professionals were 
allowed to participate, but the CBT intervention was given with certain degrees 
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of freedom (e.g., building rapport, therapist characteristics). We do not know to 
what extent within-session factors, such as the role of the therapist, the ‘therapy 
alliance’, or patient compliance may have influenced the individual effects of the 
intervention. Indeed, therapy alliance seems to be an important factor for the 
outcome of psychological treatment.52 Therapy alliance is not just the ‘therapeutic 
relationship’, but reflects an emergent partnership and mutual collaboration 
between therapist and patient. In hindsight, we should have assessed therapy 
alliance, as it is a vital component of any therapy where the working relationship 
is important, such as in cognitive behavioral therapy. Therapy alliance can be 
easily measured after each session with the ‘Session Rating Scale’,53 ‘Outcome 
Rating Scale’,54 or ‘the Working Alliance Inventory’.55,56 Furthermore, it was our 
intention to assess patients’ participation in the therapy sessions, which could 
have provided indications about the client-therapist relationship. In chapter 3, 
we mentioned that the Pittsburgh Rehabilitation Participation Scale57 (PRPS) 
would be completed by the therapists after each therapy session. Unfortunately, 
there were too much missing data on the PRPS, possibly because it was the only 
assessment we asked of the therapists, while their focus was more on correctly 
following the treatment protocol. 
We already discussed that the patient and caregiver should be regarded from 
a dyadic perspective. In the risk factor study (chapter 2) we did not take into 
account the influence of the caregiver, although the role of social support is 
important. Social support from caregivers and others was not assessed throughout 
this thesis, but has an important ‘protective role’ against the development of post-
stroke depressive symptoms.58,59 It would have been interesting to see whether 
social support would have influenced goal attainment and therapy response in 
our trial. To this end, we could have included a social support questionnaire and 
have analyzed how social support might have mediated treatment response. 
Future perspectives
Although there are several study limitations to acknowledge, we conducted 
one of the first trials investigating the effect of CBT for post-stroke depressive 
symptoms. Moreover, we were the first to include caregiver data and to consider 
the cost-effectiveness and cost-utility of CBT compared to CCT. Apparently, well 
controlled (cost-)effectiveness studies of psychological treatment for post-stroke 
depressive symptoms are complex and hard to perform. Many more studies 
on this topic are needed to develop cost-effective interventions. However, 
this study is the first to provide an overview of the societal costs in this patient 
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population. Therefore, this study may serve as a benchmark for future cost-
effectiveness studies that investigate other psychological interventions within 
this patient population (e.g., acceptance and commitment therapy). Moreover, 
it may be important to stratify patients and their caregivers based on specific 
psychosocial profiles in order to individually target specific interventions to 
obtain the best long-term results. Future intervention studies would benefit from 
consensus on the terminology regarding depressive symptoms after stroke as 
well as from consensus on the standardized use of assessment tools for including 
and evaluating patients and caregivers. In addition, to investigate or monitor the 
impact of different intervention program elements (e.g., therapy alliance) on the 
analysis of effectiveness a process evaluation is recommended.60,61 
Risk analysis studies should further focus on psychosocial factors, including 
caregiver characteristics and social support, with the aim to determine 
psychosocial profiles that can be related to the risk of developing depressive or 
anxiety symptoms and to the response to psychological treatment. Timing is a 
critical factor in this respect, which may imply the need for specific interventions 
adjusted to the different phases post stroke. Future cost-effectiveness studies 
should take into account not only healthcare costs related to the patients with 
stroke, but integrate healthcare and societal costs related to both the patients and 
their caregivers.  
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Samenvatting
Depressie- en angstklachten komen veel voor in de chronische fase na het CVA 
(cardiovasculair accident), ofwel beroerte. Deze klachten hebben een negatieve 
invloed op revalidatie, sociale re-integratie en kwaliteit van leven. Momenteel 
is er geen zogenaamde evidencebased behandeling voor de klachten van deze 
groep patiënten bekend. Het doel van dit manuscript was daarom om een nieuwe 
behandeling, gebaseerd op cognitieve gedragstherapie (CGT) voor ‘reguliere’ 
depressie en aangepast op de doelgroep (patiënten na CVA), te ontwikkelen en 
evalueren. Om ondersteuning te bieden bij de praktische, activiteitsgerelateerde 
behandeldoelen van de patiënt werd de ‘aangepaste CGT’ aangevuld met een 
aantal individuele sessies met ergotherapie of bewegingsagogie. De nieuwe, 
aangepaste CGT-behandeling werd in een trial vergeleken met een controlegroep, 
waarbij de deelnemers een cognitieve training op de computer (CCT) kregen. 
In hoofdstuk 1 worden de fysieke en psychische consequenties van het CVA 
geïntroduceerd. In dit hoofdstuk beschrijven we verschillende behandelopties 
voor de psychische consequenties zoals depressieve klachten. Daarnaast wordt 
onderbouwd waarom we een psychologische benadering gekozen hebben voor 
deze klachten in dit manuscript. 
Vervolgens presenteren we de onderstaande centrale onderzoeksvragen van het 
manuscript:
1. Zijn psychische factoren belangrijke risicofactoren voor depressieve 
klachten na een beroerte?
2. Uit welke onderdelen zou een aangepaste CGT-behandeling moeten 
bestaan wanneer we kijken naar de fysieke, cognitieve en emotionele 
gevolgen van een beroerte? 
3. Is een dergelijke aangepaste CGT-behandeling effectief om 
depressieklachten te reduceren, om sociale re-integratie te stimuleren en 
om kwaliteit van leven te verbeteren? 
4. Heeft deze aangepaste CGT-behandeling ook een positief effect op de 
ervaren last van partners van patiënten? 
5. Is de aangepaste CGT-behandeling vanuit een economisch perspectief 
effectief?
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In hoofdstuk twee behandelen we de eerste onderzoeksvraag. De 
Restore4Stroke Cohort-studie (met een longitudinaal design)  leverde data 
waarmee we berekenden of psychische factoren van invloed zijn bij het krijgen 
van depressie- en angstklachten één jaar na het CVA. Deze klachten zijn de 
meest voorkomende emotionele klachten na een beroerte. Wanneer we meer 
te weten komen over de factoren die van invloed zijn bij het ontstaan van deze 
klachten, zijn we beter in staat om passende preventieve en behandelstrategieën 
toe te passen op deze beelden. De risicofactoren die in eerdere studies werden 
onderzocht zijn voornamelijk sociaal-demografisch, premorbide of CVA-
gerelateerd, maar de psychische factoren werden veelal buiten beschouwing 
gelaten. De studies die de psychische factoren wél onderzochten, hadden ofwel 
lage respondentaantallen, of gebruikten een cross-sectioneel onderzoeksdesign, 
of bekeken slechts een select aantal psychische factoren. Kortom, geen van 
deze studies laat enige voorspellende waarden zien van dit soort risicofactoren, 
waardoor de klinische toepassing van de resultaten beperkt blijft. Dit hoofdstuk 
(2) laat zien wat de relatieve bijdrage was van sociaal-demografische, premorbide 
en psychische factoren bij het ontwikkelen van depressie- en angstklachten 
één jaar na beroerte. Het onderzoek werd gedaan met data afkomstig van een 
groot cohort van subacute CVA-patiënten (n=331), die werden gerekruteerd in 
zes perifere ziekenhuizen met CVA-afdelingen in Nederland. We hebben de 
longitudinale data gebruikt om modellen te berekenen die de voorspellende 
waarde van mogelijke risicofactoren voor depressie- en angstklachten na CVA 
weergeven. Aanvullend op deze calculaties hebben we middels zogenaamde 
‘nomogrammen’ visueel weergegeven wat de predictieve bijdrage is van elke 
individuele risicofactor uit beide modellen (d.w.z. voor angst en depressie). Alle 
deelnemers werden in het ziekenhuis, enkele dagen na het CVA, in de studie 
geïncludeerd. Daarna werden ze op twee en twaalf maanden na het CVA 
gemeten met verschillende vragenlijsten. Rond de opname van de deelnemers 
in het ziekenhuis werden hun sociaal-demografische, premorbide en CVA-
gerelateerde gegevens verzameld. Informatie over de psychische factoren werd 
verzameld door middel van de metingen die plaatsvonden twee en twaalf 
maanden na opname. Tevens werden de depressie- en angstklachten op deze 
beide momenten gemeten. Hiervoor gebruikten we de twee schalen van de 
Hospital Anxiety and Depression Scale (subschalen Angst en Depressie van de 
HADS). Er werd een multivariate logistische analyse uitgevoerd om de modellen 
te berekenen die de belangrijkste risicofactoren voor het ontwikkelen van deze 
klachten lieten zien (we spreken over depressie- en angstklachten als de scores 
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op bijbehorende subschalen op de HADS boven de 7 zijn). Uit deze analyses 
bleken de belangrijkste risicofactoren voor het ontwikkelen van depressieve 
klachten één jaar na het CVA: vroege depressieklachten, ernst van het CVA, 
locatie van het CVA (achterste hersenslagader) en neuroticisme. Deze factoren 
verklaarden onafhankelijk van elkaar de variantie van de depressieve klachten 
één jaar na CVA. Voor het ontwikkelen van de angstklachten liet het model 
zien dat de belangrijkste risicofactoren ‘neuroticisme’ en ‘vroege angstklachten’ 
waren. Deze twee factoren verklaarden onafhankelijk van elkaar de variantie 
voor angstklachten één jaar na CVA. Uit deze resultaten concludeerden we dat 
psychische factoren sterkere risicofactoren zijn voor depressie- en angstklachten 
een jaar na CVA dan eerder werd gedacht. Op psychische factoren kunnen 
we, in tegenstelling tot de meeste sociaal-demografische, premorbide of CVA-
gerelateerde factoren, preventief of curatief inspelen. Hiermee leveren deze 
resultaten een significante klinische bijdrage aan de preventie en behandeling 
van emotionele klachten na CVA.  
De resultaten uit hoofdstuk twee geven aanleiding om een psychologische 
benadering te hanteren bij behandeling van depressieve klachten na beroerte. 
Omdat er nog geen evidencebased behandeling voor dergelijke klachten 
bestaat, hebben we een nieuwe psychologische behandeling, gebaseerd op 
CGT, ontwikkeld. Deze presenteren we in hoofdstuk drie. In dit hoofdstuk 
beantwoordden we daarmee de tweede onderzoeksvraag. Eerder onderzoek 
naar depressie in de algemene populatie liet zien dat CGT een waardevolle 
behandelingsmethode kan zijn. Onze interventie is gebaseerd op CGT-principes. 
In de eerder uitgevoerde pilotstudie liet dit behandelprotocol positieve resultaten 
zien. De behandeling die wij ontwikkelden is gericht op de behoefte van de CVA-
patiënt. Dit betekent dat we gelet hebben op de sensorimotorische, cognitieve 
én gedragsproblemen die gepaard kunnen gaan met depressieve klachten na 
CVA. We hebben daarom in het behandelprotocol elementen ingevoegd 
als motiverende gespreksvoering, rouwverwerking en psycho-educatie. 
Daarnaast benadrukten we dat de behandelaar in elke bijeenkomst rekening 
houdt met mogelijke cognitieve beperkingen van de patiënt en communiceert 
middels de CRASS-principes (d.w.z.: bieden van duidelijkheid en helderheid, 
toegankelijkheid, structuur, herhaling en tempoaanpassingen). De patiënt werd 
tijdens de behandeling gestimuleerd om behandeldoelen te stellen die activiteits- 
of sociaal gerelateerd waren.  Om deze doelen te behalen vulden we het deel 
van de behandeling dat door de psycholoog wordt verzorgd aan met een optie 
voor ergotherapie of bewegingsagogie, afhankelijk van wat de specifieke doelen 
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van de patiënt waren. De hele behandeling bestond uit twaalf bijeenkomsten 
van één uur met een psycholoog,  en daarnaast drie of vier sessies van één 
uur met de ergotherapeut of bewegingsagoog. Dit protocol is innovatief, omdat 
het traditionele CGT benadert vanuit het perspectief van de CVA-patiënt en 
omdat het aanzet tot halen van doelen door o.a. de aanvulling vanuit de andere 
disciplines. 
Hoofdstuk vier beschrijft het protocol van het onderzoek, ofwel de methode van 
de Restore4Stroke-studie. Onze verwachting was dat patiënten die behandeld 
werden met de, op hun individuele behoefte aangepaste, CGT, een verbetering 
in depressieklachten lieten zien op de HADS ten opzichte van de patiënten 
die de cognitieve training (CCT) ontvingen. Naast de resultaten van de HADS 
bekeken we ook enkele secundaire uitkomstmaten, zoals kwaliteit van leven 
(Stroke Specific Quality of Life scale), sociale participatie (Utrechtse Schaal voor 
Evaluatie van Revalidatie – Participatie) en angstklachten (HADS-subschaal Angst). 
Ook hebben we naar data gekeken van de partners van de CVA-patiënten tijdens 
de trial. We verwachtten voor de partners dat zij een verbetering op ervaren 
last (vanuit emotioneel en praktisch perspectief) zouden laten zien wanneer hun 
‘patiëntpartner’ in de CGT-groep zou deelnemen. De effectmeting van de CGT-
behandeling werd met een ‘multicenter gerandomiseerde gecontroleerde trial’ 
(RCT) uitgevoerd, waarbij de assessor geblindeerd was. Een steekproef uit de 
patiëntpopulatie met depressieve klachten na het CVA werd gerandomiseerd 
ingedeeld in ofwel de experimentele groep (CGT), ofwel de controlegroep (CCT). 
Op vier tijdsmomenten per deelnemer vonden metingen plaats: voorafgaand aan 
de randomisatie, direct na de behandeling, en vier en acht maanden na afloop 
van de behandeling. Deze studie is de eerste RCT die de (langetermijn)effecten 
van een CGT-behandeling voor depressieve klachten na CVA heeft onderzocht 
Hoofdstuk vijf beschrijft de resultaten van de studie vanuit patiëntperspectief. 61 
patiënten namen deel aan de studie. De CGT-groep bestond uit 31 patiënten en de 
CCT-groep telde 30 patiënten. De analyse die we gebruikten voor de effectmeting 
was ‘lineair mixed models’ voor herhaalde metingen. De resultaten lieten zien 
dat er voor beide groepen een significante vermindering van depressieklachten 
in tijd bestond. Daarnaast werden positieve resultaten gevonden voor beide 
groepen voor angstklachten, sociale participatie en kwaliteit van leven. 
Let wel, er werd geen significante interactie (groep x tijd) gevonden op alle 
gebruikte uitkomstmaten. Deze resultaten impliceren dat de CGT-interventie 
niet beter werkte op depressieklachten dan dat de CCT deed wanneer de 
patiëntgerelateerde uitkomstmaten werden bekeken. 
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De vierde onderzoeksvraag wordt in hoofdstuk zes behandeld. Omdat depressie- 
en angstklachten van patiënten na de beroerte een negatief effect kunnen hebben 
op het welbevinden van hun partners, werden partners van de deelnemers ook 
uitgenodigd om mee te doen aan de Restore4Stroke-studie. We onderzochten 
de emotionele last (Involvement Evaluation Questionnaire for Brain Injury / IEQ-
BI), praktische last (Caregiver Strain Index), mentale gezondheid (General Health 
Questionnaire) en emotionele klachten (HADS). In totaal namen 50 partners 
deel aan de studie. Zij werden gelijk met hun ‘patiëntpartner’ uitgenodigd om 
vragenlijsten in te vullen voorafgaand, direct na, en vier en acht maanden na het 
einde van de behandeling. We gebruikten, net als bij de patiënttrial, ‘linear mixed 
models’ voor herhaalde metingen in de statistische analyse. In tegenstelling tot de 
resultaten van de patiëntdata, lieten de resultaten van de partners wel verschillen 
zien tussen de behandelcondities. Partners in de CGT-groep lieten betere 
scores zien voor mentale gezondheid en ze maakten zich minder zorgen over 
het welbevinden van hun patiëntpartner na de interventie. Daarnaast werden 
positieve effecten voor ‘tijd’ gevonden op de schalen ‘worrying’ (zorgen maken), 
‘supervision’ (toezicht houden), en ‘tension’ (ervaren spanning). Deze resultaten 
zijn opmerkelijk, gezien het gebrek aan verschillen tussen de behandelcondities 
bij de patiëntdata. In tegenstelling tot de resultaten van de patiënttrial, lijkt de 
CGT-behandeling een positief effect te hebben op het welbevinden van de 
patiëntpartners. 
De laatste onderzoeksvraag wordt in hoofdstuk zeven behandeld. Hier 
beschrijven we de resultaten van van de trial vanuit een maatschappelijk-
economisch perspectief. Depressieve klachten na een beroerte zijn gerelateerd aan 
verhoogd gebruik van zorgfaciliteiten waardoor substantiële zorgkosten worden 
veroorzaakt. Deze studie beschrijft de kosteneffectiviteit en kostenutiliteit van de 
CGT groep in vergelijking met CogniPlus (CCT) als controle interventie. Primaire 
uitkomstmaten van deze studie waren de HADS en Quality Adjusted Life Years 
(QALYs) gebaseerd op de five-dimensional EuroQol (EQ-5D-3L). De 61 patiënten 
uit de trial hebben ook deze vragenlijsten afgenomen op alle tijdsmomenten 
genoemd in de patiënt trial. De gemiddelde totale maatschappelijke kosten 
verschilden niet significant tussen de AGT interventiegroep (€8,063.7) en de 
CogniPlus controlegroep (€9,998.3), met een 95% betrouwbaarheidsinterval van 
-5,284, 1,796. De resultaten van deze studie laten zien dat de groep patiënten 
lagere kosten en lagere effecten laten zien op de HADS, en lagere kosten en 
hogere effecten voor de QALY wat duidt op een dominante incrementele 
kosteneffectiviteitsratio. Met een aangenomen te betalen prijs van €40,000 
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per QALY, heeft de CGT interventie 76% kans om kosteneffectief te zijn. Alle 
sensitiviteitsanalyses gaven aan dat keuzes gemaakt in de oorspronkelijke 
analyse robuust waren. Concluderend moet gesteld worden dat de resultaten 
van deze studie met betrekking tot de kosteneffectiviteit van de AGT interventie 
niet overtuigend genoeg zijn. 
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Dankwoord
Het manuscript is klaar, de voorbereidingen zijn klaar. Wie dit leest heeft het 
gedrukte proefschrift vast en doorgebladerd tot de laatste pagina’s. Ik ben een 
grote hap volwassenheid verder waarin ik veel waardevols heb geleerd. Zo’n 
lange periode doe je niet alleen. Daarom is een woord van dank op zijn plaats.
Allereerst, de uitvoering van dit traject was lang niet zo leerzaam en succesvol 
geweest zonder begeleidingsteam. Sander, allereerst bedankt. Wat je mij mee 
geeft is niet enkel binnen de wetenschappelijke wereld in te zetten. ‘Geen glans 
zonder frictie’; waardoor ik het nut van frictie meer zie, frictie meer aanga en 
er hogere tolerantie voor kreeg. Ook hebben we gesteggeld over wat nu precies 
professioneel handelen is, terwijl je integriteit bewaart. Of, dat een begeleider 
soms hard aan de fundamenten schud om je steviger in je schoenen te krijgen. 
Op het moment niet per se leuk, maar achteraf onherstelbaar waardevol. Voor 
mij niet alleen nuttig in de loop van mijn leven, ik poog dit mijn eigen studenten 
nu ook mee te geven. Jammer dat het af is.
Luciano, ik ken niemand zo uniek zoals jij. Onze besprekingen waren zelden 
zoals ik ze vooraf plande, de agenda was nooit leidend maar je hebt altijd 
aandacht voor wat er toe doet in het moment. Je hebt veel aandacht voor het 
proces, en hebt me tot de dag van vandaag geholpen de zaken wat luchtiger te 
zien en vanuit een ander perspectief mijn problemen te benaderen. Wat leuk om 
je in Australië ook te zien, dank voor de Castro Marina tips en ik heb genoten 
van het grote onderzoekersdiner bij jou thuis. 
Mijn Co-promotor, Sascha, bedankt dat je me zo’n goed stuk op weg hebt 
geholpen in een wereld die ik nog niet kende, waarin andere regels gelden en 
hoe ik terwijl ik mezelf behoud, daar dan mee om kan gaan. Zeker in die eerste 
jaren was je support en advies super waardevol. En daarnaast was het altijd 
gezellig, dank. Koffie in Kubiko, ik kom zo weer naar Maastricht hoor! 
Caroline, de afspraken met het hele promotieteam zijn denk ik op 1 hand te 
tellen. Toch heb ik jou naar mijn idee geregeld gezien. Het was goed dat jij de 
verbinding altijd maakte tussen de vier projecten. Ook heb je tot op het laatst je 
helpende hand aangeboden, en heb je altijd een andere kijk op de zaak, wat je 
inbreng waardevol maakt. 
Naast dit team heb ik de onderzoekers van Restore4Stroke veel gezien, Nienke, 
Marloes, Mitchel, namens deze Restore4Stroke hekkensluiter dank en veel succes 
voor jullie professionele toekomst. Mitchel, ik mocht jou bijstaan in Maastricht, 
ik ben heel blij dat jij er nu ook bij mij bij kan zijn. Wat hebben we veel aan 
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elkaar gehad in dit traject! Bijzonder dat onze carrières per toeval op elkaar 
lijken nu.. Op dat we dat maar vaak mogen nabespreken met een goed glas in 
etablissementen in Utrecht en Den Bosch.
Dit onderzoek was onderdeel van een groter project; Restore4Stroke, waar 
Anne, Caroline en Sander het bestuur vormden dat geregeld samenkwam met al 
zijn consortiumleden: Allen bedankt voor inhoudelijke feedback op de projecten 
en prettige sfeer bij alle bijeenkomsten. Wij jonge onderzoekers hebben ons 
daardoor een gewaardeerd onderdeel gevoeld van het project.  
Een bijzonder woord van dank aan alle deelnemers van de studie: mensen die na 
het CVA depressieve klachten ervaren, en hun partners. Het was voor sommigen 
spannend om mee te doen met een trial waarin een controle groep en een 
experimentele groep zou plaatsvinden. Voor anderen was deze trial precies waar 
de behoefte lag. 
De inclusie verliep niet zo succesvol als verwacht, misschien hebben we de 
doelgroep overschat, en is meedoen aan een trial niet natuurlijk voor iemand 
die somberder en passiever in het leven staat dan vroeger. Maar nadat het 
krantenartikel in De Gelderlander verscheen, en er >100 telefoontjes de dag 
erna binnenstroomden, werd duidelijk dat het probleem wel degelijk urgent is. Ik 
heb zoveel verhalen van jullie mogen horen, de beleving van de klachten is per 
individu zo anders. Toch hebben jullie dit manuscript voor mij ‘gezicht’ gegeven. 
Het is voor mij meer dan logisch dat de voorkant van deze thesis op een van 
jullie verhalen is geïnspireerd. Dank. 
De dataverzameling van dit project was niet tot stand gekomen zonder de 
medewerking van de revalidatiecentra, en van al deze centra de mensen 
van deze secretariaten, die altijd, zelfs op korte termijn testruimtes voor ons 
regelden. Frits Lem in de Sint Maartenskliniek, Nijmegen; Luciano, uiteraard in 
Groot Klimmendaal, Arnhem; Tim Vaessen in (voor hem toen nog) VieCurie 
Venlo; Danny Mennen in Adelante zorgcentrum, Hoensbroek; Ineke Kortland 
van Tolbrug revalidatie in Den Bosch; Leoni Vlutters in Roessingh centrum van 
Revalidatie te Enschede;  en ViaReva in Apeldoorn en Deventer.
Omdat de assessment onderzoekers ‘blind’ moesten zijn bij afname vragenlijsten 
na T0, had ik student assistenten nodig die deze workload konden managen. 
Michelle Collignon en Bart Kral hebben het merendeel van de ruwe 
dataverzameling verzorgd. De ene bracht de ander binnen en een eigenwijs 
maar verantwoordelijk en zelfstandig team was geboren. Wat heb ik veel aan 
jullie gehad, waar mijn talent niet lag, stonden jullie klaar met oplossingen. Bart, 
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je hebt zoveel lichtheid en humor gebracht in een project waarin ik de bomen 
door het bos niet meer zag, de handen in het haar had of de door jou genaamde 
‘Monstro modus’ aan had. Je kwam binnen als onderzoeksassistent bij de OTip 
studie, werd mijn assistent in de penthouse en het holletje, en ik mocht je 
begeleiden in je onderzoeksstage, wat resulteerde in het partner artikel. Jij nu 
op een toffe plek bij de Sint Maartenskliniek, ik bij de HAN, wat leuk dat onze 
loopbanen blijven kruisen. Je hebt een groot aandeel gehad in mijn ontspanning 
tijdens de uitvoer van dit traject en ik ben heel blij dat jij mijn paranimf bent en 
kan zijn. 
Op dag drie na mijn aanstelling werd ik gered door Chantal. Dank dat je me 
meenam naar de onderzoekersgang, waarvan ik het bestaan niet wist, en dat 
je me een plek gaf in jullie kamer met Merel en Annemieke. Edith en Ingrid, 
kamergenoten na de verhuizing naar de Penthouse. We zaten ver weg, maar 
wat hebben we het leuk gehad en genoten van het uitzicht. Dank dat jullie altijd 
een luisterend oor hadden als ik op de praatstoel zat (altijd), of als ik met al 
mijn energie weer door het kantoor hupste. Dat werd nog een grotere uitdaging 
toen we verhuisden naar het (nog kleinere kantoor) holletje. Edith, fijn dat je 
zo’n mooie carriere-stap kon maken maar daarbij onze buurvrouw bleef. Ingrid, 
twee mensen kunnen haast niet meer verschillen dan wij, maar wat heb ik 
het fijn gevonden dat jij mijn vaste kamerbuddy bleef. Samen met Yvonne en 
de andere holbewoners hebben we er wat fijns van gemaakt daar op de ergo 
afdeling. Lieve ergo’s, dank voor jullie gezellige aanwezigheid en warme welkom 
in de ergo keuken. Naast kamergenoten zijn ook de Radboudonderzoekers een 
belangrijk deel van deze onderzoekjaren geweest: Geert, Mariska, Digna, Sjoerd, 
Roland, Jorik, Hanneke (feestjes in steegjes in Istanbul), Vivian, Edzo, Arjen, Bas 
(Domstad-open terechte winnaars GD3) en Jolanda. 
Van deze groep de mensen die in het vriendenschap zijn beland: Noortje – van 
9 tot 5 met ons hoofd in de data, maar daarbuiten hebben we heel hard kunnen 
feesten, wat was het leuk! Mark de N, wat leuk dat we buren zijn, ik soms 
de oppas ben, jij het proefschrift edit, we collega’s bij de HAN zijn, we met 
scHANdalig onsuccesvol deelnemen aan de pubquiz , zwaaien op de koekoek 
met Siem en Louke, Dieuwke mij bijstaat in zware tijden, de fotografie van het 
proefschrift deed…dit is wel echt het vriend ‘schap’ hoor, komaan.
Lieve Djoek & Mark, super bedankt! 
Frankie, ‘whatzup with the wack playstation zup’? Koffie voor life, en mede 
Utrecht strijder. Lotus, je bent echt zo’n fijne aanvulling geweest op, de geregeld, 
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zo saaie onderzoeksdagen. Van Pegatina naar DTRH naar surf in Portugal, 
mede-fashionista online shop addict…wanneer zetten we onze tent weer eens 
op ergens? (ik neem de handleiding mee). Anne, we hebben elkaar ontmoet 
bij het koffie automaat op de gang, jij bij de logo’s, ik van de onderzoekers, ik 
was luid en jij nieuwsgierig naar die kabaalmaker. Vele jaren, festivals, liefdes, 
vakantietjes, huisfeestjes, shopsessies, en koffietjes verder zijn we nog altijd dikke 
vriendinnen, ik hoop dat we nog lang samen doorfladderen. 
Ik heb niet met ze samengewerkt, maar ook zij vonden mij bij het koffie automaat 
op de afdeling: Hanneke K, Simone, Imelda, Mark S, Harmen, Margina, Laurien, 
en vele anderen. Dank voor de Radboud tijd. En dank aan prof. Andries Hoitsma, 
die mij binnen NCEBP als mentor bijstond deze jaren.
Mijn lieve collega’s van Toegepaste Psychologie bij de HAN hebben me de 
laatste jaren van dit project enorm geholpen. Jullie geven me een plek om te 
ontwikkelen en geven me speelruimte om te spelen, ze geven me waardering en 
vertrouwen waar mijn zelfvertrouwen mag groeien en groeit. Ik kan en mag er 
met al mijn energie, of gebrek eraan zijn. Ik ben geïnspireerd, en jullie willen naar 
me luisteren. Het was zo fijn landen in jullie team na een toch wat solistisch PhD 
traject, waarvoor onwijs dank. Rian, de afronding van mijn proefschrift viel samen 
met een paar heftige projecten voor ons, dank voor het begrip en aandacht als 
ik vertel over het project dat ik er nog ff bij doe. Gijs, fellow onderzoeker, op stel 
en sprong figuurtjes voor mij maken..dank! Wat is ons volgende project? Nique, 
je bent voor mij een lot uit de loterij, wanneer gaan we de wereld veroveren?
Hoe ben ik beland in het onderzoek? 
Marjolein, je wist op een of andere manier een knop bij me te vinden waardoor 
ik erachter kwam dat een deel van mij heel gelukkig wordt van een Excel sheet. 
Je was begeleider in mijn Bachelor én Master onderzoek en ik vond met jou 
de rubber hand :). Daarna was je er ook toen ik in Londen mijn tweede Master 
deed en jij daar aan UCL onderzoek deed en werden we vrienden. Ik was er bij 
jouw defence, ik weet dat jij hier graag bij had willen zijn, maar dat Melbourne 
– Nijmegen lastig is. Goed dat jij, Hinze en de kids daar zo blij zijn. 
Erik M, veel avonturen beleefd met jou! We hebben nooit gepubliceerd maar bij 
jou vond ik wél antwoorden en tegelijk meer onderzoeksvragen in de combinatie 
neuro, (top) talent en prestatie die mij tot de dag van vandaag inhoudelijk boeit. 
Wie weet wat de toekomst brengt. 
Melinda, from day one at London Met we were buddies. You gave me a big 
175Dankwoord
insight in what ‘being an independent professional’ meant. You inspired me by 
being you and encouraged me to perform, and to perform better than I thought 
I could. I do not know if you will make it today, but the proportion of variance 
explained by your influence on my performance in this project is definitely 
significant, thank you for that!
Hoe bleef ik gezond?
Alle mensen die koffietjes met mij drinken, met mij eten, met mij feesten, met mij 
relaxen, sporten of goede gesprekken voeren. 
De kippen van de Notebomenlaan.. Lou, Nijn, Suus, Liek, Lin, Lies, Mai, Han… 
Wie had kunnen denken dat na ons aller uitvliegen het leven deze wendingen 
zou nemen? Nijnes, ik ben zo blij dat je nog zo dichtbij bent en woont.. Vanaf 
dag 1 in Utrecht waren we een team. Op onze eigen manier hebben we pittige 
jaren gehad, maar het wordt langzaamaan lichter en er is zo meteen écht tijd 
voor dat jubileum. Liek, aan het begin van dit PhD traject zag jouw leventje er 
heel anders uit.. Ik ben blij dat deze PhD-job ruimte bood om er voor jou te 
kunnen zijn toen het nodig was. Het is zo heftig geweest en ik ben zo trots op 
waar je nu staat en het Studio Lieke Sanders succes. Mai, ik mis John met je mee. 
Ik ben onder de indruk van hoe je al die tijd aandacht en interesse voor anderen 
inclusief mij hebt getoond. Ik kijk zó uit naar volgende maand, waar we midden 
Amerika onveilig(er) gaan maken. Je kan er niet zijn vandaag, maar je was een 
dikke steun en toeverlaat. Suus, je hebt me wederom met mach 3 ingehaald, ik 
ben blij dat ik je je mede PhD-kip word! Lin, jouw advies om naar Evelien te 
gaan gaf me een heel belangrijk tikkie de goede kant op, en zorgt er tot op de 
dag van vandaag voor dat ik beter door het leven rol. 
Dan, de Denders, ook studententijdrestanten. Jullie onuitputtelijke interesse 
voor hoe het mij vergaat in dit traject is hartverwarmend geweest. Onze 
ardenderweekendjes zijn bijna helend, ik kwam vaak helemaal kapot binnen 
en kon er altijd na een aantal dagen bijtanken (gedeelde calorieën zijn halve 
calorieën) weer tegenaan. Ik mocht met jullie 29 worden op Ibiza, sommigen van 
ons gaan nu al richting de 40. We worden oud maar we blijven luid. Ik kijk uit 
naar onze tijd in het culinaire verzorgcentrum. 
Marco & Kim, al jaren kan ik die éne vrije dag die ik heb bij jullie terecht voor 
wat slappe ouwehoer of goede gesprekken. De koffie is in jaren niet zo goed 
geweest, en de spontane avonden aan de Lebowski bar zijn legendarisch. 
Natuurlijk feesten we vanavond bij jullie! 
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Flokkie, kom maar snel weer in Nederland wonen, het is nog leuker aan de 
bar mét jou. We wisselden de wacht in Londinium, wat hebben we daar toffe 
weekendjes gehad, Ik hoop dat Tallinn net zo leuk wordt! 
De vrienden uit Den Helder, wat bijzonder dat er zo lang na mijn vertrek (>16 
jaar inmiddels) nog altijd fijn contact is. Het is altijd fijn terugkomen naar het 
Helderse en jullie zijn altijd nog zo lief en geïnteresseerd. Ik blijf vast spontaan 
verschijnen op feestjes maar met mijn Nijmegen job te weinig in het Helderse 
te vinden. 
Lel en Pienk, we doen maar in dit grotemensenleven. Maar nooit voelt het anders 
dan of als vroeger. We zien elkaar weinig maar ik ben zo blij dat we nog dikke 
vriendinnen zijn..
Elske, Cas, Roland, Arthur.. wat gaaf dat we elkaar weer zo gevonden hebben nu 
we groot zijn. 
Mijn tenniscarrière is voorlopig ten einde, maar heeft me veel opgeleverd. Jelle, 
we hebben nauwelijks een bal geslagen, maar je hebt me veelvuldig gepoogd 
door dit project heen te sleuren. Vaak met iets in de trant van ‘niet zeuren’, of 
‘over geld praat je niet…’. Een van je sterkste quotes: ‘Just finish the g***damn 
proefschrift’. Óf het hielp dont know.. Wat zeker hielp waren onze vele 
zondagmiddagborrels, de domstadfeestjes en altijd de donkerste humor van de 
bovenste plank. Redgie, ook jij bent van een dergelijke soort. Wat kan ik met je 
lachen!! Het leven is lichter met jou, tof dat je er al die tijd bent. 
Marc en Carol, ik ben zo blij met jullie zo dichtbij. Wat begon met 
zondagmiddagborrels tijdens de studententijd is gebleven. Carol, koffie drinken 
begon bij jou. Na jaaren mentale investering is het je gelukt mij aan de koffie te 
krijgen. En hoe. Onze vriendinnen van de Rocking Chair koffietent vragen waar 
de rest van de familie is als een van ons alleen binnen komt… Jullie zijn al jaren 
een superfijne constante factor in mijn leven. In betere en mindere tijden zijn 
jullie er gewoon altijd. En niet in de minste plaats: de beste cure voor alles zijn 
knuffels van Nora en Boris. Marc, ik weet dat je er klaar voor bent om me te 
coachen als paranimf vandaag.
Dan mijn lieve familie.
Ik ben de zoveelste Kootker nicht op rij die promoveert, we moeten wel oppassen 
dat het niet normaal wordt. Ik kijk altijd uit naar de Kootker feestjes. Ik hoop dat 
we deze in de boeken kunnen bijschrijven.. Mo, onwijs tof dat we de laatste 
jaren met elkaar op pad gaan, en wat bijzonder dat de M-Company mij voor 
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deze gelegenheid ondersteunt!
Ze is er helaas niet meer bij, maar mijn Oma Gees, betaalde mijn ticket naar 
Nederland voor het sollicitatiegesprek voor deze baan, en maakte daarmee het 
begin van mijn wetenschappelijke carriere mogelijk. Mijn tante Janneke, dank 
dat je me af en toe op vitale momenten in mijn carriere van advies voorziet. Een 
opleiding in Londen, een huis kopen, medische klachten, en een zetje in de rug 
bij de planning van deze laatste fase. Blij dat je er voor mijn lieve moeders bent 
in goede en mindere tijden!
Zus(je), je bent me er eentje en je blijft altijd mijn zus. Ik heb genoten van de 
culinair hoogstaande avonden met Paul, de kerstdiners, de bbq’s.. Die tijd ligt 
achter jou, je gaat nu met Thom en Elise een nieuw hoofdstuk aan.
Lieve As, je hoort in dit laatste deel van mijn dankwoord. Je bent al sinds mijn 
tienertijd een belangrijke persoon in mijn leven. Eerst als stiefmama, toen als 
ex-stiefmama. Jij maakt verschil. Je inspireert mij, je opende mijn ogen voor de 
wereld van de kunst en cultuur. Later werd dat de psychologie. En tegenwoordig 
zijn onze gesprekken haast van filosofische, en soms spirituele aard. Meer reisjes 
en tripjes naar lommerrijke omgevingen met jou! 
Mam en Henk, jullie hebben het maar met me te doen. Ik vlieg weg naar Utrecht, 
en omdat dat niet ver genoeg was, nam ik een uitstap(je) naar Londen, en bleef 
ik vervolgens half in Nijmegen hangen. Ik leef soms op mijn eigen eiland, maar 
ik weet dat jullie er altijd voor me zijn, dank.  
Vaders, dit avontuur begon bij jou. In een tapastent in London Spitalfields, 
december 2009. Je vroeg: “Joyce, wat ga je hierna doen met je leven?”. In dat 
gesprek was jouw advies om zo lang mogelijk te leren in dit leven. Dank je wel 
voor deze aanzet tot het uitzetten van deze juiste koers. Ik weet dat je trots bent 
op mij en dat vind ik tof.
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For a successful research Institute, it is vital to train the next generation of young 
scientists. To achieve this goal, the Donders Institute for Brain, Cognition and 
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(DGCN), which was officially recognised as a national graduate school in 2009. 
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